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 i 
Abstract 
 
Synthetic targets that mimic key structural and conformational features in proteins are 
of intense scientific interest. These structures can reproduce the biological activity of their 
naturally occurring counterparts, while improving their properties in vivo. This project focuses 
on the synthesis of -turn mimetic structures, based on the opioid pentapeptide leu-enkephalin. 
More specifically, the target mimetics in this project are based on the enkephalin derivative, 
leu-enkephalinamide. 
 
 
 
Leu-enkephalin is conformationally very flexible, giving it the ability to bind to 
different opioid receptors. This results not only in the physiological relief of pain, but also in 
various potential side effects such as miosis or physical dependency. Natural peptide 
structures also have limited suitability for drug applications because of their poor transport 
properties and their tendency to undergo proteolytic degradation. The synthesis of macrocyclic 
mimetics can overcome these problems and give a conformationally rigid molecule that 
exhibits a desired biological activity. 
This thesis will discuss some published examples of β-turn mimetic structures that 
have been designed and synthesised by research groups working in this field. The examples 
that are shown have been chosen to illustrate some of the work that has taken place in this area 
over recent years. Advances in the synthesis of ynamides and other ynamine analogues is also 
discussed, due to the importance of this type of chemistry in the research project. 
Efforts towards the synthesis of several 10-membered macrocycles are described 
herein. The target structures are model compounds that are designed to explore varied 
chemical approaches towards such ring systems. This thesis will discuss the synthesis of 
several linear precursors to the proposed macrocycles and efforts to cyclise these structures to 
form the desired targets. 
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The targets that were synthesized employed varied approaches to the key cyclisation 
reaction. Initially, a metal-mediated coupling approach to an ynamide target was chosen. This 
was subsequently refined by including a proline residue in the linear precursor to bring the 
reacting groups into closer proximity. Finally, several approaches were investigated to close 
an alkyne bonded macrocycle by coupling the amide functionality at the opposite side of the 
ring. 
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Chapter 1 
Introduction 
 
1.1 Proteins, Peptides and their Folding 
 
1.1.1 Amino Acids: Protein Building Blocks 
In nature there are thousands of different peptides and proteins all with their own 
unique properties. These structures can be accurately described as chains, or polymers, of 
amino acids held together using amide bonding units. These structures are all synthesised from 
a group of 20 naturally occurring amino acids that are displayed in Figure 1.
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Figure 1: 20 Naturally Occurring α-Amino Acids 
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An amino acid is a structure consisting of a carboxylic acid and a primary amine 
located on either terminus, connected by an alkyl carbon unit with a functionalised side chain. 
The naturally occurring amino acids all have their unique functionality located on the carbon α 
to the carbonyl group, hence are referred to as α-amino acids. 
Any peptide or protein that is isolated in nature can be attributed to some combination 
of these structures held together by amide bonds. These can be as small as a dipeptide, 
containing just two amino acid residues, or as large as a polypeptide, containing hundreds, if 
not thousands, of residues. Due to the variation in chain length and the number of possible 
combinations of residues, the diversity of protein and peptide structures is staggering. 
Similarly, the applications of these proteins are just as varied. Figure 2 shows two naturally 
occurring proteins that illustrate the complexity and variation in protein structure, which 
translates directly into the wide scope of protein functions. On the left is immunoglobulin,
2
 a 
protein involved in immune response, and on the right is actin,
3
 an abundant protein largely 
involved in cell infrastructure. 
 
 
 
Figure 2: Examples of Proteins Occurring in Nature, Left: Immunoglobulin, Right: 
Actin
4,5
 
 
 The difference in definition between peptides and proteins lies only in the length of the 
peptide chain that is being described. There is not a strict cut-off point that marks the 
Introduction 
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boundary between proteins and peptides, but conventionally peptides are described as 
containing less than 50 monomer units. 
 Proteins are among the most important compounds found in nature due to their diverse 
uses and biological properties. The word protein is derived from the Greek word prōtos, which 
means ‘of prime importance’. This is an apt term to apply to proteins and accurately reflects 
the necessity of these compounds in life sustaining processes. Their structures are often 
remarkably complex and their functions are incredibly diverse, ranging from acting as 
enzymes to participating in immune response and cell signaling. 
 
 1.1.2 Protein Structure and Biological Activity 
 A sequence of amino acid residues will not retain a straightforward open-chain 
conformation once it has formed. It will instead fold into a complex three-dimensional 
structure of lower energy, stabilised by non-covalent interactions between the residues. This is 
known as the protein’s native structure. The overall three-dimensional structure of a protein, 
and its functional groups, is extremely important in dictating biological activity. It is these 
folded structures that lend proteins their high selectivity and makes them perfect for use in 
natural systems. Protein folding is one of the most fundamental processes in naturally 
occurring systems.
6 
 A protein will fold into its native conformation in response to a variety of 
physiological conditions. Solvent, pH, ionic strength and the presence of metal ions or 
prosthetic groups (groups other than amino acids) are several factors that will directly 
influence the folding of a protein in a biological system.
7 
Figure 3 displays a diagrammatical representation of the enzyme lysozyme. This 
enzyme consists of 129 amino acid residues and is useful in breaking down bacterial cell 
walls. The structure was determined in 1965 using X-ray analysis.
8,9
 This representation 
contains several units of secondary structure and effectively demonstrates the complexities of 
a folded protein structure. The long chain represents the amino acid sequence, with various 
recognisable secondary structure motifs represented by arrows and coils. These secondary 
structures will be discussed in more detail later on. 
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Figure 3: Folded Representation of the Enzyme Lysozyme
10,11 
 
In biology, for a molecule to exhibit any kind of activity it must be able to interact with 
a particular site or receptor. Natural systems are notable for their extremely high selectivity, 
which is necessary to avoid unwanted interactions as well as competition at, or inhibition of, 
active sites. This is of course where the ‘lock and key’ principle is important. A receptor will 
only be able to interact with a molecule of appropriate size, structure and functionality, much 
like a key fitting into a lock. A protein must be of an appropriate size and shape to fit into a 
binding pocket, and it must have the appropriate functional groups to interact non-covalently 
with the groups on the inner surface of that pocket. The importance of proteins and peptides in 
metabolic processes is without doubt. The failure of a protein to fold correctly is the cause of a 
variety of physiological conditions.
12
 
Figure 4 shows a basic representation of bovine pancreatic ribonuclease, a protein that 
consists of 124 amino acid residues. Each amino acid residue is represented in the chain by its 
three-letter abbreviation and the chain is folded into its native conformation. The folded 
structure is stabilised in this case by four disulfide bonds, which are marked on the chain. 
These are covalent bonds that form between the thiol side chains in cysteine residues. The 
diagram does not show the complexity of non-covalent interactions that are at work in the 
structure nor does it indicate the recognisable secondary structure features. However, this 
image does give a good representation of both the length of the protein and how this folds into 
a more complex native structure. It also illustrates another possibility in representing a 
complex protein diagrammatically. 
Introduction 
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Figure 4: Amino Acid Chain of Bovine Pancreatic Ribonuclease
13 
 
 The structure of a protein can be classified in four broad terms, each representing a 
different level of complexity. The most basic representation is simply the order of residues in 
the polypeptide chain and this is referred to as the primary structure. Traditionally, the 
sequence of amino acids is reported starting from the amino terminus to the carboxy terminus. 
The secondary structure describes several recognisable structural sub-units that are present in 
the folded state, such as an α-helix or a β-sheet. The tertiary structure includes the overall 
structure of the folded protein, including the various secondary units. Finally, the quaternary 
structure applies in cases where a protein combines multiple individual units in one overall 
structure, i.e. haemoglobin, the oxygen carrier in the blood, which exists as a tetramer.
14
 The 
structure of the deoxygenated form of haemoglobin is illustrated in Figure 5. 
 
Figure 5: Human Deoxyhaemoglobin Structure
4,5 
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Within the secondary structure of a protein, chemists can glean valuable information 
about structure activity relationships (SAR’s) revealing important factors that are required for 
recognition and binding to take place. There are several known secondary structure units that 
repeat within a folded conformation such as the aforementioned α-helix and β-sheet, and these 
have been studied extensively in recent decades. 
The mechanism by which a chain of amino acids folds into its native conformation is 
not completely understood. A well known thought experiment was developed in 1969 by 
Cyrus Levinthal.
15
 It has since become known as the Levinthal paradox and considers the vast 
number of possible conformations an extended chain of amino acids can theoretically adopt. 
Taking a simple example, a chain of 100 amino acids is bonded together by a total of 99 amide 
bonds. This in turn means that there are 198 different φ and ψ angles associated with the 
structure and, assuming each of these can exist in 3 distinct stable conformations, there will be 
3
198
 different folded conformations to explore. If the protein reached its native conformation 
by sequentially fulfilling each of these conformations it would take longer than the universe 
has existed to reach the appropriate one. This is true even if the random search for the correct 
conformation is carried out on a picosecond timescale. Of course, proteins fold very rapidly on 
the order of minutes, therefore it was suggested that protein folding is based on a funnel-like 
energy model with the protein ‘falling’ into a lower energy state. The protein will achieve its 
thermodynamically most favourable state with lowest Gibbs’ free energy depending on the 
order of residues and the interactions taking place between them. 
The process of protein folding is very accurate with specific sequences of amino acids 
giving the same native conformation every time. It has been suggested that folding begins with 
local interactions between residues, which then facilitate interactions between more remote 
groups as the folding brings them into proximity with each other.
1
 Although a precise 
relationship between amino acid sequence and three-dimensional structure remains elusive, 
extensive work in the field is providing new insights into protein folding.
16
 With enough 
understanding, scientists should hopefully be able to predict the native conformation of a 
protein simply by knowing the order and number of residues. 
Proteins developed in natural systems specifically to function under certain 
physiological conditions. As previously mentioned, factors such as pH have a direct effect on 
the folding of a protein, and so these structures often have a very narrow band of conditions in 
which they can operate. This explains why a protein will denature at extremes of pH or 
Introduction 
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temperature. A denatured protein will have lost its native structural features and be unable to 
undertake its designed biological function, thus leaving it inert. The number of factors 
involved in directing a protein into its native conformation makes it a challenging area of 
research with many discoveries still to be made. 
 
1.1.3 Secondary Structure Units 
 The various secondary structure units that a protein can form have been studied 
extensively in recent decades in an attempt to develop an understanding of all aspects of 
protein structure and function. When studying a folded protein or peptide several units of 
secondary structure quickly become apparent such as strands, coils, helices and turns. These 
conformations are stabilised by multiple non-covalent interactions taking place between 
various sections of the peptide chain. 
One of the most prevalent and fundamental stabilising interactions is hydrogen 
bonding
17
 which can take place between NH groups and CO groups in the peptide backbone or 
by interactions between polar groups in the functionalised side chain. There are also 
opportunities for alternative types of interaction such as π-stacking interactions or ionic 
interactions. This latter situation will be observed in cases where amino acid residues contain 
NH2 (lysine) or CO2H (glutamic acid) groups in the side chain that will form charged 
zwitterionic species through proton transfer to give NH3
+
 and COO
-
. 
 
α-Helix 
One of the most frequently encountered units of secondary structure is the α-helix. 
This is a repeating unit that is characterised by a coil or spiral formation, which is stabilised by 
repeated hydrogen bonding. Each NH group forms a hydrogen bond with a carbonyl group 
located on an amino acid residue that is further along the chain. The two functional groups are 
described as having a 1 to 4 relationship as the hydrogen bond always occurs between groups 
that are 4 residues apart in the amino acid sequence. 
Two prominent examples of proteins that extensively utilise the α-helix are 
myoglobin
18
 and haemoglobin, which are both essential proteins in oxygen transport in the 
body. Myoglobin contains eight α-helices and is structurally similar to a single subunit of 
haemoglobin. This structure is illustrated in Figure 6 with the α-helix structures represented by 
coil formations. 
Introduction 
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Figure 6: Myoglobin Structure
4,5 
 
 The existence of the α-helix structure was originally postulated by Linus Pauling19 and 
this was confirmed by the first three-dimensional structure determination of myoglobin using 
X-ray crystallography in 1958.
20
 
 
 β-Pleated Sheet 
 Another prominent secondary structure unit is the well-known β-sheet or β-pleated 
sheet. This consists of several β-strands lining up alongside each other and  subsequent 
stabilisation with hydrogen bonding. A β-strand is a chain of amino acids, typically 3 to 10 
residues long, arranged largely in their extended conformation. The β-strands can align 
themselves either parallel or anti-parallel, meaning that they are either arranged with the 
amino acid chain running in the same direction or in opposite directions respectively. The 
direction of the chain is indicated on diagrammatic representations with an arrow (Figure 7). 
The hydrogen bonding can also form between chains that are not necessarily adjacent to each 
other. This means that a β-sheet can consists of several chains of amino acids from portions of 
the protein’s extended conformation that are remote in the primary sequence. 
 
Figure 7: Example of 2 Layered Orthogonal Antiparallel β-Sheets11,21 
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The pleated appearance of a β-sheet is derived from the tetrahedral geometry of the 
α-carbon centres.  If the two β-strands of the sheet are arranged so that the Cα functional 
groups on the strands are in the same plane, then the bonds from the C
α
 leading into the rest of 
the chain will lead backward or forward from that plane, meaning that the bonding will 
alternate above and below the plane of the sheet giving it a pleated appearance. 
 
 1.1.4 The β-Turn Structure 
 Turns are particularly important units of peptide secondary structure. There are several 
distinct classes of turn and they are defined by the extended peptide chain folding back on 
itself in a U-turn conformation. This feature is stabilised by non-covalent interactions. The 
turn type is classified by the number of residues involved in the turn and hence the size of the 
pseudo-ring system that is formed.
22
 Figure 8 shows a concise representation of the difference 
between three distinct turn types. The amino acids are coloured differently to clearly illustrate 
the number of residues that are involved in each turn. The α-turn (5 residues), β-turn 
(4 residues) and γ-turn (3 residues) form 13-, 10- and 7- membered hydrogen bonded rings 
respectively.
23  
 
Figure 8: Three Distinct Turn Types
24 
 
  The most common turn-type found in nature is the β-turn. The β-turn was first 
recognised in the 1960s by Venkatachalam.
25
 This structural unit is now known to be found 
commonly in peptides and proteins, comprising up to 25% of all residues.
26
 The β-turn is also 
present in the active conformation of many biologically active peptides and proteins 
These units populate a folded structure between regions of regular secondary structure 
such as helices and sheets.
27
 A β-turn consists of four residues that are labelled i, i+1, i+2 and 
i+3. The hydrogen bonding typically takes place between NH and carbonyl groups located on 
the i and i+3 residues. The less common α- and γ-turns will utilise hydrogen bonding 
interactions between the i and i+4 or the i and i+2 positions respectively.  
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Figure 9 shows a general representation of a β-turn that highlights the four residues 
that are involved in the turn. There are generally four opportunities for functionalisation at the 
4 R groups around the turn. The hydrogen bonding that stabilises the turn is formed between 
the carbonyl group and NH proton of residues i and i+4 respectively and this can be further 
stabilised down the peptide chain by further hydrogen bonding between proximal groups. 
 
Figure 9: A General Representation of a β-Turn Structure28 
 
 β-Turns can be further sub-categorised into types. These are labelled, for example, as 
type I, type II, type II’ etc. There are a total of more than 10 different types of β-turn known 
today.
29
 These types are distinguished by the dihedral angles, represented as ψ-angles and 
-angles in Figure 9. Table 1 shows a selection of some different β-turn types as defined by 
their characteristic bond angles.
28 
 
Table 1: β-Turn Types and Their Ideal Angles 
Angle Type I Type I’ Type II’ Type III 
1 60 60     60 60 
1 30 30 120 30 
2 90 90   80 60 
2     0   0        0 30 
 
 A β-turn can also be involved in a β-sheet if two of the β-strands are adjacent to each 
other on the extended chain. The turn that brings the two strands into close proximity for 
hydrogen bonding is referred to as a β-hairpin.21 It is important to note that the term β-hairpin 
is a generic term that is used to describe the turn motif that is bringing the two β-strands into 
proximity and can mean any type of turn, be it a γ-, α- or β-turn i.e. it can include, but is not 
restricted to, a β-turn. 
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 β-Turns in a protein’s native conformation can be a contributing factor to the overall 
tertiary structure. The formation of a β-turn does not involve a large decrease in entropy 
because the interactions that are involved are largely local. A turn does however bring other 
groups in the amino acid chain into closer spatial proximity to each other thus improving the 
likelihood of their interaction. Thus, a turn can make the formation of further secondary 
structure units more energetically favourable and can contribute to a hierarchical folding 
model where the formation of a turn induces further protein folding in the extended chain. 
 Alternatively, β-turns can play a passive role in the overall process of protein folding. 
In this case, they are themselves induced by the other secondary structures in the native 
conformation in a process whereby a section of the chain is simply forced into a turn, which 
further stabilises itself through hydrogen bonding. In either event, the β-turns are important 
secondary structure units and they are often found in the active conformation of peptides and 
proteins that exhibit biological activity. 
 Bearing in mind that the three-dimensional structure of a protein is critical for its 
biological interactions, a β-turn that is located on the surface of the protein can be a significant 
feature as it exhibits a distinctive structure that may be essential for recognition at a receptor 
site. Due to the abundance of β-turns in biologically active proteins and peptides there has 
been a surge of interest towards the study of β-turns in recent years. It is hoped that the study 
of naturally occurring proteins with biological activity could inspire research into synthetic 
drug molecules with similar, desirable biological activities (vide infra). 
 
 1.2 Opioid Peptides and Peptidomimetics 
  
 1.2.1 Opioid Peptides and Receptors 
 Opioids are compounds that will bind to opioid receptor sites resulting in the 
physiological relief of pain. Opioid receptors are found principally in the central nervous 
system and the gastrointestinal tract. There are several different classes of endogenous opioid 
peptides in humans such as the enkephalins, the dynorphins, and the endomorphins, examples 
of which are show in Figure 10. 
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Figure 10: A Selection of Endogenous Opioid Peptides 
 
 There are three types of opioid receptors that are widely accepted today. These are 
labelled as the δ-, κ- and μ-sites and can be further sub-categorized. The existence of opioid 
receptors was first suggested in the 1950s,
30
 and this was followed in the 1960s and 1970s by 
the proposal that there were several different classes of opioid receptor. This latter proposal 
was based upon a series of opioid peptides each displaying different profiles of 
pharmacokinetic activity in vivo. Three opioid receptor types were proposed and labelled μ, κ 
and σ. The δ-receptors were identified shortly after the discovery of the enkephalins in 1975.31 
The σ-receptor is no longer regarded as an opioid receptor as it does not exhibit the 
stereoselectivity characteristics of opioid receptors or antagonism by opioid antagonists.
32 
 Each of the three types of opioid receptor have a series of side effects that are 
associated with their binding, for example physical dependence, depression, miosis or 
euphoria. The μ-opioid receptor is a well known target for pain relief and is the subject of 
many current opiate analgesics such as morphine. Having said this, the use of opiates is 
limited by their side effects which include respiratory depression, desensitisation with chronic 
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use and the development of dependence.
33
 The δ-opioid receptors are known to exhibit side 
effects that include convulsions and the κ-opioid receptors are accompanied by dysphoria 
(depression), hallucinations and sedation. 
These issues can be problematic if an opiate binds to multiple receptors, as this will not 
only result in the analgesic effects, but will also ensure the full range of unwanted side effects 
is experienced by the patient. These effects are where the addictive properties of morphine 
(Figure 11) and other related opiates originate. Understanding these receptor sites is key to 
developing new drugs with increased analgesic potency and reduced side effects.   
 
 
Figure 11: Structure of Morphine 
 
 The endogenous opioid peptides have varying structures and their own individual 
binding characteristics. It is important to consider this fact when designing a molecule to 
exhibit opioid activity. Selectivity is an important issue as illustrated by the diversity of side 
effects associated with each receptor type. Both endomorphin-1 and endomorphin-2 show a 
high affinity for binding to the μ-receptors. leu- and met-enkephalin display affinity for 
μ-receptors but they also bind with the δ-receptors.34 The β-endorphins, dynorphin and 
neoendorphin all bind to the κ-receptors. Clearly the ability of each of these to bind to opioid 
receptors is determined by its amino acid sequence and its secondary structure characteristics. 
Furthermore, being that the β-turn secondary structure unit has been identified as the most 
likely conformation for ligand binding to opioid receptors, it must only require very subtle 
variations between turn types to affect binding affinity to specific receptor types. 
  
 1.2.2 Leu-Enkephalin 
 In 1975, two endogenous opioid pentapeptides were discovered.35 These two peptides 
were named leu-enkephalin and met-enkephalin and were isolated from pig brain (Figure 12). 
The two peptides have very similar structures, only differing in the identity of the terminal 
residue. The two peptides are shown below with their extended chain conformations and the 
different terminal residues highlighted. The ratio of met-enkephalin to leu-enkephalin in 
Introduction 
 14 
biological systems appears to be species-specific with four times more of the former than the 
latter in pig brain. Both types of enkephalin show an affinity for δ- and μ-opioid receptors, 
with a strong preference for the δ-receptors in particular.36 
 
 
Figure 12: Chain Structure of Both Enkephalin Pentapeptides. 
 
 Three years after the elucidation of the enkephalins the three dimensional structure of 
leu-enkephalin was revealed using X-ray diffraction.
37
 It was apparent that the pentapeptide 
adopted a β-turn conformation in the solid state. Based on this finding it was proposed that the 
enkephalins utilised a β-turn in their bioactive conformation. This theory has since been 
supported by the bioactivity of structural analogues of enkephalin β-turns.38-40 The turn is 
stabilised by intramolecular hydrogen bonding between the tyrosine carbonyl oxygen (i) and 
the phenylalanine NH (i + 3) thus fulfilling the 1 to 4 interaction that is characteristic of the 
β-turn. 
Two representations of the folded conformation of leu-enkephalin are illustrated in 
Figure 13, one clearly highlighting the four residues involved in the turn, and the other based 
upon the X-ray structure that was determined in 1978.
37
 X-ray analysis indicated that the 
tyrosine side chain was disordered and occupied two discrete positions with nearly equal 
frequency. This is shown on the X-ray structure at the lower terminus of the chain by the two 
possible orientations of the p-hydroxyphenyl group. These two orientations are both displayed 
in the X-ray crystal structure. 
 
 
Figure 13: Representations of Leu-Enkephalin in its β-Turn Conformation13 
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 Both diagrams show that as well as the hydrogen bond stabilising the turn, there is a 
second hydrogen bond further along the extended structure. This second H-bond is induced by 
the conformation of the chain and takes place between the phenylalanine carbonyl oxygen and 
the primary amine group of tyrosine, thus giving an antiparallel relationship between the two 
hydrogen bonds. 
 Whilst the X-ray structure of leu-enkephalin in its solid state is not definitive proof that 
it will adopt the β-turn conformation in its active form, it is a promising starting point. 
leu-Enkephalin is, in fact, a highly flexible pentapeptide and has been found to occupy type I, 
I’, II’ and III β-turn conformations in solution.41 This conformationally dynamic structure 
presents some problems when trying to determine its biologically active state. Further 
difficulties have arisen from the fact that it is difficult to obtain sufficient quantities of purified 
opioid receptor of the μ- and δ-type, for which the enkephalins show the highest affinity for 
binding.
42
 
 Despite the difficulty inherent in studying the active conformation of the enkephalins, 
research to further understand these peptides is ongoing. One avenue of investigation involves 
the development of peptide analogues and peptide mimetic structures that can be used to 
further probe the biological interactions of opioids with their receptors.
43,44  
 
 1.2.3 Introduction to Peptidomimetics 
In some respects a natural protein or peptide should be theoretically ideal as a drug 
molecule. They exhibit known biological activity and they clearly don’t have any appreciable 
toxicity or serious side effects. However, there are two main practical reasons why naturally 
occurring peptides and proteins are unsuitable for clinical use.
45
 
Firstly, they are prone to undergoing proteolytic degradation and so the peptide chain 
can be broken down quite easily under physiological conditions. The second reason relates to 
their poor transport properties which results from the difficulties that peptides have in crossing 
membranes due to their propensity to form hydrogen bonds.
46
 These two factors contribute to 
peptides and proteins exhibiting generally poor pharamacokinetic properties. These are, of 
course, beneficial for natural proteins as it means that they can be broken down quickly once 
they have performed their function and can be localised in the specific region of action. 
However, if a peptide is introduced into a biological system as a drug molecule (i.e. orally) it 
cannot reach the site at which it exhibits its activity and it is broken down very rapidly. 
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It is unfortunate that peptides are such poor candidates for drug applications as there is 
a great deal of information to be learned from them and how they interact with biological 
systems. Instead of using the natural structures to induce the biological activity of interest, 
chemists and biologists have taken inspiration from these structures when considering the 
development of synthetic molecules for drug use. 
Focusing on a particular peptide or protein with a known activity, there are several 
lessons to be learned about how to reproduce the same activity. Determining the 
three-dimensional structure of a peptide in its receptor-bound form is important as this 
develops understanding of exactly which structural features and functional groups are 
important for activity to take place. A good understanding of structure activity relationships 
(SAR’s) is essential when designing a mimetic with targeted biological activity. 
Once a reasonable understanding of the essential elements required for biological 
activity has been developed, a simplified model can be constructed utilising only these 
essential features. A small molecule can be designed that will stabilise these functional groups 
and three-dimensional features in a covalent scaffold.
47
 A common approach towards 
synthesising these mimetic structures involves a generic synthetic pathway that permits 
inclusion of a variety of side chain functionalities. This produces libraries of similar 
compounds that can then be screened for biological activity. In this manner, chemists can learn 
more about the features that will improve or impede desired activity. Through repeated 
syntheses the structure is further refined to optimise the required activity. 
Ultimately, the molecules that are synthesised via this method can have even greater 
potency than the natural peptides upon which they are based. Furthermore, by synthesising a 
covalently bonded analogue, the poor pharamacokinetic properties associated with natural 
peptides and proteins can be bypassed. The new structure can be tailored to make it more 
robust under physiological conditions. A further benefit lies in the entropic qualities of a small 
molecule mimetic. A flexible peptide will suffer a large decrease in entropy in order to interact 
with a receptor site, but a small covalently bonded, and comparatively rigid, mimetic, will not 
experience such a large decrease in entropy. A mimetic can therefore bind more efficiently to 
a receptor as it is thermodynamically more favourable to do so.
48
 
In this manner, it is ultimately possible to synthesise structures that exhibit high 
biological activity and selectivity. Ultimately, these studies constitute a pathway to generate 
medicinally useful compounds. 
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The applications of peptidomimetics do not stop with drug development. This type of 
synthesis also finds promising applications in the field of synthetic vaccines. Synthetic 
systems have several advantages over traditional, whole-killed, live-attenuated vaccines
45
 such 
as simplified preparation, increased safety and the ability to focus the immune response to a 
particular antigenic determinant of the pathogen. In practice, natural peptides have several 
drawbacks in this area. They are often unable to elicit a high-titer, high-specificity antibody 
response to the native protein from which the peptide sequence was chosen. The difficulty lies 
in the conformational flexibility of the natural peptides and their inability to preserve the 
specific topological and conformational features that are required for recognition and 
induction of high-titer, high-affinity antibodies. 
Again, natural peptides and proteins can provide a blueprint in developing biologically 
active structures of defined function. As understanding of the structural features of proteins 
and peptides improves, so will the efficacy of artificial mimetics based on them. 
It is estimated that of all modern drugs that are in use, almost half of them target 
G-protein coupled receptors (GPCRs) in order to exhibit their effects. The GPCRs are a large 
family of proteins that share a similar structure composed of seven transmembrane helices
49 
as 
shown in Figure 14. Located on the surface of cells, GPCRs are responsible for the translation 
of various types of external stimuli into some form of intracellular response. They can exhibit 
a response to both endogenous chemical signals and exogenous environmental agents, for 
example, peptides, proteins, metal ions, pharmaceuticals and light.
23
 
 
Figure 14: Ribbon Drawing of Rhodopsin, a G-Protein Coupled Receptor
24 
 
Due to their diverse utility, designing ligands for such receptors is a fertile area of 
research in the pharmaceutical industry.
50
 It has been shown previously that most peptide 
activated GPCRs bind to their ligands through a turn structure.
23
 Furthermore, turns often take 
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place on the exposed surfaces of proteins. As a result they can be important for molecular 
recognition events such as interactions between antibodies, antigens and regulatory enzymes 
and their corresponding substrates. The use of protein and peptide mimetics is an effective 
method of exploring the interface between secondary structures and receptors using small, 
robust molecules with reliable and accessible syntheses. 
 
1.3 β-Turn Peptidomimetic Structures and Synthesis 
 
1.3.1 Previously Reported β-Turn Mimetics 
 Of the various secondary structure units found in proteins, β-turns are among the most 
widely utilised for peptidomimetic synthesis.
28
 This is due to the fact that this structural 
feature is used for biological recognition by many different types of protein e.g. antibodies and 
T-cell receptors.
51
 Additionally, the β-turn, as a unit, is readily amenable to mimetic design. 
The use of peptidomimetics in developing therapeutic structures was anticipated by 
Farmer
52
 who proposed the idea of replacing a peptide scaffold with a cyclohexane ring prior 
to functionalisation with relevant amino acids.
53
 The cyclohexyl ring would effectively act as a 
tether that replaces the U-turn in the chain structure. This forces the extended chain into a 
similar conformation to the natural turn structure. This was explored some time later, when 
Bélanger and Dufresne developed a nonpeptidic mimetic of the enkephalin opioid peptides, 
shown in Figure 15.
54 
 
Figure 15: Early Peptidomimetic Based Upon Leu-Enkephalin 
  
Some time later, Olson and co-workers
55
 reported a similar approach to thyrotropin 
releasing hormone (TRH), effectively installing all of the side chains from the natural 
tripeptide onto a cyclohexane ring, similar to the approach suggested by Farmer. In this case, 
the peptide mimetic did not bind to the endocrine receptor for which it was designed. Having 
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said this, it did show oral activity in animal models of cognitive dysfunction. The structure of 
the mimetic and its natural counterpart are shown in Figure 16. 
 
 
Figure 16: Peptidomimetic Based Upon TRH  
 
 In recent decades, the field of peptidomimetic chemistry has received a significant 
amount of attention. The possibilities for synthesising libraries of bioactive compounds are 
astounding and as a result countless structures have been developed to mimic a range of 
known peptides and their secondary structure conformations. Some compounds have 
displayed activity whereas some have not lived up to their promise. As a result, the scientific 
literature is peppered with publications containing hundreds of mimetic structures. This area 
of chemistry lies at the interface between several different scientific disciplines i.e. biology, 
peptide chemistry, medicinal chemistry etc. The following sections will discuss some notable 
examples from the past decade that have been published by accomplished and experienced 
groups in the field. These examples were chosen to highlight some of the diversity that can be 
considered in a mimetic structure and also some of the difficulty inherent in identifying an 
appropriate structure. All of these cases were published in the past decade and, although not 
all of them have been tested biologically, or were able to achieve a truly general synthetic 
approach conducive to library synthesis, they illustrate a broad range of approaches to β-turns 
as well as some structural diversity. This diversity highlights the varied possibilities for using 
artificial structures to induce covalently bonded turn mimetics. 
 
1.3.2 Kahn’s Synthesis of an Opioid Peptidomimetic 
In 2002, Kahn and co-workers proposed a rigid bicyclic structure, which enforced a 
conformation similar to that found in the endogenous opioid peptides enkephalin and 
endomorphin.
56
 The general structure of mimetic 1 is shown in Figure 17. 
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Figure 17: Left: Leu-enkephalin Molecule, Right: Kahn’s Bicyclic Mimetic Structure  
 
 The bicyclic core of this structure incorporates several sites for potential 
functionalisation. Kahn and co-workers proposed the use of a library synthesis approach that 
allowed the development of varied similar structures for biological testing. In this manner, 
potent and selective ligands were revealed that bind selectively to opioid receptors, thus 
providing new insights into the SAR’s of the opioid peptides. 
 Kahn and co-workers demonstrated, using X-ray crystallography and 2D NMR 
spectroscopy, that their designed molecule mimics a type I β-turn conformation. The turn is 
successfully maintained by the rigid 6,6-bicyclic structure. Further investigation by the group 
also showed that their β-turn mimic shares similarities between its 3D structure and the 
receptor selectivity profile of the opioid peptides endomorphin-1 and endomorphin-2, thus 
opening further avenues of investigation. The bicyclic structure can be used to study several 
different conformations of the β-turn which are shown in Figure 18 as enkephalin 4→1 (A), 
enkephalin 5→2 (B) and endomorphin 4→1 (C). To this end, the group synthesised a library 
of compounds utilising the mimetic structure in conjunction with a variety of functionality at 
the i to i+3 positions via their established solid phase synthesis procedure shown in Scheme 1. 
 
 
Figure 18: Representation of Enkephalin 4→1 (A), Enkephalin 5→2 (B) and 
Endomorphin 4→1 (C)57 
 
The solid phase synthesis procedure utilised the commercially available bromoacetal 
resin 2. Nucleophilic displacement of the bromide with a primary amine, 3, delivered 
secondary amine intermediates, 4. These were then coupled with Fmoc-protected α-amino 
acids, 5, using HOAt/DIC to provide intermediates 6. Treatment with 25% piperidine in DMF 
was carried out to cleave the Fmoc group, followed by a second coupling with 
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Fmoc--alanine, 7, to give compounds 8. Again, the Fmoc group was removed using 
piperidine in DMF towards intermediates 9. The deprotected amines were then coupled with a 
corresponding alkyl p-nitrophenyl carbonate of type 10 to form compounds 11. The final step 
involved cleavage from the acetal resin, followed by a stereoselective tandem acyliminium 
cyclisation and this was accomplished by the straightforward addition of formic acid. This 
gave access to a variety of 6,6-bicyclic -turn mimetics 1a, with a choice of functionality at 
the i to i+3 positions.  
 
 
Scheme 1: Synthesis of Bicyclic Mimetic Unit 1a 
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The synthetic procedure described above resulted in 1a giving good overall yields, 
ranging from 11% to 37% for the entire synthesis. Figure 19 displays the range of different 
side chain functionalities that were incorporated into the general structure 1a and highlights 
the utility of this type of library synthesis for the efficient preparation of multiple analogous 
compounds. One synthetic pathway is designed and optimised, which then leads to a diverse 
array of structures that can be tested for the desired biological activity. 
 
 
Figure 19: Range of Side Chains Employed in Kahn’s Mimetic Structure 
 
Once Kahn and co-workers had achieved their objective of optimising the synthetic 
route, they turned their attention towards studying the binding of the synthesised structures to 
opioid receptors. This was studied by looking at competitive binding of radioligand 
[
3
H]naloxone with relatively non-selective opioid receptors in rat cerebral cortex.
56
 This gave 
some insight into the relative ability of the mimetics to bind in comparison to each another. 
Further investigation highlighted structures 1b to 1e as having the highest binding affinities of 
all compounds that had been prepared (Figure 20). 
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Compounds 1b and 1d are representative of the enkephalin 4→1 type β-turn model 
shown in Figure 18, based on the functional groups at the i and i+4 positions. Compounds 1c 
and 1e are analogous to the endomorphin 4→1 type β-turn model. 
 
 
Figure 20: Four Mimetics Exhibiting High Binding Affinities to Opioid Receptors 
 
 The four structures described above were tested to determine their IC50 values. It was 
found that there was an increasing ability to bind to nonselective opioid receptors in rat 
cerebral cortex for the four structures, with structure 1b showing the least binding affinity and 
compound 1e the highest. In fact, compounds 1d and 1e were 5- and 15-fold more active 
respectively towards opioid receptors than compound 1b. Structures 1d and 1e were further 
studied for activity against cloned human μ-, δ- and κ-receptors and it was found that they both 
exhibited particularly high selectivity for the μ-receptors.  
As a comparison, another novel structure was synthesised containing all of the relevant 
functionality from compound 1d in a linear peptide sequence (Figure 21). 
 
.  
Figure 21: Linear Control for Compound 1d 
 
 This linear peptide was tested for the same biological activity as the mimetic 
structures. It was found that at 1 μM concentration, no binding activity was observed. This 
strongly suggests a specific three-dimensional structure is essential for receptor binding 
affinity. The linear peptide, having all of the necessary functional groups, was unable to bind 
to the opioid receptors as it lacked the conformational rigidity of the bicyclic mimetics. This is 
further evidence of the nature of the active conformation of the endogenous opioid peptides. 
The β-turn conformation is seemingly essential for biological activity. 
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 In addition, structure 1d was used for an in vivo evaluation of its analgesic effect on 
mice. It was found that, while it had a similar initial activity level to morphine, its half-life in 
vivo was 2-fold less. 
 Overall, Kahn and co-workers were able to synthesise a library of -turn mimetic 
compounds that were successfully tested in biological systems. From these studies, they were 
able to identify the most promising functional groups with regard to opioid receptor binding. 
Further examination proved that they had synthesised a turn mimetic system that was highly 
selective towards μ-receptor sites at nanomolar concentration. This research also suggested 
that the bioactive conformation of endomorphin is a type III 4→1 -turn and the μ-active 
conformation of enkephalin is a 5→2 -turn.  
 
1.3.3 Kihlberg’s Mimetic Structures 
 -Turn structures have been developed that utilise several different ring types and sizes 
to induce the extended structure to fold back upon itself. This diversity is readily apparent 
when examining a selection of reported mimetic structures. Where Kahn and co-workers 
utilised a bicyclic mimetic, other groups developed structures that induced a turn conformation 
using a single medium-sized ring. 
Figure 22 illustrates two cyclic mimetics, 12 and 13, that were developed by Kihlberg 
and co-workers in 2004 and 2006 respectively.
58,59
 The side chains are positioned slightly 
differently in the two structures because of the different ring sizes. Structure 12 contains a 10-
membered ring system, whilst molecule 13 contains a smaller 7-membered ring. 
 
 
Figure 22: Two Macrocyclic -Turn Mimetic Structures Developed by Kihlberg 
 
 Both of these turn mimetics have similar features in so far as they both have an 
ethylene bridge in the ring system and a methylene ether isostere. This type of system was 
deliberately chosen as it has been shown in previous work that replacement of the 
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tyrosine-glycine amide bond in leu-enkephalin with a methylene ether isostere is well tolerated 
by the opioid receptors.
60
 
 The 10-membered cyclic structure 12 was introduced first in 2004 and was synthesised 
in the solution phase. Conformational studies based on 
1
H NMR data indicated that this 
mimetic was conformationally flexible, but that at low temperatures adopted a similar 
conformation to a type-II β-turn.58 This conformation resembled that of crystalline 
leu-enkephalin. In an effort to further explore these structures, and aware that there would be 
significant scope to explore turn conformations, Kihlberg and co-workers embarked on the 
synthesis of the 7-membered cyclic mimetic 13 as a natural extension of the work that had 
already been reported. This structure was synthesised as illustrated in Scheme 2. 
The synthesis of the mimetic was performed on a solid support so as to minimise 
oligomerisation during formation of the 7-membered ring and also to establish conditions that 
would allow the development of a library of turn mimetics. The first step in the synthesis was 
deprotection of Boc-leucine attached to a Tentagel resin under acidic conditions. The 
deprotected amine was then coupled with Fmoc-protected phenylalanine using DIC and HOBt. 
Once the coupling was successfully achieved, the Fmoc group was removed using piperidine 
in DMF to furnish the solid phase bound dipeptide, 15. 
 Reductive amination was carried out using aldehyde 16 to provide the desired 
secondary amine using sodium triacetoxyborohydride as the reducing agent. Following this, 
the phenolic t-butyl ether and the t-butyl ester were removed simultaneously under acidic 
conditions. The authors were pleased to carry this out successfully while not degrading any 
other functionality in the molecule. 
 Subsequently, activation of the carboxylic acid in the resultant compound 18 was 
achieved using DIC and pentafluorophenol to give the pentafluorophenyl (Pfp) ester, 19. The 
cyclisation reaction to deliver the 7-membered ring was performed using TEA in refluxing 
dioxane, giving 20. This is the stage at which problems were encountered when carrying out 
this synthesis in the solution phase. In solution, this reaction often resulted in polymerisation, 
which competed with the desired cyclisation reaction. As a result, this stage can only be 
carried out at low concentrations in solution phase. The use of a solid support was Kihlbergs 
solution to this problem. 
 Once the ring closure was achieved it was possible to remove the solid phase support. 
This was accomplished via treatment with sodium methoxide resulting in 21. Over the course 
of all of the steps carried out in solid phase, Kihlberg and co-workers were able to achieve an 
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appreciable overall yield of 25%. The final two steps involved the deprotection of the 
carboxylic acid and amine units on the mimetic. Firstly, the azide was reduced to give amine 
22 and finally the methyl ester was hydrolysed using lithium hydroxide to give the target 
-turn mimetic, 13. These last, solution phase, steps gave an overall yield of 56%. This 
resulted in a synthesis towards the desired mimetic structure that was performed in 11 steps, 
nine of which were carried out in the solid phase, with a total overall yield of 14%. 
 
Scheme 2: Synthesis of 7-Membered Cyclic Mimetic 13 
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 Further study of these two mimetic structures was undertaken using a similar approach 
as described by Kahn. The binding affinity of the compounds was tested in rat brain using a 
competitor to probe the selectivities of the two structures. Kihlberg also used two linear 
analogues of the mimetic structures to investigate the effect of the cyclisation on the binding 
affinity of the mimetic (Figure 23). Structures 23 and 24 correspond to structures 12 and 13 
respectively. 
 
 
Figure 23: Linear Analogues 23 and 24 
 
 The 10-membered ring structure 12, showed no affinity for either μ- or δ-opioid 
receptors, whereas compound 13, containing the 7-membered ring, binds to both receptor 
sites. The inability of the 10-membered ring to bind to either receptor site is not a factor of 
having replaced the glycine-tyrosine amide bond with an ethylene ether isostere. The linear 
analogue 23, which corresponds to structure 12, exhibits a very high binding affinity for both 
sites despite the fact that it shares this feature. 
 It has been suggested that the cyclic conformation of the 10-membered ring in 12 
renders the structure very rigid and unable to adopt the appropriate conformation for binding. 
In addition, it is possible that loss of a hydrogen bond involving the phenylalanine amide 
proton is a factor. Both factors may contribute, but neither of them explains fully why 
compound 12 does not bind whereas 7-membered lactam ring 13, which shares these features, 
is able to bind effectively. On the other hand, structure 24, which is the linear analogue of 13, 
does not bind, most likely because of the entropic cost of folding around into a turn 
conformation. 
  
1.3.4 Hruby’s Mimetic Structures 
 Hruby and co-workers have been working at the forefront of peptide mimetic design 
and synthesis for many years and have developed several mimetic systems including structures 
based on -turn conformations.61,62 This group has studied several conformationally restricted 
bicyclic structures as potential -turn mimetic units.63 The bicyclic units that they have 
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developed restrict the conformation due to the stereochemistry of the scaffold, the presence of 
different substituents and the frame size. The group developed a bicycle leu-enkephalin 
analogue built from four subunits, shown in Figure 24. Of the fragments that were proposed 
(25–28), two were protected α-amino acids that are commercially available (25 and 28) and 
two are novel amino acid analogues that needed to be synthesised (26 and 27). 
 
 
Figure 24: A Series of -Turn Mimetics with Opportunities for Variation of 
Functionalisation and Ring Size Designed by Hruby and Co-workers 
 
 The goal of this research programme was to develop a range of different sized bicycles 
with the opportunity to incorporate various functional groups around the chain. This type of 
flexibility allows for a wide range of structures and functionalities to be studied for biological 
activity, particularly for the effects of varying side chain topography. By varying ‘n’ Hruby 
and co-workers were able to construct bicycles containing 5-, 6- and 7-membered rings. This 
allowed the group to synthesise a library of compounds with broad diversity for biological 
testing. 
Scheme 3 illustrates the synthesis of analogues of fragments 26b and 26c in the form 
of lactone 34, which was formed by spontaneous cyclisation of 33. While this fragment is 
visually different from 26, previous research by this group had shown that this type of lactone 
can act as a masked aldehyde and is electrophilic enough towards nitrogen and sulfur for 
thiazolidine formation, as required in the proposed synthesis.
64
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Scheme 3: Hruby Synthesis of Bicylic Dipeptide Turn Mimetic 
 
Initially, the -,- unsaturated amino acid starting material 29 had to be synthesised for 
use in this section of the synthesis. This transformation was carried out using a nickel catalyst 
with glycine and the appropriate alkyl bromide as shown in Scheme 4,
65,66 
and the reaction 
was optimised to give the alkylated product in overall 94 % yield. 
 
 
Scheme 4: Synthesis of ,- Unsaturated Amino Acid Starting Material, 29 
 
 Once this material had been isolated, the amino group was protected by reaction with 
N-(9-fluoroenylmethoxycarbonyloxy)succinimide (FmocOSu). The reaction took one day or 
three days when reacting with the homoallylglycine and bishomoallylglycine respectively. 
Fmoc protected 30 was then cyclised to furnish the oxazolidinone 31, by refluxing in the 
presence of paraformaldehyde. The heterocycle was cleaved under acidic conditions, affording 
32. Finally reaction with osmium tetroxide afforded aldehyde 33, which spontaneously 
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cyclised to give 34. This fragment was now ready to be coupled with the other fragments to 
synthesise the desired bicyclic turn mimetics. 
 The second novel amino acid fragment 27 was synthesised in a relatively 
straightforward manner (Scheme 5).
67
 9-Fluorenemethanol was treated with p-toluenesulfonyl 
chloride to give 38. The OTs group was then displaced with sulphur from the cysteine side 
chain, giving the amino acid 39 in excellent yield. Finally the NH terminus of the amino acid 
39 was protected using Fmoc, again in excellent yield, affording protected fragment 27. It is 
important to note that in this synthesis, as well as in previously reported work from the same 
group concerning the formation of 5,5-bicycles, the R’i+1 and R’i+2 positions were both 
unfunctionalised. In these syntheses, only the Ri and Ri+3 positions are open to modification by 
selection of an appropriate initial amino acid residue for reaction. 
 
 
Scheme 5: Synthesis of Protected Cysteine Fragment 
 
 Following preparation of all four fragments necessary for mimetic synthesis, the target 
was prepared using solid phase synthesis. Fragment 34 was synthesised with two ring sizes, 
translating into the synthesis of both a 6,5 and a 7,5-bicyclic system.  
This stage in the synthesis was performed on a solid support, beginning with a 
N
α
-Fmoc-Leu-Wang resin 40 (Scheme 6). Removal of the Fmoc protecting group with 
piperidine in DMF was followed by a standard coupling of Fmoc protected phenylalanine, 
yielding dipeptide 41. This was again deprotected and the resulting amine was subjected to 
further peptide coupling, this time with the Fmoc protected cysteine to give the tripeptide 42. 
Simultaneous removal of Fmoc and Fm protecting groups was achieved using 50% piperidine 
in DMF. Coupling with the previously synthesised fragment 33/34 was performed using the 
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unpurified mixture. This afforded thiazolidine 43 as required, thus installing the 5-membered 
ring of the bicycle. 
The lactam ring in 44 was easily constructed by reaction of carboxylic acid 43 with 
HBTU in just 1 hour. This procedure was equally effective for formation of both the 6- and 
7-membered lactams. The Fmoc group was removed from the secondary amine before 
coupling with Fmoc protected tyrosine derivative giving lactams 45, the penultimate 
compound in the route. The last two steps simply require removal of the final Fmoc group and 
cleavage of the mimetics from the resin using a mixture of TFA with H2O and TIPS. This last 
stage also cleaved the phenolic t-butyl ether from the tyrosine residue and afforded both the 
[6,5] and [7,5] bicyclic mimetics 46. 
 
 
Scheme 6: Completion of Hruby Synthesis 
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 Hruby and co-workers used this general approach to synthesise various bicyclic 
mimetics possessing variation in the stereochemistry around the rings (Figure 25). These 
compounds were tested for binding affinity against δ- and μ-receptor sites by assessing the 
competition with [
3
H] deltorphin II for the δ-sites and [3H] DAMGO for μ-sites. Most of the 
analogues showed binding affinity for the δ-receptors and it was found that the 
stereochemistry of the bridgehead hydrogen had a limited effect on the outcome, most likely 
due to conformational flexibility of the systems. The L-, L- analogues with both ring sizes 
showed the greatest potency, however the D-, L- and L-, D- analogues also showed some 
activity. 
 It was also found that the 6,5-bicycles showed good selectivity for the δ-receptors, 
whilst not showing any binding affinity for the μ-receptors, This differed from the 
7,5-bicycles, which showed far less selectivity, binding to both μ- and δ-receptors. This is 
most likely due to the greater conformational flexibility afforded by the larger ring size. 
 
Figure 25: Various Turn Mimetics Utilising Different Stereochemistry Around the 
Bicyclic Core 
 
 Victor Hruby has carried out a great deal of research into the field of peptidomimetic 
structures. In this case, he was able to replace a section of the peptide chain of leu-enkephalin 
with bicyclic systems of varying ring size. This example highlights quite effectively the 
Introduction 
 33 
benefits of a library-based approach to these compounds. Testing similar compounds with 
distinct structural differences can give new insights into important features for biological 
activity and contributes to a further understanding of peptide interactions at sites with high 
selectivity. 
 
1.3.5 Jurczak’s 2,5-Diketopiperazine Based Mimetics 
 In recent literature, 2,5-diketopiperazines (2,5-DKPs) have been pursued as interesting 
targets for incorporation into -turn mimetic structures. 2,5-DKPs are found in many natural 
products, for example the Asperigillus ustus metabolite phenylahistin (47),
68
  which exhibits 
promising antitumor activity, and the weakly cytotoxic tetracyclic compound roquefortine E 
(48),
69
 isolated from Penicillium rocquefortii (Figure 26). 
 
  
Figure 26: Naturally occurring 2,5-DKPs 
 
 However, beyond their significance as constituents of natural products, 2,5-DKP 
structures have potential applications as peptidomimetics. The 2,5-DKP structure possesses 
structural similarities to peptides, but without some of the limitations that are inherent in 
peptide systems such as poor sub-receptor stability and poor biostability. The replacement of 
biologically active peptide compounds with 2,5-DKP derivatives leads to improved resistance 
of the amide bond to metabolic cleavage and reduced conformational flexibility thus 
improving its ability to interact with macromolecules. Previous structures incorporating 
2,5-DKPs have been synthesised during the drug discovery process and have shown diverse 
biological activities.
70-72
 These structures are of potential interest in the continuous search for 
useful structural motifs to emulate the β-turn. 
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Figure 27: Bicyclic Mimetic Structure Utilising 2,5-DKP Unit 
 
 This type of -turn mimetic was previously reported by Golebiowski and co-workers 
in 2000,
73-75
 an example of which is shown in Figure 28. Despite the widespread interest in 
developing 2,5-DKP analogues for biological applications, only a few structures analogous to 
Golebiowski’s proposed structure have been reported, most of which are derived from racemic 
substrates and include little or no spectroscopic data. The Jurczak group took it upon 
themselves to develop a library of mimetics of this type using a general approach and 
beginning from optically pure (S)-piperazine-2-carboxylic acid.
76
 
 
 
 
Figure 28: Golebiowski’s 2,5-DKP Structure and X-Ray Structure Comparison With 
Type II -turn Unit77 
 
The library synthesis of 2,5-DKPs is shown in Scheme 7. The first step in the synthesis 
is the protection of both amines from the optically pure starting material, (S)-piperazine-2-
carboxylic acid dihydrochloride. This is accomplished with orthogonal protecting groups in 
order to selectively deprotect one over the other in a subsequent step. In this case, the Boc and 
Fmoc groups were chosen to form the protected intermediate 50. The carboxylic acid was then 
bound to the Wang resin under Mitsunobu conditions, resulting in formation of 51. Treatment 
of 51 with a solution of TFA in CH2Cl2 cleaved the Boc protecting group, furnishing structure 
52. The next step involved a Petasis reaction with glyoxylic acid and an appropriate boronic 
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acid to give amine intermediates 53. These intermediates were then coupled at the carboxylic 
acid to the appropriate primary or secondary amine coupling fragment using standard 
DIC/HOBt conditions to give functionalised compounds 54. This was determined to be the 
best approach after testing several different coupling conditions. 
The next step was the removal of the Fmoc group, which was accomplished using a 
solution of piperidine in DMF. The free amines were then coupled with an appropriate 
Boc-protected α-amino acid, again using DIC/HOBt conditions. Treatment of the newly 
coupled intermediates with a solution of TFA removed the Boc group leading to formation of 
structures 55. Finally the resin was removed using 10% acetic acid in isopropyl alcohol. Upon 
removal of the substrate from the resin, the final cyclisation reaction took place spontaneously 
resulting in the target functionalised bicyclic structures 56. 
 
 
Scheme 7: Solid Supported Synthesis of 2,5-DKP -Turn Mimetic Library  
 
 Jurczak and co-workers synthesised a library of compounds with an overall yield 
ranging from 18% to 47% for the full synthetic sequence. The targets contain up to 3 
stereogenic centres. The first is present in the optically pure starting material, the second is 
introduced by the Petasis reaction and the third is present after the coupling with an optically 
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pure amino acid to form 55. As a result of the non-stereoselective addition of R
1
, all of the 
final compounds were isolated as 1:1 mixtures of two diastereomers. Unfortunately, the 
research group was unable to separate the diastereomers using chromatographic methods, and 
as a result was only able to report the targets as mixtures. A selection of the synthesised 
structures is displayed in Figure 29. 
 
Compound Number R2 R3 
56a 
 
 
H 
56b 
 
 
Me 
56c 
 
 
Ph 
56d 
  
 
Figure 29: 4 Structures Synthesised Using Jurczak’s Synthetic Pathway 
 
 Although it was not possible for Jurczak and co-workers to isolate single optically pure 
2,5-DKP’s for use in biological studies, this research does demonstrate a possible approach to 
the synthesis of similar, potentially useful, peptidomimetic structures. At the time of 
publication of this research, no biological studies had been performed and such studies have 
yet to be published. This research represents a potentially useful approach to the use of 
2,5-DKP’s as effective β-turn mimetics and holds promise for future beneficial results. 
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1.3.6 Aceña’s Cyclic Peptidomimetics 
 Another example from recent literature demonstrates an approach to the synthesis of 
cyclic and bicyclic lactam rings of varying size.
78
 This research involves the use of chiral 
imino lactones as starting materials: Scheme 8 shows a brief representation of the route by 
which Aceña and co-workers intended to prepare their targets. 
 
 
Scheme 8: General Forward Synthesis of Cyclic Mimetic 
 
The initial bicyclic system was constructed using two similar protocols, both involving 
the application of ring-closing metathesis reactions of appropriately functionalised dienes, 
which were readily obtained from chiral imino lactones. A straightforward procedure for the 
synthesis of the starting chiral imino lactones is the condensation of the corresponding α-keto 
esters with (R)-phenyl glycinol.
79
 
The first of the two syntheses involved the preparation of a 7,6-bicyclic system and 
started with a chemo- and stereoselective addition of Grignard reagent MeMgBr to imine 57 
mediated by BF3·OEt2 to give 58 (Scheme 9). Compound 58 was isolated as a single isomer 
with the phenyl and methyl groups in a trans relationship. Reaction of 58 with acryloyl 
chloride then generated the diene 59 in 90% yield. Ring-closing metathesis was very 
successful, resulting in formation of the bicyclic compound 60, containing a 7-membered ring 
in 95%. 
The next step was the functionalisation of the double bond in 60, firstly by reaction 
with Br2 creating a mixture of diastereomeric dibromides, which were then converted to the 
vinyl azide 61 using NaN3, in an overall yield of 60%. Hydrogenation of the azide and 
subsequent protection of the resulting amine to give the carbamate 62 was swiftly followed by 
hydrogenation of the double bond to give a 90:10 mixture of lactams 63 and 64. These 
diastereomeric compounds were easily separated via column chromatography 
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Scheme 9: Synthesis of Bicyclic Lactam 
 
At this stage, Aceña and co-workers explored the development of a general method for 
the installation of rings of varying sized that would complement library synthesis techniques 
(Scheme 10). Imino lactones functionalised with vinyl or allyl groups similar to 57, are not 
simple to prepare, which prevents them from being used to introduce 5-, or 6-membered rings 
into the target. Instead, Aceña decided to use a starting material, such as 57a, in which the 
methyl group was in place prior to incorporation of rings of varying size via the use of vinyl- 
allyl-, but-3-enyl- and pent-4-enylmagnesium bromides. This afforded compounds 58a-d with 
variable yields. Subsequently, these compounds were converted into acrylamides 59a-d with 
variable yields, before performing the key ring-closing metathesis reaction using the second 
generation Grubbs catalyst. Unfortunately, this approach was only successful when applied to 
the preparation of compounds possessing 6- and 7-membered rings e.g. compounds 60b and 
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60c respectively. There was no reaction when attempting to form a 5-membered ring (60a) 
and poor yields were obtained upon formation of an 8-membered ring (60d). 
 
 
Scheme 10: General Approach to Fused Bicyclic Lactams of Varying Size 
 
Alternatively, the same ring-closing metathesis was employed to prepare systems 
containing problematic ring sizes by first opening the lactone on 58d and protecting the 
resulting diol 65 as a TBS ether (Scheme 11). The acrylamide 67 was then synthesised and 
underwent a ring closing metathesis reaction to give the desired 8-membered ring 68 in good 
yield. It was anticipated that this method would relieve any element of constraint that might be 
retarding the cyclisation reaction, but in the case of the 5-membered ring this approach was 
not successful and none of the desired RCM product was obtained. 
 
Scheme 11: Alternative Approach to 8-Membered Ring 
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Having achieved a reasonably general approach to the synthesis of systems containing 
various ring sizes, Aceña and co-workers focused their efforts on completing the synthesis for 
the previously synthesised bicycle 63. This ring system was subjected to ester reduction to 
give the diol 69. Hydrogenolysis yielded lactam 70, and this was followed by reoxidation to 
give the carboxylic acid 71. The final step required installation of a new amino acid residue 
using HOBt and DIC with glycine methyl ester hydrochloride to give tripeptide mimetic 72. 
This is as far as this recently published research extends, but the cyclic structure that has been 
developed has good prospects for further functionalisation so that it can serve as the central 
segment in a β-turn mimetic. 
 
 
Scheme 12: Final Synthesis of β-Turn Mimetic 
 
Indeed, the synthesis of lactam 71 is in itself potentially useful because both ends of 
the structure can be easily functionalised with a variety of amino acid residues to create an 
extended peptide mimetic. Having effectively established a method to synthesise structures 
containing 6-, 7- and 8-membered rings these various rings can be carried through the same 
synthetic pathway as 7,6-bicycle 63 to create systems with varying ring sizes and, importantly, 
different enantiomers. Compounds 60b, 60c and 68 are equivalent to compound 60 in Scheme 
9 and ideally they could be used to create a small library of β-turn mimetics. As of their last 
report, Aceña and co-workers were continuing to investigate this series of targets. This work is 
being performed to establish how the conformational features of the peptidomimetics relate in 
three dimensional space when compared to β-turns of various types and also to explore the 
viability of the synthetic pathway. 
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 1.3.7 Boger’s β-Turn Mimetic Library 
 In the past decade, Boger and co-workers have explored the synthesis of libraries of 
small molecule mimetic structures. On the premise that the majority of protein-protein and 
peptide-receptor interactions are mediated by three main recognition motifs (α-helix, β-turn 
and β-strand), they have focused their efforts on small molecules that reflect these motifs. This 
research has utilised simple solution-phase protocols that complement more conventional 
solid-phase techniques. The group is tackling the three motifs sequentially and has already 
published an extensive library of 8000 α-helical mimetics.80 
 In subsequent work, Boger and co-workers began their studies into the β-turn 
structure.
33
 Initially, they calculated the mean distances between the α-carbon centres in a 
series of over 10,000 β-turns that are reported in the protein databank. Furthermore, they 
recognised that one of the amino acid residues in a β-turn often performed a structural rather 
than recognition role. This was often a proline or a glycine residue at either the i+1 or the i+2 
position. Consequently, it was decided that Cαi+1 or Cαi+2 functionality could be omitted safely 
from the mimetic structures. Based on their analysis, and in order to achieve similar geometry 
for the extended functionality leading away from the turn, trans-pyrrolidine-3,4-
dicarboxamide was proposed as a synthetically accessible template for the construction of 
β-turn mimetic structures (Figure 30). This scaffold has the further feature of being rigidified 
by a stabilising H-bond between two of the substituted side chains. 
N
R3
O
O
NH
R2
O
NH
R1  
Figure 30: trans-Pyrrolidine-3,4-dicarboxamide Mimetic Template 
 
 Before proceeding with full synthesis of this library of compounds, Boger and 
co-workers performed some exploratory studies on a small group of pyrrolidine-3,4-
dicarboximide derivatives. These structures were tested against μ-, δ- and κ-opioid receptors 
for their binding affinity and three structures were found to be very effective binders 
(Figure 31). 
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Figure 31: Most Effective Test Analogues 
 
The two most effective ligands for μ-receptor binding were 73 and 74. Compound 75 
was somewhat less effective for μ-binding (Table 2). These structures have the distinction of 
sharing their combination of side chains with the endogenous endorphin structures. 
Furthermore, it was realised that the best affinities for μ-receptor binding were obtained when 
single carbon extensions were introduced into certain side chains. In this case, this means 
using homophenylalanine (HoPhe) and homotyrosine (HoTyr). This concept was employed 
into the library synthesis approach adopted by the group later. 
 
Table 2: Binding Affinities of Mimetic Structures 73, 74 and 75 
Compound μ binding affinity 
Ki (nM) 
κ  binding affinity 
Ki (nM) 
73 930 390 
74 820 420 
75 2,700 23 
 
Interestingly, all of these compounds exhibited a much higher binding affinity for the 
κ-receptors, particularly in the case of compound 75. The origin of this affinity is as yet 
undefined, but the binding data suggests that some intrinsic properties to the trans-pyrrolidine-
3,4-dicarboxamide template favour κ binding in particular. Despite this unexpected finding, 
the high affinity of compounds 73 and 74 suggest that the template can effectively mimic the 
active turn conformation of the endomorphins. Having confirmed the viability of these 
structures, and revealing some useful structural details, work progressed towards the synthesis 
of a library of 4200 analogous compounds with various combinations of 20 side chains, all of 
which are illustrated alongside their appropriate labels in Figure 32. 
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Figure 32: 20 Side Chain Functionalities Used in Library 
 
By exploring each possible combination of the 20 residues around the 3 functional 
positions on the template, a library of 4200 compounds can be established. Due to the 
perceived degeneracy of incorporating side chains of asparagine and aspartic acid compared to 
glutamine and glutamic acid, it was decided only to include Glu and Gln in the library. For 
this same reason, only lysine was incorporated in the library where arginine was omitted. 
Cysteine was dismissed due to anticipated stability and storage issues and finally glycine and 
proline were not used due to their proposed minor role in recognition events. The six natural 
amino acids that were removed from the library were replaced by various unnatural side 
chains with a proven ability to bind in protein – protein and protein – peptide interactions. 
These were O-methyl tyrosine (TyrMe), naphthyl (Nap) and 4-chlorophenylalanine [Phe(4Cl)] 
as well as the aforementioned one carbon extension residues, namely homophenylalanine 
(HoPhe), homotyrosine (HoTyr) and 4-chlorohomophenylalanine [HoPhe(4Cl)]. The 20 
residues were incorporated into the library in their terminal amine form at the R
1
 and R
2
 
positions and in their terminal carboxylic acid form at the R
3
 position. 
 The proposed retrosynthesis of the library is shown in Scheme 13. It was suggested 
that the 4200 target compounds could be reached by acylation of the pyrrolidine nitrogen in 
compound 77 using the carboxylic acids of the 20 selected side chains. The 210 compounds 
that comprise 77 were derived from the Troc-protected precursor 78. The second side chain 
was then removed to give carboxylic acid 79, which was obtained from methyl ester 80. The 
final side chain was removed to give another carboxylic acid precursor 81, which was derived 
from the benzyl functionalised compound 82. Finally, 82 was prepared via a [3+2] dipolar 
cycloaddition leading to starting materials 83 and 84, which are both synthetically accessible. 
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Scheme 13: Retrosynthetic Analysis of Mimetic Library 
 
With a reasonable retrosynthesis in place, Boger and co-workers were confident to 
begin work on the forward synthesis. The first step involved the reaction of benzylamine with 
chloromethyltrimethylsilane to yield N-benzyl-N-(trimethylsilyl)methylamine (Scheme 14). 
This was then treated with formaldehyde under basic conditions to produce compound 83. 
This material was utilised in a [3+2] cycloaddition reaction with benzyl methyl fumarate 84 to 
furnish substituted heterocycle 82.
81
 The benzyl groups were removed by hydrogenolysis 
catalysed by Pd(OH)2/C and the resulting free amine was then Troc-protected by reaction with 
2,2,2-trichloroethyl chloroformate to give core template 81 for subsequent functionalisation. 
 
Scheme 14: Synthesis of Core Fragment 81 
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With this structure in hand, synthetic efforts diversified to include the various side 
chain groups that had been selected earlier (Scheme 15). The first peptide coupling was 
carried out to install R
1
 using EDCI/HOAt-mediated coupling conditions. This coupling 
protocol was successful in all cases, giving the 20 distinct amide compounds, 80 in variable 
yield. The next stage involved removal of the methyl ester in preparation for the subsequent 
peptide coupling reaction. This transformation was accomplished by treatment of the ester 
with LiOH giving carboxylic acids 79. 
The EDCI/HOAt conditions were also utilised in the second peptide coupling to form a 
group of 210 trans-pyrrolidine-3,4-dicarboxamides (78). Purification was performed at this 
stage using standard acid-base extraction techniques to remove unwanted starting material, 
byproducts and reagents. The Troc protecting group was removed using activated zinc 
nanopowder in a 2:1 mixture of THF/AcOH
82
 to yield secondary amine 77. The material 
obtained at this stage was purified by filtration through a pad of Celite
®
 to remove traces of 
zinc, followed by concentration in vacuo with a toluene azeotrope. Traces of acetic acid were 
removed by dissolving the residue in methanol and passing it through a short column of basic 
silica gel. These steps ensured the isolation of high purity amines. Aqueous base extraction 
was unsuitable for use at this stage because there was low product recovery in some instances 
due to aqueous solubility of the product. 
The final peptide coupling was performed by reaction of an excess of the free amines 
77 with equimolar mixtures of the 20 carboxylic acids containing the R
3
 side-chains. The 
EDCI/HOAt coupling conditions were used once again and excess base was removed at the 
end of the reaction by extraction with aqueous acid. Global deprotection was carried out using 
a 3:1:1 mixture of TFA/MeOH/H2O. This removed Boc, tert-butyl ester, TIPS and trityl 
groups within 12-16 h to give 210 mixtures of 20 functionalised trans-pyrrolidine-3,4-
dicarboxamides (76). Time consuming chromatographic techniques were avoided in the latter 
stages of the synthesis, which is extremely useful when synthesising such a large number of 
different compounds. 
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Scheme 15: Library Synthesis of 4200 Mimetic Structures 
 
 Boger and co-workers synthesised the final targets as mixtures in order to allow 
identification of the most potent compound families in opioid receptor binding studies. Once 
the most effective families had been identified, the individual compounds from each family 
could be isolated, thus avoiding the unnecessary purification of thousands of individual 
compounds. The end result of the synthetic scheme described above was 210 mixtures of 20 
compounds, with different R
3
 functionality. The successful coupling of 77 to the mixture of 
carboxylic acids was confirmed using mass spectrometry techniques to analyse a selection of 
20 of the mixtures. Furthermore, the quality of the mixtures was demonstrated by HPLC 
analysis of one of the mixture samples. A control sample of this mixture was produced by 
individual synthesis of the 20 compounds and equimolar mixing of the products. Although 
separation of all 20 compounds is not possible by HPLC, both the control and the originally 
synthesised compound mixture were found to have nearly identical detection profiles. This 
confirms, not only that the 20 compounds are in the mixture, but also that they are present in 
approximately equimolar amounts. 
Following the preparation of 210 final mixtures it was possible for Boger and 
co-workers to undertake screening to determine activity against multiple opioid receptors. The 
mixtures were screened at 10 μM concentration (0.5 μM per compound) in radioligand binding 
studies with cloned human receptors. The compounds showed improved inhibition of 
κ-receptors over μ-receptors and least inhibition of δ-receptors. The initial screening of 
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mixtures revealed some additional important data. It was apparent that there was a strong 
correlation between the presence of a hydrophobic aromatic side chain and the binding affinity 
of the substrate. The Phe(4Cl), Trp and Nap showed strong inhibition of the κ-receptors, where 
HoTyr, Trp and HoPhe(4Cl) showed strong inhibition of the μ-receptors. One exception to this 
finding was the potent inhibition observed with the presence of a basic His side chain, when 
combined with a bulky aliphatic side chain such as Val or Leu. 
Based on these findings, three compound mixtures were chosen for deconvolution so 
that individual binding studies could be performed whilst varying each of the substituents. The 
mixtures, and their initial results, are shown in Table 3, alongside structural representations of 
the mimetic and the chosen side chains. The mixture with Trp/Phe at R
1
/R
2
 was chosen due to 
its close resemblance to the endomorphin-1 sequence. This sequence also contains compound 
73, which was used in the initial studies carried out before library synthesis. The Trp/Phe(4Cl) 
mixture is structurally similar to the Trp/Phe mixture with the addition of a 4-Cl substituent. 
This appeared to enhance the binding affinity for both μ- and κ-receptors, hopefully meaning 
that some potent compounds can be found in this mixture. The final mixture that was chosen 
included Phe(4Cl)/Phe(4Cl) at R
1
/R
2
. This mixture showed the highest affinity for κ-receptors 
and also the greatest difference between the affinity for κ-receptors and μ-receptors. These 
mixtures were deconvoluted by resynthesising separate constituents from precursor 77, giving 
60 distinct compounds for screening. 
N
R3
O
O
NH
R2
O
NH
R1  
 
Table 3: Families of Compounds Selected for Deconvolution 
R
1
/R
2
 
Sidechains 
% Inhibition 
κ-receptors μ-receptors δ-receptors 
Trp/Phe 73 56 25 
Trp/Phe(4Cl) 86 66 26 
Phe(4Cl)/Phe(4Cl) 91 48 18 
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 The 60 compounds were screened at 10 μM concentration for activity at μ- and 
κ-receptor sites, again using radioligand binding assays. Focusing initially on the μ-receptor 
selectivity, it was expected that Tyr and HoTyr would be the most effective side chains at the 
R
3
 position based on the proposed mimicry of the endomorphin-1 peptides. As a brief 
reminder, these two side chains are illustrated in Figure 33. 
 
Figure 33: Most Effective R
3
 Side Chains 
  The most effective combinations of the three side chains are clearly illustrated in 
Figure 34. The results were encouraging and they confirmed the effectiveness of the Tyr and 
HoTyr groups at R
3
. This suggests that the presence of the free phenol can play a role in 
recognition of the structure at μ-receptor sites It was found that the most effective 
combinations were with HoTyr at the R
3
 position when Trp/Phe and Trp/Phe(4Cl) were 
located at R
1
/R
2
 (structures 73 and 86 respectively) and with Tyr at R
3
 with Phe(4Cl)/Phe(4Cl) 
at R
1
/R
2
 (structure 87). Substrates possessing other aromatic side chains at R
3
 were found to be 
consistently less effective, with aliphatic or charged side chains exhibiting even lower activity. 
N
R3
O
O
NH
R2
O
N
H
R1 73 R1 = Trp, R2 = Phe, R3 = HoTyr
86 R1 = Trp, R2 = Phe(4Cl), R3 = HoTyr
87 R1 = Phe(4Cl), R2 = Phe(4Cl), R3 = Tyr
 
Figure 34: Structures with Highest Activity Towards μ-Receptors from Each R1/R1 
Family 
 
 Screening of all 60 of the compounds against all three receptor types clearly showed 
that this type of structure shows a significantly higher affinity for κ-receptors. Of the three 
series that were deconvoluted for more detailed examination it was found that in general they 
followed a trend of activity; Phe(4Cl)/Phe(4Cl) > Trp/Phe(4Cl) > Trp/Phe. The most active 
compounds from the two most active series are shown in Figure 35. Interestingly, the most 
active compound 88 not only exhibited high activity, it also had high selectivity for 
κ-receptors and was >100-fold more selective in comparison to the δ- and μ-receptors. This 
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result also highlights a difference in interaction between the κ- and μ-receptors as the free 
phenol functional group is clearly not essential for binding to the κ-receptors as it is for the 
μ-receptors. The synthesis of this ambitious library of compounds had successfully led to 
identification of several opioid active structures with potential for future study. 
N
R3
O
O
NH
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O
N
H
R1 86 R1 = Trp, R2 = Phe(4Cl), R3 = HoTyr
88 R1 = Phe(4Cl), R2 = Phe(4Cl), R3 = Phe(4Cl)
 
Figure 35: Structures Exhibiting Highest Activity at κ-Receptor Sites 
 
 
1.3.8 Summary 
This selective overview of recent research into β-turn mimetics serves to highlight the 
diversity that can be incorporated into these structures. Considering how diverse an area 
heterocyclic chemistry is, there are virtually endless avenues for exploring cyclic and bicylic 
structures as a means of stabilising a turn conformation. The field of peptidomimetics has been 
of interest to researchers for many years now and a wide array of structures has been 
developed by various groups internationally. The examples presented here are merely a 
selection of those that have been published within the last decade. Efforts are still ongoing, 
with mimetic structures being published in the literature on a regular basis.
83,84 
The impressive biological activity of many of these mimetic structures demonstrates 
the utility of this approach. At a time when there is a need to develop novel drugs and 
medicinal treatments, the design, synthesis and application of peptidomimetics is a potentially 
important area that can not be ignored. In the examples selected above, various cyclic cores 
have been used to tether the peptide chain to enforce a turn and there is a common theme of 
trying to develop generic library approaches for the preparation of these structures. The ability 
to access large numbers of similar compounds quickly is an important aspect in this chemistry 
and the work of Boger and co-workers is certainly one of the most ambitious attempts to adopt 
this approach. 
The effort to understand proteins and peptides and their interactions in biological 
systems is an ongoing endeavour across several scientific disciplines. Research in this area lies 
at the interface between biology, chemistry and peptide science and has shown great promise 
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already. In coming years, this field will continue to grow and new insights and understanding 
will be gained, leading to new drugs, vaccines and medicines. 
The following sections introduce some of the chemistry that has been developed in the 
synthesis of ynamides. This type of functional group is of particular importance in this project. 
 
1.4 Ynamides and their Synthesis 
 
1.4.1 Introduction 
Hetero-substituted alkynes have become important intermediates in the development of 
new synthetic methodology. One of the most prominent classes of heteroatom substituted 
alkynes is that in which an amino group is located on one terminus of the triple bond.
85
 
Ynamines in particular have been valuable in synthetic chemistry since a practical synthesis of 
them was developed in the 1960s. The first recorded attempt to synthesise an ynamine was by 
Bode in 1892,
86
 but this was unsuccessful. It was not until 1958
87
 that Zaugg and co-workers 
isolated the first ynamine and a subsequent synthesis was reported by Wolf and Kowitz in 
1960.
88
 However, it was not until 1963 that a practically accessible synthesis of ynamines was 
reported by Viehe and co-workers (Figure 36).
89
 In the decades that followed this discovery, 
ynamines were of significant interest as intermediates and found applications in organic and 
organometallic chemistry.
90 
 
Figure 36: Viehe’s Practically Accessible Ynamine Synthesis 
 
Ynamines are of interest to the synthetic community because they exhibit high 
reactivity and are predictably regioselective in their transformations. Figure 37 illustrates 
clearly how the nitrogen heteroatom at one end of the alkyne imposes an electronic bias on the 
triple bond so that any reaction that takes place is dictated by the nucleophilic and 
electrophilic substituents involved. 
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Figure 37: Electronic Bias of Ynamines in Synthetic Reactions 
 
Unfortunately, the high reactivity of ynamines is also a major drawback because it 
means these compounds are sensitive towards hydrolysis, leading to difficulties in synthesis 
and handling. For this reason the use of ynamines in organic synthesis has been somewhat 
limited. Protonation of the alkyne derivative leads to the formation of a keteniminium 
intermediate, which is quickly trapped by water leading to the formation of an amide as 
demonstrated in Scheme 16. The synthetic uses of ynamines have been explored thoroughly 
since their initial synthesis; but they are often regarded as a scientific curiosity by organic 
chemists due to their high reactivity and difficulties handling them. As a consequence, any 
potential for synthetic use has declined in recent decades. 
 
Scheme16: Hydrolysis of Reactive Ynamines 
 
Logically, a possible method to stabilise ynamines and make them more synthetically 
applicable is to reduce electron density by introducing an electronegative substituent onto the 
nitrogen or the alkyne. There have been many attempts to explore these electron-deficient 
ynamine systems with some innovative approaches. Figure 38 shows some structures that have 
been synthesised to this end, utilising various aromatic substituents for example. There have 
also been investigations into the synthesis of push-pull ynamine systems in which an electron-
withdrawing group is positioned at the opposite side of the alkyne, such as those reported by 
Ishihara
91 
and Stang.
92
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Figure 38: Electron-Deficient Ynamines 
 
 Despite the many solutions to the ynamine reactivity problem, one class of compound 
has emerged as the ideal alternative in the last 15 years. By simple introduction of an electron 
withdrawing carbonyl group onto the nitrogen, thus converting the amine into an amide or 
carbamate, the ability of the nitrogen to donate electrons into the alkyne is dramatically 
curtailed, due to resonance delocalisation into the carbonyl oxygen (Figure 39). 
 
Figure 39: Carbonyl Versus Alkyne Electron Withdrawal 
 
These ynamides offer the perfect balance between reactivity and stability that 
ynamines cannot provide.
93
 The synthesis of the first ynamide was reported by Viehe in 
1972,
94
 the structure of which is displayed in Figure 40. Despite the apparent synthetic utility 
of ynamides, there were very few reports of ynamide synthesis over the 25 years that followed 
Viehe’s synthesis, with some literature articles appearing only in the late 1990s. 
 
Figure 40: Structure of Viehe’s Ynamide, 197294 
 
While other heteroatom bonded alkynes are valuable intermediates, nitrogen bonded 
alkynes are particularly important for several reasons.
93
 The trivalent nature of nitrogen allows 
for the tethering of a chirality-inducing unit to allow asymmetric induction in subsequent 
transformations. It also allows for the inclusion of the coordinating unit, which leads to 
conformational rigidity. There is a great deal more flexibility when designing intramolecular 
reactions than when using oxygen or sulfur substituted alkynes. 
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In the past 10 years interest in ynamides has increased rapidly with numerous groups 
publishing methods for their synthesis and application in synthetic chemistry. The field of 
ynamine chemistry has essentially been revived in the form of ynamide chemistry. As work 
progresses towards truly general synthetic methods with broad applicability, the synthetic 
utility of ynamides will only increase. The following sections will give some insight into the 
various methods available to access ynamides and the degree to which they are useful as 
intermediates in organic synthesis. For generality, nitrogen bonded alkynes containing other 
types of amide functionality, such as carbamates or sulfonamides, will be referred to under the 
broad term of ynamides. 
 
1.4.2 Isomerisation Methods 
The synthesis of ynamides by isomerisation is of limited scope and applicability, but is 
still appropriate in certain circumstances. Only a handful of successful isomerisation reactions 
have been used for the preparation of ynamides. The method was originally used to synthesise 
an ynamine in 1958 as reported by Zaugg (Scheme 17).
87
 
 
Scheme 17: Zaugg’s “Unusual Reaction of Propargyl Bromide” 
 
In this case, Zaugg and co-workers were trying to alkylate phenothiazine using 
propargyl bromide to give N-(2-propynyl)phenothiazine 91 but the unexpected ynamide 
isomer N-(1-propynyl)phenothiazine 90 was obtained instead. The N-alkylation reaction took 
place successfully but the resulting terminal alkyne was isomerised in situ to give the ynamine 
instead of the propargylic amine. 
This approach was used by Galy
95,96
 and Katritzky
97
, some 20 years later, in order to 
access aromatically functionalised ynamines. Galy and co-workers reported the propargylation 
of acridones 92 using phase transfer conditions (Scheme 18). These workers were 
investigating the preparation of functionalised acridanone derivatives because the compounds 
are known to possess therapeutic properties. The resulting terminal alkyne was isomerised in 
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situ to yield the target ynamide 93 in yields ranging from 55-80%. Interestingly, Galy also 
reported that when only a 12.5% aqueous solution of KOH was used over a shorter reaction 
time, the corresponding allenamide was isolated instead.
96
 
Katritzky and co-workers reported the use of the reaction to prepare ynamine 93 from 
amine 92 in a two-step process. The procedure involved propargylation of 92 by treatment 
with NaH and propargyl bromide. The resulting alkyne was isolated and isomerised to give 
ynamine 93 using KOH.
 
 
 
Scheme 18: Galy’s Reported N-Alkylation/Isomerisation Sequence 
 
Despite early success in using this approach to synthesise ynamines, it was not applied 
to ynamide synthesis until 2001.
98
 During investigations into development of a valid route to 
ynamides, Hsung and co-workers attempted to synthesise chiral ynamides but with limited 
success, initially (Scheme 19). 
 
Scheme 19: Hsung’s Initial Attempts at Isomerisation Approach 
 
In 2002, Hsung reported isomerisation of propargyl amides 94a-c to give their 
ynamide counterparts 96a-c upon treatment with KOt-Bu.
99
 The results of these reactions are 
illustrated in Scheme 20. 
 
 
Scheme 20: Hsung and Co-Workers Isomerisation 
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This chemistry was then extended to the preparation of ynamides containing alkene 
functionality in order to carry out subsequent ring-closing enyne metathesis. Examples of 
enyne ring-closing metathesis reactions performed on C1-heteroatom-substituted alkynes were 
only reported very recently, prior to this work (Scheme 21).
100
 Hsung and co-workers were 
successful in demonstrating several examples of enynamide metathesis using the Grubbs 
second generation catalyst,
101
 and reported the first examples of tandem RCM of diene-
ynamides. This sequence of reactions allows the synthesis of fused heterocyclic systems in 
good yield and is indicative of the value of ynamides as synthetic intermediates. 
 
 
Scheme 21: Hsung’s Enynamide Metathesis Products 
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1.4.3 Elimination 
Elimination is an approach that was originally used by Viehe in 1972
94
 to generate the 
first ynamides (Scheme 22). The simple amide 97 was reacted with phosgeneimmonium 
chloride 98 to deliver the chloroformamidinium salt 99. This compound then underwent 
hydrolysis to provide urea 100 in 89% yield. Finally, HCl was eliminated from the double 
bond to give the desired ynamide 101 in 64 % yield. 
 
Scheme 22: Viehe’s Ynamide Synthesis 
 
Several groups have attempted the synthesis of ynamides using this approach including 
Hsung
98,99
 and Brückner,
102
 with the latter having explored the conversion of formamides to 
dichlorovinylamides, followed by dehalogenation. An improved protocol for the elimination 
reaction was reported by Saá and co-workers in 2004. 
103
 They were inspired to use metal-
mediated cross coupling reactions. Initially, Sonogashira conditions were tested resulting in 
the formation of complex mixtures of compounds of which the most prominent were dimeric 
alkyne products. Subsequently, Negishi coupling reactions were tested, but these resulted in 
only partial consumption of starting material, isolation of the alkyne dimer product and in 
some cases very poor yields of the desired coupled product. 
The results described above encouraged Saá and co-workers to focus on the slightly 
different approach shown in Scheme 23. Starting with β,β-dichloroenamides 102, treatment 
with n-BuLi followed by transmetallation with ZnBr2 gave the desired zinc acetylide 103. 
Following installation of zinc onto the terminal alkyne to give an alkynyl zinc reagent, it was 
possible to perform Negishi coupling with various aryl iodides to deliver the required 
ynamides 104. Saá demonstrated the utility of this procedure by presenting several examples 
of the reaction giving excellent yields. It is worth noting that the Sonogashira approach was 
further perfected by Hsung and co-workers in 2004.
104
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Scheme 23: Saá’s Improved Elimination Procedure 
 
Saá and co-workers re-visited this area of chemistry in 2007
105 
with a further modified 
procedure (Scheme 24). Having treated compound 102 with n-BuLi, the resulting lithium 
acetylide could be quenched with various electrophiles to give products possessing a wider 
variety of functionality adjacent to the alkyne.  
 
 
Scheme 24: Saá’s Further Modified Approach to Ynamide Synthesis 
 
Both isomerisation and elimination approaches to ynamide synthesis have their merits 
and are worth considering when designing a synthetic pathway towards these compounds. 
However, both methods lack the wide scope of applicability that is desirable in any synthetic 
procedure. In order to make ynamides truly accessible to the synthetic community it was 
essential to develop more robust methods that would be effective for the preparation of a 
diverse range of structures with various functional groups. 
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1.4.4 Synthesis Using Alkynyliodonium Salts 
The reaction of alkynyliodonium salts with lithiated amines has proven to be an 
effective means of accessing ynamides, and especially for the preparation of sulfonyl-
substituted ynamides. This approach was first reported by Stang in the 1990s to synthesise 
ynamine 107 (Scheme 25).
92,106
 It is believed that this reaction proceeds via a vinylcarbene 
intermediate that is first generated by nucleophilic addition β to the iodine and this is followed 
by a 1,2-shift to form the acetylide. 
  
Scheme 25: Stang’s Ynamine Synthesis and Proposed Mechanism 
 
It was by this method that the first chiral ynamides were synthesised in 1996. Feldman 
and co-workers
94,107
 reacted electrophilic iodonium triflates 109 and 112 with chiral 
sulfonamides 108 and 111 (Scheme 26). Feldman performed these reactions while 
investigating 1,5 C-H insertion reactions. The use of the more electrophilic alkynyliodonium 
triflate salts was expected to overcome some of the problems of low reactivity and lengthy 
reaction times. Instead of promoting the reaction of interest, these salts prevented formation of 
any of the 1,5 C-H insertion products and delivered ynamide products instead. The chirality 
was preserved during the reaction and the outcome was the successful synthesis of the chiral 
ynamides 110 and 113, albeit in moderate yields. 
Introduction 
 59 
 
Scheme 26: Chiral Ynamides Synthesised by Feldman 
 
 Additional studies have been performed by Witulski and co-workers
108
 using this 
method of ynamide synthesis. The aim of these studies was to explore the proposed 1,2-shift 
mechanism of the reaction and probe the various steric factors that affect its outcome. Witulski 
was successful in synthesising a range of ynamides of general structure 116 in up to 89% 
yield. In cases where α-branched amides were used, it was found that lower yields were 
observed suggesting that steric factors are an issue in this type of ynamide synthesis. Witulski 
and co-workers also demonstrated that terminal ynamides could be obtained by treatment of 
the silylated products 116 with TBAF to remove the TMS group. The products 117 were 
obtained in moderate to good yields using this procedure. In later studies from Witulski and 
co-workers a terminal ynamide was synthesised directly using compound 118. 
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Scheme 27: Witulski’s Studies of the Alkynyliodonium Triflate Approach 
 
By the end of the twentieth century the use of alkynyliodonium salts seemed to be the 
most effective method of producing ynamides. Unfortunately, this method still suffered from 
some serious limitations that curtailed its widespread use in organic synthesis. The main 
drawbacks are the lack of availability of the starting iodonium salts and the fact that it is 
necessary for them to be substituted by a silyl, aromatic or electron-withdrawing group for the 
reaction to be successful.
109  
There are severe practical limitations for all three of the methods that have been 
described thus far. Low substrate scope, harsh reaction conditions and lengthy reaction 
sequences resulted in a lack of generality towards ynamide synthesis and resulted in the very 
slow growth of this field. It has only been within the past decade that efficient methods have 
been developed with a sufficient breadth of applicability to allow appropriately functionalised 
ynamides to be readily accessible to those working in a wide range of research areas. 
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1.4.5 Amidative Cross Coupling Methods 
The first example of ynamide synthesis via a metal-mediated process was reported by 
Balsamo and Domiano in 1985.
110
 The authors were attempting to carry out a reaction to 
displace the iodine in 120 with the copper acetylide of 121 but to their surprise, ynamide 122 
was the sole product and its structure was confirmed using X-ray crystallography (Scheme 
28). In this example, a stoichiometric amount of CuCl was used to promote the reaction. 
 
Scheme 28: Metal-Mediated Amidation of a Terminal Alkyne 
 
 This approach had not been widely utilised in chemical synthesis until recent years, 
after Hsung and co-workers advanced the field in 2003.
111
 The authors were inspired by the 
work of Buchwald and Hartwig
112-114
 towards the N-arylation of amines. It was their belief 
that a metal mediated coupling of an alkynyl halide and an amide would have wide scope. To 
this end Hsung and co-workers began to research this approach initially using palladium-
catalysed conditions.
115
 Reactions with alkynyl halides and stannylated or other metalated 
amides were tested with little success. Instead of the desired amidation taking place at the 
alkyne, the dominant reaction was instead alkyne homocoupling. 
When looking for possible alternative procedures, Hsung and co-workers were 
encouraged by some recent work in copper catalysed N-arylation of amines.
116,117
 The reaction 
between oxazolidinone 123 and alkynyl iodides 124 was used to test and optimise the reaction 
conditions. The optimal conditions are depicted in Scheme 29, but at this stage the results 
were still highly variable and homocoupling of the alkynyl iodides continued to be a problem. 
 
Scheme 29: Hsung’s Amidation Protocol Using Alkynyl Iodide 
 
The homocoupling problem was overcome by replacing the iodides with alkynyl 
bromides. It was also found that whilst CuI was an effective catalyst for the reaction, CuCN 
provided more consistent results overall. The general protocol involved performing at reflux in 
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toluene in the presence of K3PO4 as a base (Scheme 30). This procedure was particularly 
effective for the alkynylation of oxazolidinones and lactams, affording the ynamides 128 in 
good to excellent yield. Unfortunately, when the reaction was applied to imidazolidinones and 
sulfonamides, very poor yields were obtained. Nevertheless, this type of reaction was a major 
breakthrough in the search for an atom economical and efficient method to synthesise 
ynamides. Further research was required in order widen the substrate scope of the reaction. 
 
Scheme 30: Hsung’s Optimised 1st Generation Amidation Protocol and Examples 
 
At the same time as Hsung was developing his protocol, Danheiser and co-workers 
described another procedure for the copper-catalysed amidation of alkynyl bromides,
118
 as 
illustrated in Scheme 31. In this procedure, a stoichiometric amount of CuI was used to 
generate the copper derivative, which reacts with the deprotonated amide or carbamate. 
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Scheme 31: Danheiser’s Stoichiometric Cu(I) Protocol 
 
This protocol resulted in good to excellent yields of the product and was shown to be 
tolerant of a variety of functional groups. Its utility was also successfully demonstrated in 
several multi-gram scale reactions. Of course this is not a catalytic process, but the metal that 
is used is relatively cheap and so this is not a serious drawback to the overall efficiency of the 
reaction. In addition, the reaction was used to alkynylate some sulfonamides for which 
Hsung’s procedure had proved to be unsuccessful. This protocol also had the advantage that it 
can be performed at room temperature, thus making it a viable route for the preparation of 
thermally sensitive ynamides. 
In 2004, Hsung and co-workers reinvestigated this area and published a modified 
approach to ynamide synthesis (Scheme 32). 
118,119
 In this second generation protocol, Hsung 
and co-workers used copper sulphate pentahydrate as the copper source, 1,10-phenanthroline 
as a ligand and K3PO4 as the base. This proved to be a more efficient and general approach to 
generating ynamides than the first generation protocol. The reaction was carried out in toluene 
at temperatures below reflux and in some cases as low as 60 °C. This approach was useful for 
the reactions of substrates that had proven difficult using the first generation protocol. 
 
 
Scheme 32: Hsung’s 2nd Generation Amidation Protocol 
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Hsung and co-workers continued to demonstrate the synthetic utility of this protocol by 
successfully applying it to several intramolecular examples. Nitrogen-containing cyclic 
systems with rings ranging from 9- to 19-members (compounds 135 to 138, Figure 41) were 
successfully prepared. The ability to synthesise nitrogen-containing heterocycles means that 
this chemistry is of interest from the perspective of natural product synthesis. Having said this, 
the yields fall dramatically with larger ring sizes, likely due to the entropic cost of cyclising 
longer chain lengths. 
 
Figure 41: Intramolecular Amidation Products 
 
Progress towards synthetically accessible ynamides in the past 10 years has brought 
this class of compound into mainstream organic chemistry. The pioneering work of Hsung and 
Danheiser in advancing this field has been built upon in subsequent years, with several other 
research groups making their own contributions. Some notable efforts include the synthesis of 
ynamides from 1,1-dibromo-1-alkenes that was published by Evano and co-workers
120
 and the 
copper catalysed aerobic oxidative amidation of terminal alkynes as published by Stahl and 
co-workers
121
 as shown in Scheme 33. 
 
 
Scheme 33: Upper: Evano Protocol, Lower: Stahl Protocol 
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There was also an interesting procedure published by Zhang and co-workers
122
 in 2009 
in which an iron source (FeCl3·6H2O) was utilised alongside DMEDA to give successful 
coupling (Scheme 34). This provided access to ynamides by reaction with a selection of 
oxazolidinone and sulphonamide starting materials. This reaction had the added benefit of 
utilising an inexpensive and environmentally benign catalyst. 
 
Scheme 34: Zhang’s Iron Catalysed Amidation 
 
This field of chemistry methodology is continuing to produce versatile procedures for 
ynamide synthesis
123,124
 and will undoubtedly continue to do so in future. The number of 
publications describing the use of ynamide synthesis methods to produce useful intermediates 
is steadily growing, demonstrating the potential synthetic value of these compounds. 
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1.4.6 Summary 
Ynamides are a class of compound that the synthetic community has been aware of for 
some time. Until recently, however, they have been under-utilised despite their clear value in 
organic synthesis, largely because of their inaccessibility. In the past 10 years this situation has 
changed drastically, and while the field of ynamide synthesis will continue to improve through 
innovation and new approaches, chemists now have practical tools to access ynamides quickly 
and easily.
125 
As a direct result of the latest metal mediated coupling conditions that are being used 
in ynamide synthesis, the number of ynamides being used as intermediates in organic 
syntheses has increased dramatically. Evano and co-workers accurately described this as an 
“ynamide boom” in their review of synthetic applications of ynamides in 2010.109 
As has already been discussed, ynamides are excellent substrates for regioselective 
addition of electrophiles and nucleophiles due to their unique electronic properties (Figure 42). 
This is a property that they share with their ynamine counterparts. 
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Figure 42: General Reactivity of Ynamides 
 
Ynamides can now be functionalised in a variety of ways, meaning that they can be 
used to introduce unique structures into larger molecules. They can undergo oxidation and 
reduction reactions as a novel way of introducing, and then manipulating, functionality. They 
have also been shown to be competent reactants in several types of cycloaddition
126-128
  ring-
closing metathesis
100,129
 and cycloisomerisation reactions.
130
 This allows for the synthesis of 
nitrogen-containing heterocycles, which are desirable targets and intermediates in many areas 
of chemistry including natural product synthesis and medicinal chemistry. 
The growth that has been demonstrated in this field in the past decade is impressive 
and there is no sign of it slowing down in the near future. As researchers become more 
acquainted with ynamides and methods of synthesising them are continually improved, even 
more novel and exciting uses for them will quickly become apparent. 
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Chapter 2 
Results and Discussion 
 
2.1 Introduction 
 β-Turn mimetics are promising tools in the fields of drug discovery and synthetic 
vaccines. The number of mimetic structures that have been reported and tested for biological 
activity in recent decades has exploded.
131-133
 Most of these structures have been based upon 
macrocyclic or bicyclic systems with functional handles located around the ring allowing 
incorporation of peptide chains found in the natural structures and the utilisation of library 
synthesis techniques to generate families of structurally related compounds for biological 
evaluation. 
 This type of research is in progress in several areas of medicinal chemistry and is a 
fertile area in which potential drug targets are abundant.
134-136
 Turn-like structures are 
particularly attractive targets for several reasons. Firstly, β-turns are present, or postulated to 
be present, in the active conformations of many naturally occurring peptides and proteins.
137
 
Secondly, β-turns are readily amenable to mimetic design due to their relative simplicity.138 
 Leu-enkephalin is one of two enkephalin opioid peptides that were discovered in 
1975
35
 and is a pentapeptide that binds to both δ- and μ-opioid receptors. Although an X-ray 
crystal structure of this peptide in its bound conformation has not been obtained, there is 
strong evidence to suggest that its biologically active conformation contains a β-turn.139 X-ray 
crystallography of unbound leu-enkephalin shows that it forms a β-turn, with a stabilising 
H-bond between the phenylalanine and tyrosine amino acid residues. As a result, the 
enkephalins have been a popular choice for validating β-turn mimetics. The aim of this project 
was to synthesise a macrocyclic ynamide unit that mimics the turn conformation of 
leu-enkephalinamide (Figure 43). 
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Figure 43: Leu-Enkephalinamide β-Turn Structures (139a and 140a) and Corresponding 
Mimetic Structures (139 and 140) 
 
 The ynamide functional group was chosen to act as a covalent tether and was expected 
to enforce the turn conformation of the extended chain and consequently rigidify it. 
Leu-enkephalin is conformationally flexible and can conceivably adopt a β-turn at several 
positions.
140
 This probably accounts for its ability to bind to different types of opioid receptor. 
Consequently, two mimetic structures, labelled 139 and 140, have been proposed as mimics 
for two corresponding turn structures, 139a and 140a, respectively. 
 The ynamide unit was selected as the covalent linker in the mimetic structure for 
several reasons. Firstly, the use of an ynamide retains as many of the original functional 
groups as possible in the mimetic target. The only group that is completely absent from the 
mimetic structures is the hydrogen bonded carbonyl group. Otherwise, maximum retention of 
functionality is achieved. Furthermore, the bond distances are appropriately similar between 
the ynamide unit and the hydrogen bonding in the natural substrate. Using known average 
bond lengths and calculating the total length of the bonds involved, the two chains of the 
reverse turn are stabilised at 4.14 Å distance from each other as illustrated in Table 4. The 
distance between equivalent N and C atoms in the natural peptide substrate is very similar at 
4.21 Å. This figure was calculated based on average carbonyl bond distances and 
measurements published alongside the X-ray crystal structure of leu-enkephalin. Of course the 
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hydrogen bonding in the natural structure is not as rigid as a covalent bond, and, as a result, 
the natural system will likely have more variation in distance than the covalent target. 
However, the ynamide unit should maintain a suitable distance across the turn that 
approximates that in the average representation of the natural turn structure. 
 
Table 4: Bond Lengths of Mimetic 
Atoms (Bonds) Bond Length (Å) Atoms (Bonds) Bond Length (Å) 
N–C 1.47 N to O distance 2.99 
C≡C 1.21 O=C 1.22 
C
sp–Csp3 1.46   
Total 4.14 Total 4.21 
 
 The advances that have been made in ynamide synthesis in the past decade are very 
encouraging and provided a potential route to access the desired structures.
109
 It is also 
worthwhile to note that one side of the ynamide linker incorporates a chiral centre into the 
structure. This raises the possibility of modifying stereochemistry and testing different 
stereoisomers for biological activity, thus opening an alternate avenue of investigation. 
 There are also several sites on the ring that can be modified to incorporate varied 
functionality, for example amino acid side chains. This versatility is important for 
peptidomimetics in order to screen numerous related structures.
141
 This type of diversity can 
probably be introduced in a general synthesis using commercially available protected amino 
acids. 
 A preliminary retrosynthesis (Scheme 35) suggests that the most efficient way of 
accessing the target macrocyclic mimetics would involve a combination of peptide coupling 
methodology and alkyne amidation coupling chemistry to construct the ynamide functional 
group. Beginning with target 139, the leucine fragment can be removed taking the structure 
back to the terminal phenylalanine residue that is protected, for example, as a methyl ester. At 
this stage, the ynamide ring can be opened giving tripeptide precursor 142. This can be further 
simplified, again using peptide disconnection to give dipeptide fragment 143 and alkynyl 
bromide fragment 144. Dipeptide 143 could be synthesised by amide coupling between 
suitably protected phenylalanine and glycine. 
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 Fragment 144 is significantly more complex than the dipeptide 143, due to the fact that 
it contains novel, non-peptidic functionality in the form of an alkyne. This fragment is a 
dipeptide analogue of glycine and tyrosine. This can be simplified by C-N bond disconnection 
to give the protected diamine 145 along with t-butyl bromoacetate. 
 
Scheme 35: Preliminary Retrosynthetic Analysis of Target Mimetic 139 
 
 A similar analysis can be utilised to inform the synthetic design of the alternative 
leu-enkephalinamide mimetic 140 and is illustrated in Scheme 36. The first step involves the 
removal of tyrosine residue by peptide disconnection. This leaves the cyclic ynamide that is 
ring-opened to give a linear tripeptide precursor 147. This can then be simplified using another 
peptide disconnection, to provide fragments 148 and 149. Dipeptide 148 could be synthesised 
from protected leucine and phenylalanine residues using standard coupling conditions. Finally, 
fragment 149 is simplified by C-N bond disconnection to give the 1,2-diamine 150. 
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Scheme 36: Retrosynthetic Analysis of Mimetic 140 
 
 Both of these retrosyntheses imply that well-known peptide coupling techniques will 
be used in the forward synthesis. This makes it possible to effectively tailor the syntheses, 
utilising diverse amino acids to install varied groups at the four possible sites of functionality. 
While the initial targets are analogues of leu-enkephalin, and the functional groups selected 
reflect this, further investigation could be carried out to incorporate alternate groups that may 
be found in other opioid peptides such as the endomorphins. 
 
  
2.2 Synthesis of Ynamide Model Compounds 
 
2.2.1 Original Model Compound Synthesis 
In order to proceed effectively and confidently with the synthesis of complex mimetic 
structures based on a 10-membered ynamide macrocycle, it was necessary to test the 
chemistry that would be used to construct the core structure. To this end, a simple model (151) 
of the ynamide macrocycle was selected as a target in order to test the alkyne coupling 
reaction that would be used to assemble the ring. The proposed key reaction is illustrated in 
Scheme 37. 
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Scheme 37: Coupling Protocol Towards Ynamide Core 
 
Sections of the mimetic structures could be synthesised using standard amide coupling 
methods which have been very well explored and for which there are many alternatives.
142-145
 
Accessible methods for ynamide synthesis are a fairly recent innovation and, although several 
new approaches to the synthesis of ynamides have been published in recent years, the 
chemistry is still in its infancy and as a result is not as robust as it should be. It was this 
chemistry that required further investigation in order to ensure that it was reliable enough to 
permit construction of the target macrocycles. 
A retrosynthetic analysis of the model target 151 is illustrated in Scheme 38. The first 
step in the retrosynthetic scheme was to disconnect the ynamide bond and open the ring, 
simplifying the target structure to give the tripeptidic precursor 152. The alkyne in this 
retrosynthesis is protected by a TMS group to prevent unwanted reactions either at the 
terminal alkyne or at the analogous alkynyl bromide. Structure 152 can be disconnected to 
give the fragments 153 and 154, implying a standard amide coupling reaction in the forward 
direction. Dipeptide 153 is a protected dipeptide that can be further simplified, again using an 
amide bond disconnection. This implies the use of protected phenylalanine t-butyl ester (155) 
and Boc-glycine (156) as two of the starting materials. The alkyne 154 was disconnected into 
two fragments (157 and 158) using a reductive amination protocol. The amino ester 158 is 
another protected derivative of glycine and so is easily obtained either commercially or 
through a simple esterification reaction. Fragment 157 can be synthesised using relatively 
straightforward procedures starting from propargyl alcohol. The use of derivatives of naturally 
occurring amino acids meant that the synthesis of the model target is simplified significantly. 
With the retrosynthesis in place it was possible to focus on developing the forward synthesis. 
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Scheme 38: First Proposed Retrosynthesis of Model Compound 
 
Several of the required fragments were easily synthesised as shown in Scheme 39. 
L-Phenylalanine was easily protected as its t-butyl ester by treatment with t-butyl acetate in 
the presence of perchloric acid.
146
 This compound was then coupled to Boc-glycine using 
standard DCC/HOBt conditions
147
 to produce the protected dipeptide 160. Glycine t-butyl 
ester (158) was synthesised by the reaction of t-butyl bromoacetate with liquid ammonia 
diluted in a solution of diethyl ether.
148
 The TMS protected alkyne 157 was synthesised from 
propargyl alcohol. This was accomplished by deprotonation of the terminal alkynyl group and 
reaction with TMSCl, followed by a PCC oxidation to generate the aldehyde as required.
149
 
With all of these fragments in place the aforementioned reductive amination of the aldehyde 
157 with the amine 158 was performed to obtain a coupling partner analogous to structure 
154. 
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Scheme 39: Synthesis of Individual Fragments 
 
The reductive amination reaction was performed using sodium triacetoxyborohydride 
(Scheme 40). This reaction was attempted several times but with little or no success. The 
reaction either did not proceed or produced only a minimal yield of the target amine. Several 
attempts were made to optimise the reaction but with little success; a yield of just 10% was 
obtained in the best case. The reaction was also carried out with the intention of isolating the 
intermediate enamine and then reducing this separately. Although enamine formation 
appeared to work well under these conditions, the intermediate decomposed during work up 
and could not be isolated. The amine material that was successfully isolated was promising 
however the inability to improve the yield to >10% rendered this approach unsuitable. 
 
 
Scheme 40: Reductive Amination Procedure 
 
In order to achieve a similar fragment, an alternate approach was considered. 
Pleasingly, using propargylamine as a starting material, treatment with p-toluenesulfonic acid 
in the presence of pyridine furnished the tosylated propargylamine 165 in excellent yield 
(Scheme 41).
150,151
 This compound was then N-alkylated using t-butyl bromoacetate in the 
presence of potassium carbonate to produce the required acetylenic fragment 166 in excellent 
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yield. Both of these reactions were reliable and provided clean material for subsequent 
transformation. 
 
 
Scheme 41: Alternate Synthesis of Acetylenic Fragment 
 
It quickly became apparent that by using protected dipeptide 160 there were obvious 
difficulties with subsequent steps in the synthesis. By removing the Boc protecting group 
under acidic conditions, the t-butyl ester would also be removed, meaning that the resulting 
carboxylic acid would have to be protected once again in order to proceed further. In order to 
avoid this problem, the dipeptide was synthesised as its methyl ester 167 starting from 
commercially available Boc-glycine and L-phenylalanine methyl ester hydrochloride (Scheme 
42). This was accomplished in good yield using standard DCC/HOBt coupling conditions. 
The N-alkylated intermediate 166 was deprotected under acidic conditions to give the 
carboxylic acid 169 in quantitative yield. Dipeptide 166 was deprotected using the same 
conditions, again giving the product in quantitative yield. Initially, the Boc deprotection 
reaction was worked up by neutralisation of the remaining TFA, extraction of the free amine 
of 168 into organic solution, and concentration in vacuo. This presented problems for the 
subsequent coupling step because the free amine was particularly insoluble in the reaction 
solvent. As a result, only partial reaction of the amine took place and the yields were very 
poor. As an alternative approach, the TFA salt 168 was isolated by concentration of the crude 
reaction mixture to remove all of the TFA; trace amounts were completely removed by 
concentration several times with toluene in vacuo, followed by an extended period under high 
vacuum. This was essential, as traces of TFA interfere with the subsequent coupling reaction.  
The TFA salt 168 was readily soluble in the CH2Cl2/DMF reaction solvent and it was 
successfully coupled with carboxylic acid 169 to give the acetylenic tripeptide 170. The next 
stage involved bromination of the terminal alkyne and the reaction was first attempted using 
recrystallised NBS and silver nitrate at room temperature. Unfortunately, the desired alkynyl 
bromide 171 could not be isolated. Instead TLC indicated the formation of a complex mixture 
of products suggesting that the tripeptide was brominated at several positions, including the 
desired one. Separation of the mixture of products was not possible as several of them were of 
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similar polarity. Consequently, it was decided that it would be necessary to introduce the 
bromine substituent at an earlier stage in the synthesis to bypass this difficulty. 
 
 
Scheme 42: Synthesis of Acetylene Bromide Precursor 
 
 Terminal alkyne 166 was successfully brominated using recrystallised NBS and silver 
nitrate to give compound 172 in excellent yield (Scheme 43). The ester functionality was 
removed using a 1:1 mixture of TFA and CH2Cl2, giving carboxylic acid 173 in quantitative 
yield. Finally, this fragment was coupled with dipeptide 168 using DCC/HOBt, to obtain the 
required cyclisation precursor 171. Although this final coupling reaction did not give the high 
yields observed in the previous peptide coupling reactions, it was adequate for the purposes of 
constructing this model compound and so was not optimised further. Having prepared the 
cyclisation precursor, the next stage was to test the ynamide coupling chemistry on this 
system. 
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Scheme 43: Early Installation of Bromide and Completion of Tripeptide Precursor 
 
 The field of ynamide synthesis has taken some dramatic strides forward in the past 
decade.
109
 This is largely due to the improved generality and accessibility that has been 
afforded by the development of metal mediated coupling reactions to prepare these systems. 
Much of this pioneering work has been performed by Richard Hsung and co-workers, and his 
second generation Cu(II) protocol is often regarded as the benchmark in ynamide synthesis.
119
 
This appeared to be an ideal procedure for the synthesis of cyclic ynamide 174, particularly 
because intramolecular variants of this transformation had already proven to be effective for 
the synthesis of medium-sized ring systems. It was found that cyclisation reactions leading to 
large ring sizes gave poorer yields with 9- and 11-membered rings showing the optimal 
results. Thus, target 174 falls into what should be the ideal category of substrates for 
cyclisation using this chemistry. The desired transformation is illustrated in Scheme 44 and 
involves coupling of the alkynyl bromide with the relevant amide centre to form the 10-
membered ynamide ring.  
 
 
Scheme 44:  Proposed Coupling Reaction Towards Macrocyclic Ynamide 
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Although there are two possible centres on which this bromide can potentially react, 
only one centre is really a feasible intramolecuar nucleophile. Reaction at the rightmost amide 
centre in structure 171 would result in a 7-membered ring 175 as illustrated in Figure 44. The 
linear alkyne system alone would make this ring size highly strained and most likely 
impossible, or at the very least highly unfavourable. 
 
Figure 44: Highly Strained Alternative 7-Membered Cyclisation Product 
 
Based on this reasoning, the relevant coupling reaction was approached with 
confidence and the 10-membered lactam was expected as the only product. 
 
 
2.2.2 Ynamide Coupling Reactions Towards Macrocyclic Core 
Initially, the coupling protocol was performed using standard literature conditions 
reported by Hsung and co-workers. This chemistry has been utilised extensively by others to 
synthesise ynamide intermediates that are suitable for further transformations.
119 
This particular reaction required the addition of 10 mol% of CuSO4·5H2O and 
20 mol% of 1,10-phenanthroline in the presence of two equivalents of K3PO4. Unfortunately, 
the precise reaction mechanism has not been elucidated, but it is likely to proceed via insertion 
of the copper into the alkynyl bromide and subsequent activation and coupling with the amide. 
Initial attempts to utilise Hsung’s second generation amidation protocol were 
unsuccessful (Scheme 45). In this case the reaction only showed limited progression with 
traces of possible products or decomposition fragments evident by TLC analysis. A large 
proportion of the tripeptidic starting material was isolated from the reaction mixture. The new 
product traces were analysed by NMR spectroscopy, which clearly indicated that they were 
not the desired structure and were deemed to be decomposition products. 
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Scheme 45: Attempted Intramolecular Amidation Using Hsung’s Conditions 
 
Following the failure to synthesise the required product using standard conditions, 
further experiments were performed under various conditions, the results of which are 
illustrated in Table 5. Hsung’s intramolecular protocol can also be performed using K2CO3 as 
the base and so the reaction was carried out with this modification as illustrated in entry 1. 
However, the reaction resulted in almost complete recovery of starting material; subsequent 
reactions were performed using K3PO4 as the base. 
In the literature examples, intramolecular reactions were carried out using a higher 
loading of catalyst than the intermolecular examples. Hsung’s procedure began using 10 mol% 
of copper catalyst and 20 mol% of the ligand, with successive additions to double the catalyst 
loading during the reaction. The intramolecular reactions were also performed at reflux over a 
prolonged period, four days in the longest case. In light of this, the coupling reaction was 
undertaken using progressively harsher conditions over longer reaction times. 
In entries 2 and 3 of Table 5, the loading was kept at 10 mol% and 20 mol% for the 
catalyst and ligand respectively. The temperature was increased slightly in entry 3, but there 
was no improvement in the reaction outcome – starting material remained and there were no 
identifiable products. Subsequently, entries 4 and 5 doubled the catalyst and ligand loading 
and increased the temperature further. Both of these examples showed the formation of new 
material. Although TLC analysis showed that only very small amounts of the products were 
present, separation of the constituents by chromatography for attempted characterisation was 
deemed to be worthwhile. Unfortunately, NMR analysis of the isolated material was 
inconclusive and the compounds were thought to be decomposition products. Reaction of the 
substrate at lower concentrations was investigated as a means of avoiding possible 
dimerisation reactions but unfortunately this did not give better results (entries 3 and 5). 
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Table 5: Attempted Amidation Using Hsung Protocol 
Entry CuSO4·5H2O 1,10-
Phenanthroline 
Base Conc. Temp. Result 
1 10 mol% 20 mol% K2CO3 15 mM 70 °C S.M. 
2 10 mol% 20 mol% K3PO4 10 mM 70 °C S.M. 
3 10 mol% 20 mol% K3PO4 5 mM 75 °C S.M. 
4 20 mol% 40 mol% K3PO4 10 mM 80 °C Slight Decomp. 
5 20 mol% 40 mol% K3PO4 3.7 mM Reflux Decomp. 
 
As the reaction conditions became progressively harsher there was further evidence of 
starting material decomposition. Under reflux, and using a double loading of the catalyst, the 
starting material was completely destroyed. The higher temperature of the reaction further 
stimulated decomposition and TLC analysis of the reaction showed a complex mixture of 
products with similar polarity. Efforts to isolate the constituent products did not deliver the 
desired macrocycle but gave mixtures of decomposition products instead. 
 Having encountered serious difficulties in using copper-catalysed amination of alkynyl 
bromides to affect the intramolecular coupling, several alternative procedures were 
investigated. The field of ynamide synthesis has been a fertile area of chemistry in recent years 
and so there are protocols that can be used to undertake this type of transformation. 
 Initially, the reaction was performed using iron-catalysed conditions reported by Zhang 
and co-workers.
122
 Their standard conditions involve the utilisation of FeCl3·6H2O as the 
metal source, DMEDA as the ligand and K2CO3 as the base. This example involves the 
reaction between an alkynyl bromide and an amide and is generally performed in toluene at 
90 °C. Zhang reported successful coupling when using oxazolidinones, sulfonamides and in 
one example, a 5-membered lactam. No examples were reported when the reaction was carried 
out intramolecularly, but the reaction was attempted nevertheless (Table 6, entry 1). In this 
case there was no indication that the reaction had progressed at all. No new products were 
evident in the reaction mixture after 22 hours and the starting material was recovered. No 
by-products or decomposition products were evident either. This negative result meant that the 
reacton did not merit any further investigation and alternative catalytic systems were explored 
instead. 
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It is worthwhile noting that subsequent to the publication of the iron-catalysed system, 
Buchwald and Bolm reported that in some cases, the outcome of the reactions can be 
significantly affected by the presence of trace amounts of copper.
152 
 Subsequent reaction conditions were tested using protocols that were developed and 
published independently by Hsung and Danheiser in 2003.
111,153
 Both of these protocols were 
instrumental in developing the field of metal catalysed amidation reactions as a method of 
preparing ynamides. Danheiser’s stoichiometric Cu(I) protocol was carried out using CuI and 
KHMDS at room temperature as detailed in the literature (Table 6, entry 2).
154
 It had shown 
some impressive versatility when used in the cases of small molecule reactions, but when this 
protocol was used in our intramolecular case, starting material was not consumed and new 
products were not isolated. 
The first generation Hsung amidation protocol utilised CuCN as a catalyst and the 
reaction was carried out at 90 °C in toluene. This protocol was not as effective in some cases 
when compared to the second generation protocol that Hsung published several years later. 
However, it was still worth attempting the reaction using our substrate because both 
procedures had produced similar results in the case of couplings involving standard amides 
(Table 6, entry 3). Unfortunately this reaction was also unsuccessful and there was no 
consumption of starting material. 
 
  
Table 6: Alternative Conditions for Amidation Reaction 
Entry Conditions Results 
1 FeCl3·6H2O, DMEDA, K2CO3 
Toluene, 90 °C 
No Reaction 
2 CuI, KHMDS, Pyridine 
THF, r.t. 
No Reaction 
3 CuCN, K3PO4, Pyridine 
Toluene, 90 °C 
No Reaction 
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Having investigated numerous conditions to affect the cyclisation, but without success, 
an alternative approach was considered. Rather than trying to perform ring closure by 
intramolecular reaction to give the ynamide, a group that can sometimes be difficult to 
produce and uses chemistry that is still in its infancy, it was decided to try and install this 
group earlier in the reaction sequence and then close the ring by amide bond formation in the 
last step (Scheme 46). Due to the likely ring strain in the target system, this would appear to be 
a more robust approach and uses well-established chemistry for the intended cyclisation 
reaction. The ring closing stage in the synthesis would now involve tried and tested chemistry 
that has been developed and perfected for decades. In addition, there is an abundance of 
different coupling reagents that could be used for amide coupling reactions and there are also 
many less conventional alternatives that could be explored in order to find the optimal 
approach. 
In the new approach, coupling of alkynyl bromide 172 with amide 167 would be 
carried out, followed by a double deprotection of the required termini to afford the cyclisation 
precursor 177. Finally, amide coupling chemistry would furnish the desired ynamide 
macrocycle 174. 
 
Scheme 46: Alternate Approach to Cyclic Ynamide Target 
 
Before this approach could be considered, the synthesis of the ynamide unit needed to 
be tackled. Utilising previously synthesised fragments 167 and 172, the reaction was carried 
out using Hsung second generation conditions and Danheisers stoichiometric approach 
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(Table 7, entries 1 and 2). This system was investigated despite there being two possible 
amide centres at which the desired coupling could take place. If the alkyne reacted at the 
carbamate nitrogen instead of the amide as was required, this would still have been an 
encouraging result because it would prove that the reaction was effective in the case of 
bromide fragment 172. Unfortunately, the reactions that were carried out did not proceed and 
only starting materials could be recovered from the crude mixtures. 
 
Table 7: Intermolecular Amidation Approach 
Entry Conditions Results 
1 CuSO4·5H2O, 1,10-Phenanthroline, K3PO4 
Toluene, 75 °C 
No Reaction 
2 CuI, KHMDS, Pyridine 
THF, r.t. 
No Reaction 
  
Following the setback described above, the ynamide coupling chemistry was explored using 
simpler substrates that had been described in the literature by Hsung and co-workers. The 
versatility of the procedures had been demonstrated in several intermolecular reactions 
involving small cyclic and acyclic amide compounds such as oxazolidinone 178 (Scheme 47) 
and so the required literature substrates were synthesised to allow attempted coupling with the 
relevant peptide fragments 167 and 172. Oxazolidinone 178 was synthesised from diethyl 
carbonate and 2-phenylglycinol in the presence of potassium carbonate. While the yield 
obtained from the reaction was not particularly good, sufficient quantities of the oxazolidinone 
were prepared for the subsequent test reactions to be explored. Alkynyl bromide fragment 179 
was obtained in excellent yield by reaction of phenylacetylene with NBS. 
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Scheme 47: Synthesis of Simple Amidation Substrates 
 
 With these simple substrates in hand, their coupling to the fragments 167 and 172 was 
tested first. It was thought that these substrates, which are known to couple effectively, would 
be useful to help probe the potential reactivity of our substrates in the desired coupling 
reactions. Due to the fact that fragments 178 and 179 had been coupled successfully using the 
Hsung second generation protocol, and because the versatility of this approach has been 
demonstrated in the literature, these conditions were the primary focus for the series of 
experiments shown in Scheme 48. 
 
 
Scheme 48: Amidation Coupling Experiments 
 
 The oxazolidinone 178 was reacted with alkynyl bromide fragment 172. The reaction 
was carried out over a prolonged period of time, but even after several days the reaction had 
not progressed. During this time, the reaction was supplemented with further catalyst and 
gentle increases in temperature, but to no avail. A second amidation reaction was carried out 
in parallel utilising phenylacetylene bromide fragment 179 with dipeptide fragment 167. The 
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progression of the reaction was monitored by TLC, which clearly showed newly developed 
product material. Following workup and isolation, NMR analysis of the new product showed 
that it was very similar to the alkynyl bromide starting material, suggesting that it was in fact 
the dimeric product 182 (Figure 45). In any event, it was clearly not the desired ynamide and 
thus the reaction was abandoned. 
 
 
Figure 45: Alkyne Dimer Product 
 
A subsequent variant of this reaction was performed at a higher dilution. The first 
reaction was carried out at ~50 mM concentration, whilst a subsequent reaction was carried 
out at ~10 mM. This alteration in concentration prevented formation of the putative 
dimerisation product, but, the desired product was not produced even after prolonged reaction 
times.  
 The failure of the experiments above led us to investigate the reaction using the 
specific conditions and substrates – compounds 178 and 179 – reported in the literature 
(Scheme 49). The reaction was attempted in an effort to compare laboratory yields with those 
reported in the literature. It was hoped that by investigating a specific reaction that was known 
to be successful, any intrinsic difficulties with the reaction procedure could be identified and 
understood. 
 
 
Scheme 49: Attempted Reproduction of Literature Example 
  
 Initially, when the reaction was attempted following the literature procedure, the best 
yield obtained was only 9%. In the literature it had been reported that the reaction could be 
carried out in greater than 80% yield. It quickly became apparent from the literature that there 
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were some reproducibility issues relating to the Hsung second generation protocol.
128
 In light 
of this disappointing preliminary result, it was decided that the best course of action was to 
optimise reaction conditions towards literature yields. These new conditions could then be 
applied to the desired intramolecular variant of the reaction. 
 
2.2.3 Optimisation of Amidation Reactions 
When performing the reaction in the manner described in the literature a high degree of 
variability in the yields was observed. Initially, the reaction failed to give any product, but on 
a subsequent attempt, the target compound was isolated in 9% yield (Table 8, entries 1 and 2). 
Both reactions were performed at almost the same concentration. The reaction seemed to be 
somewhat erratic, which pointed to some, as yet, undiscovered cause that affects its outcome. 
In the literature a yield of 88% was reported when this specific reaction was performed on a 
small scale
118
 and a yield of 71% was recorded when the reaction was performed on gram 
scale.
119
 
In a subsequent run, the reaction was carried out at a higher concentration but 
maintaining the temperature and catalyst loading (Table 8, entry 3). In this case, a sample of 
K3PO4 that had been dried for 12 hours in a Kugelrohr distillation apparatus was used. This 
gave a marked improvement in yield (43%), which was very encouraging. Unfortunately, a 
subsequent attempt using exactly the same reaction conditions on slightly larger scale gave a 
yield of only 22% (Table 8, entry 4). In further experiments, the reaction was performed using 
a stoichiometric amount of the copper catalyst, an approach previously adopted by Danheiser 
and co-workers, but this reaction also gave a yield of just 26 % (Table 8, entry 5). Finally, this 
reaction was attempted at higher temperature, but the yield was largely unaffected (Table 8, 
entry 6). The approach of drying K3PO4 immediately prior to reaction seemed to be somewhat 
unreliable in this reaction, but the approach was adopted further later in the project. 
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Table 8: Conditions Tested on Literature Reaction 
Entry CuSO4·5H2O 1,10-Phenanthroline Conc. Temp. Yield 
1 10 mol% 20 mol% 0.017 M 75 °C S. M. 
2 10 mol% 20 mol% 0.015 M 75 °C 9% 
3 10 mol% 20 mol% 0.85 M 75 °C 43% 
4 10 mol% 20 mol% 0.85 M 75 °C 22% 
5 1 eq. 2 eq. 0.34 M 75 °C 26% 
6 1 eq. 2 eq. 0.34 M 100 °C 24% 
 
In conjunction with these test reactions, the alternative approach pioneered by Evano 
and co-workers involving the reaction of a 1,1-dibromoalkene and an amide centre to yield the 
ynamide, was investigated (Scheme 50).
155
 This procedure was reported in 2009 and was 
demonstrated to be successful using a range of sulfonamides, cyclic carbamates and cyclic 
amides. The general reaction was reported alongside its proposed mechanism, which is based 
on the known reactivity of trans C-Br bonds in dibromides, such as 184, towards oxidative 
insertion. This substrate is believed to undergo reaction to give the organocopper intermediate 
187 which then participates in regioselective coupling to produce the bromo enamine 188. 
Finally dehydrobromination in the presence of Cs2CO3 produces the target ynamide 186. This 
final step was proven by isolation of an intermediate of type 188 and its subsequent 
transformation into ynamide 186 by treatment with Cs2CO3 in a separate reaction. 
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Scheme 50: Evano’s General Protocol and Proposed Mechanism 
 
This type of reaction was attempted using analogous starting substrates in an effort to 
prepare the ynamide 183 (Scheme 51). This approach was tested before investigating the 
optimisation of Hsung’s protocol in the hope that these conditions would be more reliable and 
could be applied to the target system. The main difficulty with this approach would be the 
installation of the the 1,1-dibromoalkene group on the tripeptide fragment prior to cyclisation, 
which would most likely be achieved from an aldehyde. 
The 1,1-dibromoalkene 189 was synthesised by reaction of benzaldehyde with CBr4, 
using the Corey-Fuchs procedure:
156,157
 the compound was isolated in good yield after column 
chromatography. The 1,1-dibromoalkene 189 was then reacted with oxazolidinone 178 using 
CuI and DMEDA as catalyst and ligand respectively, at 60 °C in dioxane, to give the coupled 
product 183 in a yield of 39%. 
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Scheme 51: Employing Evano’s Approach 
 
It was found that yields are reduced if the reaction is performed at higher temperatures 
– for example, when the reaction was performed at 75 °C, a yield of 29% was obtained. This 
approach did not yield results that were significantly better than those obtained using the 
Hsung protocol. Even so, it was decided to test the reactivity of the simple 1,1-dibromoalkene 
with the dipeptide fragment 167 under the Evano conditions to determine if reaction would 
take place at the desired centre (Scheme 52). 
 
Scheme 52: Application of Evano’s Approach to Target Dipeptide 
 
The reaction was attempted several times but, as with other methods, it failed to deliver 
the required product. When the reaction was performed at 60 °C there was no reaction and at 
higher temperatures it appeared that the dibromoalkene starting material decomposed – partial 
decomposition was observed at 70 °C and complete decomposition took place at 100 °C.  
Having found that this approach was unlikely to be successful, efforts were once again 
focused on optimising the Hsung protocol. A further search of the literature revealed an 
example where this type of alkyne amide coupling had been performed on a protected glycine 
analogue 190 in reasonably high yields.
158 
This system was then chosen for all future 
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optimisation work as it bore a close resemblance to the polypeptide systems that were required 
for the actual target. 
The glycine analogue was synthesised, very simply, by reacting glycine ethyl ester 
hydrochloride with di-tert-butyl dicarbonate in the presence of NaHCO3.
159
 This reaction gave 
the target carbamate 190 in 92% yield and so provided plenty of material for optimisation 
reactions (Scheme 53). 
 
Scheme 53: Synthesis of Glycine Analogue 
 
 In the literature example, 190 had been coupled with phenylacetylene bromide 179 to 
give the desired ynamide 191 in 70% yield. The first attempt with this reaction gave a very 
disappointing yield of just 18% (Scheme 54). This result was achieved following the standard 
Hsung protocol that had been utilised previously. The substrates were treated with 
CuSO4·5H2O (10 mol%), 1,10-phenanthroline (20 mol%) and K3PO4 (2 eq.) in toluene at 
80 °C. The reaction was performed at reasonably high concentration, and the mass of catalyst 
and ligand was doubled mid way through the reaction because it was apparent that it was not 
proceeding efficiently towards completion. Increasing the concentration appeared to have no 
effect on the outcome of the reaction. 
 
Scheme 54: Amidation of Glycine Derivative 
 
It is interesting to note that the analogous reaction was carried out in the laboratory 
using the methyl ester analogue (Scheme 55). The methyl ester 192 was prepared
160 
and 
reacted with alkynyl bromide 179 using similar conditions to those previously mentioned. 
Curiously, the reaction failed and there was no apparent progression at all. The reaction was 
also repeated at 80 °C but again the substrate appeared to be completely unreactive. 
Results and Discussion 
 91 
 
Scheme 55: Attempted Amidation With Methyl Ester of Glycine 
 
While this system was being tested, it also seemed prudent to explore the reaction of 
the 1,1-dibromoalkene in order to gain a more complete picture of the methyl esters reactivity. 
This reaction was carried out under standard Evano conditions, but once again no reaction 
took place after 24 hours (Scheme 56). There is no satisfactory explanation for the failure of 
both of these reactions and the use of the methyl ester was abandoned in favour of the ethyl 
ester. 
 
Scheme 56: Evano Approach Towards Ynamide 187 
 
At this stage, studies were performed in an attempt to improve the reaction and identify 
the optimum conditions for application to the desired system. Initially, it was proposed that the 
use of an additional metal additive may have a reinforcing effect on the reaction. The basis for 
this was the possibility that cross contamination of metal sources can often occur in small 
amounts. It was postulated that perhaps another metal might be at work in addition to the 
copper in Hsung’s published reactions. 
To this end, several available metals were screened at 10 mol% alongside standard 
Hsung coupling conditions. The metals included cobalt, nickel, manganese, zinc, rhodium and 
copper (I). Palladium had been tested previously, in the reaction of 178 and 179, during some 
preliminary work and had been found to completely inhibit the coupling reaction, with no 
consumption of starting material (Scheme 57). For this reason no further reactions were 
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carried out using palladium compounds. The results from this series of reactions are shown in 
Table 8 and in some cases the yields obtained were very encouraging. 
 
Scheme 57: Use of Palladium Additive 
 
In several of the reactions that were carried out the yields showed significant 
improvement over the initial yield of 18%. This appeared to support the proposal that 
additional metal additives were of appreciable synergistic benefit to the reaction. The presence 
of zinc appeared to inhibit the reaction entirely (Table 9, entry 1), whereas iron had only a 
slight effect (entries 2 and 3). The two additives that delivered the most significant 
improvements were the Co(II) and Ni(II) salts, therefore these two metals received further 
attention (entries 6 and 7). Mn(II) also showed some promise (entries 4 and 5), but was not 
investigated further because it did not show as much improvement as Ni or Co. The addition 
of Rh (III) resulted in comparable yields to those obtained without metal additives (entry 8). 
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Table 9: Screening of metal additives 
Entry Metal Salt Isolated Yield 
1 ZnCl2 0% 
2 FeCl2 26% 
3 FeCl3 16% 
4 Mn(OAc)2 31% 
5 Mn(acac)3 23% 
6 Co(acac)2 37% 
7 NiBr2 36% 
8 Rh(acac)3 20% 
 
Further investigation of the cobalt additive revealed some interesting results. TLC 
analysis of the reaction mixture showed almost complete consumption of the alkynyl bromide. 
The bromide being the limiting reagent in the reaction, this appeared to be a positive outcome 
at first glance but it was quickly apparent from the yields that all of the bromide had not been 
utilised to give the ynamide target. Instead, a second product was isolated that appeared to be 
the alkynyl dimer 182 and this was confirmed by mass spectrometry (Figure 45). 
 
Figure 46: Alkynyl Dimer Product 
 
From the revelation that Co(II) was an efficient dimerisation catalyst, more so than an 
amidation catalyst, it was decided to focus attention exclusively on Ni(II) as an additive. In 
addition, a test reaction was carried out using the best Co(II) and Ni(II) sources as a catalyst in 
place of Cu(II) to determine if these metals could catalyse the coupling reaction in the absence 
of copper. In the nickel case, no formation of the ynamide was detected. Instead, only a small 
quantity of the alkynyl dimer was isolated. In the cobalt case, the target ynamide was isolated 
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in 6% yield and more of the dimer was obtained. These results indicate that these metals were 
largely ineffective as catalysts in this type of reaction, in the absence of copper. 
 
Scheme 58: Test Reactions of Metal Additives in the Absence of Copper 
 
At this time several reports appeared in the literature suggesting that it was difficult to 
reproduce the high yields reported by Richard Hsung and his co-workers in their original 
publications. A study was performed by Skrydstrup and co-workers in which batches of 
K3PO4 from various well-known chemical suppliers were tested.
161
 A correlation was found 
between yield of reaction and quantity of K3PO4 hydrates. K3PO4 is particularly hygroscopic 
and can often be found as a lumpy white solid. Using two simple test reactions (Scheme 59), 
Skrydstrup and co-workers found that the yields were highly dependent on the commercial 
source of K3PO4. Depending on the supplier, the yields ranged from 17- 54% (reaction 1) and 
51-84% (reaction 2). It was found that in cases where low yields were obtained, the K3PO4 
source had very high quantities of K3PO4·7H2O and K3PO4·1.5H2O hydrates. When the 
highest yields were obtained the batch of K3PO4 contained very low quantities of hydrates. 
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Scheme 59: Skrydstrup’s K3PO4 Screening Reactions 
 
In order to investigate this in the laboratory on the chosen model system, the K3PO4 
was first dried in a Kugelrohr distillation apparatus over a prolonged period of time. This 
approach had been investigated briefly in a previous ynamide formation reaction (cf. Table 8, 
entries 3 and 4). In the previous case, the dried K3PO4 showed some improvement on one 
occasion, but the results could not be replicated on a second attempt. The freshly dried K3PO4 
was tested in the reaction of a glycine derivative (cf. Scheme 54) and was found to give only 
marginal improvement of 3-5% yield. This was an extremely disappointing result but did not 
mark the end of this second avenue of investigation. It was also found that the small 
improvement was quickly lost as the K3PO4 reabsorbed water vapour from the air. 
In an alternative approach, the K3PO4 was ground into a fine powder using a mortar 
and pestle immediately prior to addition. Furthermore, the toluene that was used as solvent 
was thoroughly degassed by purging with argon before use in the reaction. 
Previous studies had found that scrupulously dried CuSO4 was detrimental to the 
reaction outcome so this was never pursued as a possible avenue for investigation. At this 
stage, several reactions were carried out using different sources of Ni(II) in an effort to 
determine the best additive. These reactions tested the new approach using ground K3PO4 
alongside the various Ni sources (Table 10). The metal additives were used at 10 mol% in 
conjunction with CuSO4·5H2O. 
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Table 10: Screening of Ni(II) Additives 
Entry Metal Salt Isolated Yield 
1 NiCl2 72% 
2 Ni(acac)2 73% 
3 NiBr2 49% 
 
Results from this series of screening reactions were very promising and showed that 
the previously reported literature yield had been surpassed by 3% when using Ni(acac)2 as an 
additive (Table 10, entry 2). NiCl2 also showed a comparable improvement (entry 1) where 
NiBr2 was not as impressive (entry 3). 
When taken straight from the bottle, K3PO4 is a white solid with a very lumpy 
consistency. By grinding the K3PO4 to a fine white powder immediately prior to reaction, the 
dry inner surfaces were exposed to the reactant material. While an improvement in yield was 
the goal of this latest series of reactions, such a large increase was unexpected. It was 
important at this stage to ascertain the contribution of both of the altered conditions i.e. the 
nickel additive and the finely ground K3PO4. 
In order to do this, two subsequent reactions were carried out to probe the effects of the 
individual conditions. One reaction was carried out using ground K3PO4 and degassed toluene 
in the presence of Ni(acac)2, where one was carried out in the absence of Ni(acac)2. These 
reactions gave 55% and 62% respectively. While it seems that the greatest improvement in 
yield comes from the dry K3PO4, the addition of the Ni(acac)2 was also improving the reaction 
yield. As a result, both alterations to the procedure were maintained in subsequent reactions. 
Having achieved such an improved yield, it was decided that the best conditions had been 
found. 
 When the optimised conditions were applied to the desired model system, the reaction 
was still unsuccessful (Scheme 60). Analysis of the crude mixture after prolonged reaction 
times showed that significant amounts of starting material were still present and no new 
products were obtained except very small quantities of decomposition products. This was 
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extremely disappointing as it was hoped that the modified approach would produce at least 
some of the cyclisation product. The isolation of even a small quantity of target material 
would have shown that the cyclisation reaction could take place to some degree and that it had 
potential for optimisation. 
 
Scheme 60: Application of Optimised Conditions to Target Synthesis 
 
The newly developed reaction conditions were applied to an alternative intermolecular 
coupling reaction to determine if they were effective in achieving an ynamide synthesis using 
the dipeptide fragment. For this experiment, the dipeptide was protected at the terminal amine, 
so that no N-H was present at this position and the reaction would only take place at the 
desired amide centre (Scheme 61). 
 The TFA salt of dipeptide 168 was protected at the amine terminus using a phthalimide 
group.
162
 The protection reaction was carried out using phthalic anhydride at reflux and a very 
modest yield (38%) was obtained. This was not a serious drawback, because only relatively 
small quantities of 194 were required for these test reactions. Unfortunately, the 
intermolecular coupling reaction of the substrate 194 was also unsuccessful. This may have 
been due to steric factors, perhaps with regards to the two bulky aromatic substituents flanking 
either side of the amide centre. Analysis of the reaction mixture again gave no indication that 
the starting materials had reacted or that there were any new products. 
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Scheme 61: Intermolecular Amidation Using Modified Conditions 
 
 It was clear at this point that the Hsung second generation protocol was not delivering 
useful results in spite of all attempts to improve it. Consequently, an alternate set of reaction 
conditions was tested. 
In recent literature, a catalytic system for the synthesis of allenamides had been 
reported (Scheme 62). This chemistry had also been demonstrated peripherally with regard to 
the synthesis of ynamides.
163
 This approach appeared to be promising and so it was worthy of 
further investigation. Again, this chemistry was to be carried out with a halogenated alkyne 
and an amide, in this case utilising copper thiophenecarboxylate as a catalyst and a 
1,2-dimethylaminocyclohexane ligand 196. The literature procedure stated that the alkynyl 
bromide or alkynyl iodide were both suitable for this reaction. 
 
 
Scheme 62: Allenamide Synthesis Catalytic System 
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The required ligand and copper complex were easily synthesised by methods shown in 
Scheme 63. The dimethylaminocyclohexane ligand was synthesised from racemic trans-1,2-
diaminocyclohexane 197 by reacting with ethyl chloroformate to give the bis-carbamate 198, 
followed by reduction using LiAlH4 to furnish 196.
164
 The copper complex was synthesised in 
82% yield, by reaction of 2-thiophenecarboxylic acid with copper (I) oxide in toluene at 
reflux.
165 
 
 
Scheme 63: Synthesis of Ligand and Catalyst 
 
 Having successfully isolated both the ligand and the copper complex, the 
literature conditions were applied to the system of interest (Scheme 64). The reaction was 
carried out over the course of 24 hours, during which time a new product was clearly visible 
by TLC analysis. Although the reaction did not progress to completion, it was worked up and 
the new product was isolated. Unfortunately, the product isolated was not the desired 
macrocycle. 
 
Scheme 64: Alternative Approach to Intramolecular Amidation 
 
Closer investigation of the product identified it as the dimeric product 199 formed by 
coupling at the terminus of the alkyne. The proposed structure of this by-product is illustrated 
in Figure 47. This structure was confirmed using mass spectrometry analysis and NMR 
methods. This result was in itself encouraging because, until this point, there was no evidence 
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for copper complex formation at the alkynyl position of tripeptide 171. This result proved that 
this complex was in fact being formed and that, in theory, it should be possible to couple this 
to an amide. 
 
Figure 47: Isolated Dimer Product 
 
Following this encouraging result the reaction was carried out once again, this time 
allowing it to take place over a longer period of time and with close monitoring of its progress 
by TLC. This second attempt was also carried out in a significantly more dilute solution 
compared to the first attempt, the tripeptide substrate was dissolved in toluene to produce a 4.5 
mM solution. A very small amount of another new product became apparent by TLC analysis 
and this was isolated for the purposes of characterisation. Initially, there was cause for 
excitement when the 
1
H NMR spectrum showed that one of the two amide hydrogens had 
been removed. However, after comparing with NMR spectra of the precursor it was quickly 
realised that the wrong hydrogen had been displaced. This suggested that the alkynyl bromide 
had in fact coupled onto the wrong amide centre and formed a 7-membered ring. As was 
discussed previously, this is is a highly unlikely outcome because the ring strain would be far 
too great due to the linear alkyne system imposed by the triple bond. The only reasonable 
answer was that another dimerisation reaction had taken place to give the 14-membered 
macrocycle 200 shown in Figure 48 instead of the required 10-membered lactam. 
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Figure 48: Macrocyclic Dimer Product 
 
 It was now quite clear that the intramolecular coupling reaction to make a 
10-membered ring was severely disfavoured in this case. This may be due to the propensity for 
amide groups to exist in a trans configuration thus preventing the chain from turning back 
upon itself. As a result, the alkynyl bromide may not be able to orient itself in a suitable 
proximity to the amide for reaction to take place. This is unfortunate, and somewhat 
unexpected, as this type of chain must, theoretically, be able to fold back on itself in such a 
way, otherwise it would not be viable for a β-turn in the natural system. In light of these 
results, the next objective was to consider alternative structures that could be synthesized and 
would not be subject to the same problem. 
 
2.2.4 Proline Model Structure 
The solution to the intramolecular amidation problem was considered carefully and it 
was realised that the best approach might be to alter one of the residues in the tripeptide chain. 
In naturally occurring β-turns, a proline residue is often located at the i+1 or i+2 position.166-168 
As was discussed previously in the research of Boger and co-workers, glycine and proline are 
often located in the turn and perform a structural role. The proline residue can effectively 
enforce the conformation required for turn formation. Therefore using this logic, it was 
anticipated that a proline residue could help position the two reacting functional groups in 
close proximity, in the target model system. Figure 49 displays the envisioned model system 
201 as well as its alkynyl bromide precursor 202. In theory, it should be far easier for the 
alkynyl bromide in 202 to approach the desired amide, resulting in an increased likelihood of 
reaction. 
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Figure 49: Proposed Proline Analogue and Alkynyl Bromide Precursor 
 
 This alternative target can be synthesised utilising some of the fragments previously 
used in the attempt to synthesise the macrocycle 174; the retrosynthesis is illustrated in 
Scheme 65. Cyclic target 201 is opened in a way that implies the type of ynamide coupling 
reactions explored previously would be employed to cyclise the tripeptidic alkynyl bromide 
202. This open-chain tripeptide fragment incorporates glycine and proline amino acids 
residues. This is then easily disconnected into two fragments: the dipeptide fragment 203 and 
the previously synthesised carboxylic acid 173. This carboxylic acid is easily synthesised from 
propargylamine, using the same procedure of N-alkylation and alkynyl bromination followed 
by removal of the t-butyl ester as was described earlier. Proline dipeptide 203 was further 
simplified to give the two suitably protected amino acid derivatives 204 and 205. These 
compounds are either commercially available or easily synthesised in one step. This provided 
access to the alkynyl bromide 202 in the simplest manner using familiar chemistry. The use of 
the proline residue should not only bring the two reacting groups into close proximity, it 
should also provide a dipeptide fragment, in the form of 203, for testing in intermolecular 
ynamide couplings. By protecting the proline nitrogen, there is only one suitable amide centre 
at which a corresponding alkynyl group can couple. 
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Scheme 65: Retrosynthetic Analysis of Proline Tripeptide 
 
 With a feasible retrosynthesis in place, the process of synthesising the tripeptide 
precursor commenced (Scheme 66). Firstly, L-proline was Boc-protected using di-tert-butyl 
dicarbonate to give 204 in good yield. This compound was then coupled to glycine methyl 
ester hydrochloride using standard coupling conditions, utilising BOP and DIPEA. Initially, 
the reaction was carried out under the previously utilised HOBt/DCC coupling conditions as 
they were the most familiar at this stage. Unfortunately, the reaction delivered only 12% yield, 
which was not adequate for the further steps in the synthesis. Utilising different conditions, 
BOP was found to be an effective reagent when coupling to a proline residue and so was 
subsequently adopted for all of the couplings in this route.
169 
The Boc-protected dipeptide fragment was easily deprotected using a 1:1 mixture of 
TFA in CH2Cl2 giving the TFA salt 208 in quantitative yield. Following the discovery that the 
TFA salt was far more effective at the analogous stage in the previous model synthesis, it was 
decided to, once again, scrupulously remove all traces of excess TFA and proceed using the 
salt as before. This strategy proved to be effective and the dipeptide was coupled to the 
previously synthesised alkynyl bromide fragment 173 in a straightforward manner and in 
reasonably good yield. This resulted in the proline derived tripeptide fragment 202, which was 
now ready to undergo testing in an intramolecular alkyne amidation reaction. 
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Scheme 66: Synthesis of Proline Tripeptide 
 
Several reactions were performed, much as before, to test the capability of this 
tripeptide to react at the desired centre (Table 11). The reaction was carried out using both the 
CuTC catalyst system and Hsung’s second generation protocol. When the CuSO4 catalysed 
reaction was performed under standard conditions it was unsuccessful (entry 1); only minor 
decomposition products were found by TLC analysis, and most of the starting material was 
retained. All of the reaction constituents were separated by chromatography to confirm that 
none of the products were the target cycle. Subsequently, the reaction was repeated at reflux 
temperatures (entry 2) and under these conditions greater amounts of the same decomposition 
products were isolated along with significant amounts of starting material. Both of these 
reactions were carried out at 5 mM concentration to minimise the possibility of dimerisation 
and they were allowed to proceed for a period of between 18 and 24 hours. 
The use of the CuTC standard conditions resulted in what appeared to be very small 
amounts of a new material by TLC (entry 3). This was isolated and characterised using NMR 
techniques. Only a small amount of this new product could be isolated and so results were 
somewhat ambiguous, but it appeared to be the product arising from dimerisation at the 
alkynyl position. Carrying out the reaction with higher concentrations of the ligand and the 
metal only yielded the same disappointing results (entry 4). It was apparent that the cyclisation 
reaction was just as ineffective when using a proline residue in the tripeptide chain as it had 
been in the previous model compound. 
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Table 11: Conditions For Cyclisation 
Entry Conditions Result 
1 CuSO4·5H2O (20 mol%), 1,10-phenanthroline (40 
mol%), K3PO4 (2 eq.), Toluene (5 mM), 75 °C 
Slight Decomposition 
2 CuSO4·5H2O (20 mol%), 1,10-phenanthroline (40 
mol%), K3PO4 (2 eq.), Toluene (5 mM), Reflux 
Significant Decomposition 
3 CuTC (7 mol%), Diamine ligand 43 (15 mol%), 
K3PO4 (2 eq.), Toluene (4 mM), 85 °C 
Possible Dimer 
4 CuTC (15 mol%), Diamine ligand 43 (30 mol%), 
K3PO4 (2.5 eq.), Toluene (4 mM), 85 °C 
Possible Dimer 
 
 Once the problems with the cyclisation reaction became clear, the intermolecular 
variant of the reaction was performed using the protected proline dipeptide 207 and bromide 
172. The reaction was carried out using the same CuTC promoted reaction conditions that had 
been utilised previously (Scheme 67). The reaction was performed over the course of 24 hours 
and TLC analysis of the reaction mixture revealed products along with large quantities of 
unreacted starting material. After work up and purification, it was found that all of the product 
compounds were undesired by-products. This was an extremely disappointing result and the 
reaction was performed again over a longer period to determine whether any of the products 
would develop further and allow a more conclusive NMR analysis to be performed. 
Unfortunately, after 48 hours the reaction gave the same poor results as in the first instance. 
 
 
Scheme 67: Intermolecular Reaction of Proline Tripeptide 
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  The use of copper-mediated coupling chemistry to form an ynamide had 
appeared to be a promising approach at the inception of this project. The development of 
ynamide synthesis chemistry has opened up a number of avenues for investigation in organic 
synthesis and it was hoped that it could allow us to synthesise the peptidomimetic system of 
interest. Unfortunately, the chemistry proved to be unsuitable for the preparation of these 
systems, despite many different attempts with varying reaction parameters and catalytic 
systems. 
The various reactions performed often had similar outcomes, with large amounts of 
unreacted starting material being recovered and small quantities of decomposition or 
dimerisation products being formed in some cases. It was clear at this stage that the use of 
amidative coupling was ineffective when applied to the synthesis of the target ynamides. 
Perhaps the development of more general methods for the synthesis of ynamides might allow 
this approach to be revisited in future, but at this point an alternative approach to the synthesis 
of mimetics of leu-enkephalin had to be considered. 
 
2.3 Synthesis of Alkyne Model Compounds 
 
2.3.1 Alkyne Targets and Retrosynthesis 
Due to the failure of the amidative cross coupling approach to ynamide synthesis to 
deliver the desired systems, the project targets were revised. The complexity of the target 
systems appeared to be unfavourable in conjunction with this type of chemistry. Previous 
literature examples were often successful when simpler substrates were employed and in some 
cases it was found that when using a simple amide as opposed to a carbamate or sulfonamide, 
the yields often ranged from moderate to poor. Although the chemistry had already been 
proven on intramolecular examples to form medium-sized rings, none of these compounds 
possessed an amide bond in the ring system or incorporated extended functionality leading 
away from the ring. 
The cyclisation reaction may have failed because the amide bond prevented the chain 
from folding back in the desired conformation. This problem should have been solved by the 
inclusion of a proline residue in the structure, but this approach delivered similarly poor 
results. Alternatively, the combination of amide bond and triple bond in the same ring may 
simply have made the product too strained. However, this would seem to be discounted as the 
Results and Discussion 
 107 
natural peptide adopts a very similar conformation without difficulty. It is perhaps more likely 
that there is some inherent reactivity problem with one or both of the reacting centres. The 
peptidic systems that are involved in these transformations may be too sterically crowded on 
either side of the amide for the reaction to take place, which would account for the lack of 
success in both the intramolecular and intermolecular examples. None of the reactions used to 
perform the intermolecular coupling were successful and these tested the reactivity of both the 
alkynyl bromide and the amide centre using varied reaction conditions. 
As a consequence of the serious difficulties encountered when using the amidative 
cross coupling reaction, a different target was selected for the mimetic. This new structure still 
incorporates a 10-membered ring system and is illustrated in Figure 50. 
 
Figure 50: Alkyne Mimetic Targets 
 
The revised mimetics were similar to the original target structures, but a simple alkyne 
was used instead of an ynamide in order to deliver the required conformation. This means that 
the structures deviate more from the actual peptide system than in the case of the ynamide 
targets, but that most of the functionality is still in place. The new targets have the added 
complication that they contain an additional chiral centre, but provided the stereochemistry at 
this centre can be controlled, it opens up some very interesting possibilities for different 
diastereomers to have different activities at opioid receptor sites. 
In order to make a brief comparison, the average bond lengths of the alkyne system 
were investigated (Table 12). This method of comparing the bond lengths may only give an 
approximation, however it is sufficient to show that the covalent linker will provide a 
reasonably similar distance when compared to the hydrogen-bonded system. The alkyne unit 
is slightly longer than the ynamide, meaning that it bears a closer resemblance to the natural 
H-bonded system, at least in terms of the distance between the i and i+4 turn units. 
 
Results and Discussion 
 108 
 
Table 12: Bond Lengths of All Carbon Mimetic 
Atoms (Bonds) Bond Length (Å) Atoms (Bonds) Bond Length (Å) 
 1.54 N to O distance 2.99 
 1.21 O=C 1.22 
 1.46   
Total 4.21 Total 4.21 
 
The first step towards these targets was their investigation to ensure the validity of 
synthesising the cyclic core. To this end another simple model system was selected as the 
target in an attempt to prove that this type of ring can be accessed. A structure with no 
extraneous functionality was proposed (target 212, Figure 51). This structure differs from the 
previous model compound, not only because it utilises an alkyne instead of an ynamide to 
close the ring, but also because the phenylalanine functionality that resided on the ynamide 
nitrogen has been removed. This simplifies the model significantly and removes the added 
concern of having another chiral centre at this stage - the secondary hydroxyl group is located 
on a chiral carbon and so this avoids the distraction of working with complex mixtures of 
diastereomers when the priority is closure of this type of ring system. 
 
 
Figure 51: Proposed Model Compound 
 
A relatively straightforward retrosynthesis was suggested for the preparation of the 
medium-sized ring system (Scheme 68). It was decided that the most effective approach to the 
ring closure was by amide coupling to form a lactam. This approach makes use of 
well-established chemistry, with many possible reagents to choose from and so it was felt that 
this would be the most robust approach to the synthesis of this system. This also provided 
more freedom to install the alkyne in the more complex target systems, bearing in mind that it 
must be coupled to a secondary carbon centre. This took the retrosynthesis back to the 
protected system 213. At this stage the nitrogen could be functionalised starting from the 
sulphonamide 214. This was taken back to the alcohol with a protected primary amine 215, 
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which in turn was disconnected to give the terminal alkyne 217 and epoxide 216. The 
retrosynthetic analysis seemed fairly robust and it was decided to proceed with the forward 
synthesis and identify the appropriate protecting groups as this synthesis progressed.  
 
 
Scheme 68: Initial Retrosynthesis of Lactam Model 
 
2.3.2 Towards the Synthesis of the Alkyne Model Structure 
Initially, two fragments were synthesised for the intended epoxide opening reaction. 
The first of these was the sulphonamide 220 incorporating a PMB protecting group 
(Scheme 69). The fragment was synthesised using a three-step process starting from 
p-methoxybenzaldehyde. Reaction of this aldehyde with p-toluenesulfonamide in the presence 
of TiCl4 and TEA gave the imine 218. This intermediate was extracted from the quenched 
reaction mixture and concentrated, before using in the next stage without further purification. 
The imine was reduced using NaBH4 to give sulphonamide 219 in 57% yield for the two 
steps.
170
 The amine could then be alkylated easily using propargyl bromide in the presence of 
K2CO3 to give terminal alkyne 220 in 85% yield. 
The second fragment was synthesised easily from racemic glycidol. It was decided that 
the amine in fragment 216 should be masked in such a way that there would be no N-H 
available so as to avoid a double alkylation in subsequent steps. Phthalimide seemed to be a 
perfect protecting group in this respect because it fully substitutes the amine thus preventing 
any reaction at this centre, and could be removed easily once it was no longer required.
171
 The 
protected amine 221 was synthesised by reacting glycidol with phthalimide using standard 
Mitsunobu conditions to displace the alcohol. This was achieved in a moderate 48% yield, but 
further optimisation was not pursued as sufficient quantities of material were obtained to 
satisfy the requirement of this model synthesis. 
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Scheme 69: Synthesis of Coupling Partners 
 
The attempted coupling of fragments 220 and 221 was carried out, as shown in 
Scheme 70. n-BuLi was used to deprotonate terminal alkyne 220 at –78 °C, and BF3·OEt2 was 
added followed by the epoxide 221. A temperature of –78 °C was maintained throughout and 
the reaction was monitored by TLC. Unfortunately, the reaction did not proceed and starting 
materials were recovered following reaction quench. 
 
Scheme 70: Epoxide Opening Reaction 
 
The reaction was attempted several more times under varied conditions (Table 13). 
Using n-BuLi and Et2AlCl in toluene at 0 °C resulted in the formation of a new product which 
was visible by TLC. However, it was found that the new product could not be isolated as a 
pure sample because it co-eluted with starting material (entry 1). 
1
H NMR analysis showed 
clearly that it was not the target product and so it was not purified further. Most of the starting 
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materials could be recovered from this reaction. The next attempt, using Me2AlCl in toluene at 
temperatures ranging from –25 °C up to 0 °C (entry 2), showed significant decomposition. 
The products were separated by column chromatography but none of them was identified as 
the desired product. When this reaction was repeated in THF (entry 3) it did not progress at all 
and starting materials could be cleanly isolated from this reaction mixture. In a final attempt, 
n-BuLi and DMPU were used in toluene and the reaction was allowed to warm from –25 °C 
up to room temperature (entry 4). Under these conditions the outcome was similar to that 
obtained under the initial conditions utilising Et2AlCl; slight decomposition was noted along 
with recovery of most of the starting material. 
 
Table 13: Testing of Conditions for Epoxide Opening 
Entry Conditions Result 
1 n-BuLi, Et2AlCl, Toluene, 0 °C Slight Decomposition 
2 n-BuLi, Me2AlCl, Toluene, –25 °C to 0 °C Decomposition Products 
3 n-BuLi, Me2AlCl, THF, –25 °C to 0 °C Starting Material Recovered 
4 n-BuLi, DMPU, Toluene, –25 °C to 20 °C Slight Decomposition 
 
The difficulties encountered when attempting to open the epoxide were somewhat 
unexpected, so a brief test reaction was performed using TMS acetylene and the phthalimide 
protected epoxide 221 (Scheme 71). The initially employed conditions were used in this case 
and it was found that the epoxide was opened, giving the secondary alcohol, albeit in a fairly 
modest yield. 
 
Scheme 71: Epoxide Opening Test Reaction 
 
It was clear that in this instance, the epoxide exhibited limited reactivity towards a 
deprotonated alkyne. The next logical step was to modify one of the reacting substrates and 
attempt a similar coupling reaction. The most obvious way in which to do this was to alter the 
protecting group of the nitrogen on the epoxide fragment. The phthalimide group is rather 
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bulky with plenty of freedom to rotate which could block the approach of the deprotonated 
acetylene to the epoxide. 
As an alternative, it was decided to protect the epoxide using a 2,5-dimethylpyrrole 
group. This has been used successfully in the past as a protecting group and can be removed 
using very mild conditions.
172-174 
Its use means that potential reaction at the terminal amine is 
avoided, a feature it shares with the phthalimide group. The epoxide was easily prepared by 
deprotonating 2,5-dimethylpyrrole at 0 °C and then displacing the bromide from 
epibromohydrin.
174
 Protected amine 224 was afforded in respectable yield, (Scheme 72). 
 
Scheme72: Synthesis of 2,5-Dimethylpyrrole Protected Epoxide 
. 
 The newly protected epoxide 224 was immediately used in a reaction with previously 
synthesised alkyne 220. The same conditions that have been tested previously were utilised 
initially; n-BuLi was used to deprotonate the alkyne at –78 °C and BF3·OEt2 to activate the 
epoxide. This first attempt at the reaction resulted in a very disappointing 7% yield. In the 
literature it was suggested that using BF3·THF gave higher yields for this type of reaction.
175
 
A second attempt, using BF3·THF instead, resulted in a 34% yield of the product 225, a 
significant improvement (Scheme 73). The yield was still a fairly modest one but enough 
material was isolated for the next stage of the synthesis to be attempted. 
 
 
Scheme 73: Successful Epoxide Opening 
 
The subsequent step required the removal of the PMB protecting group, which was 
attempted using two sets of conditions (Scheme 74).
176,177
 Firstly, the PMB-protected amine 
was reacted with Pd/C in the presence of ammonium formate in methanol at reflux. This 
reaction showed no progression after 2 hours and so it was abandoned in favour of a reaction 
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in which the substrate was treated with α-chloroethyl chloroformate starting at 0 °C and 
heating gradually up to reflux. This second set of conditions also resulted in no reaction and 
the recovery of clean starting material. Rather than carry out further reactions to try and 
remove the PMB protection, it was decided to synthesise the unprotected amine and try to 
perform the epoxide opening directly on this substrate. 
 
 
Scheme 74: Attempted PMB Deprotection 
 
 Tosylated propargylamine 165 had been prepared previously during the synthesis of 
the tripeptidic alkynyl bromide target 171. This substrate was reacted with the 
2,5-dimethylpyrrole protected epoxide 224, again using n-BuLi and BF3·THF to generate the 
reactive species (Scheme 75). It was, of course, important to use more than two equivalents of 
n-BuLi in order to completely deprotonate both the terminal alkyne and the amine. Attack of 
the epoxide originated solely from the acetylenic position due to its relative instability in 
comparison with the nitrogen centre. Initially, this reaction gave disappointing yields of 
approximately 25% when performed on a 100-200 mg scale. It was found very quickly that the 
yield could be improved significantly (up to 58%) by performing the reaction on a larger scale 
(1-2 g). The same reaction was also carried out in the presence of BF3·OEt2 in order to 
compare yields. In this case, the reaction gave a very disappointing yield of 16%. It is 
important to note that, at this stage in the synthesis, the product was prone to degradation even 
when stored under argon in the freezer. Immediately after isolation the product had the 
appearance of a clear oil, but turned viscous and brown within 24 hours, requiring purification 
to be performed once again before use. This made it somewhat difficult to handle the alcohol 
226 and to obtain good characterisation data. 
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Scheme 75: Epoxide Opening with Unprotected Amine 
 
 With the secondary alcohol in place and the free sulphonamide available for 
N-alkylation, the next synthetic transformation was attempted. This step in the reaction 
sequence required alkylation of the nitrogen and was performed using t-butyl bromoacetate 
and K2CO3 as a source of base (Scheme 76). 
 
 
Scheme 76: N-Alkylation Before Alcohol Protection 
 
 When N-alkylation was performed it was found that the yields were particularly low 
and did not rise above 24%. This is most likely because of the possibility of alkylation of the 
unprotected oxygen as well as the desired NH. On TLC analysis, there were products other 
than the desired N-alkylated target 227. To remedy this it was decided that the secondary 
alcohol should be protected prior to alkylation. The protecting group would not need to be 
removed later in the synthesis, as the alcohol does not have any further role in this model 
study. Thus, the only requirement for this protecting group was that it would survive intact 
during the remaining synthetic steps. 
 The protecting group that was selected was a TBDPS ether. The reason that such a 
bulky silyl ether was chosen was that it needed to survive the acidic conditions that are 
required to remove the t-butyl ester in the later stages of the synthesis. Of all the silyl ethers, 
the TBDPS group is the most likely to survive under these conditions. 
The conditions for successful protection of the hydroxyl group required some 
exploration. Due to the bulk of the silyl group that is being attached in this case, coupled with 
the fact that it is reacting at a secondary alcohol with reasonably large groups on either side, 
this is a problematic reaction to carry out. Table 14 details the reaction conditions that were 
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applied to this system. Initially, the substrate was treated with TBDPSCl with imidazole in 
DMF (entry 1), but this reaction did not progress at all and the starting material could be 
recovered. The subsequent two reactions utilised TBDPSCl again, this time in the presence of 
DMAP and TEA. Firstly the reaction was performed at room temperature, giving a modest 
35% yield of the protected alcohol (entry 2). The second attempt under these conditions was 
carried out at reflux to try and drive the reaction further towards completion (entry 3). 
Unfortunately, this resulted in the decomposition of the starting material. Finally, the alcohol 
was treated with the more reactive TBDPSOTf in the presence of 2,6-lutidine giving the best 
yield of 47% (entry 4). This last reaction was attempted in parallel using purchased 
TBDPSOTf and laboratory synthesised TBDPSOTf. It was found that the best yields were 
obtained when using the commercial material. 
 
Table 14: TBDPS Protection Reactions 
Entry Reaction Conditions Reaction Outcome 
1 TBDPSCl, imidazole, DMF, 90 °C No Reaction 
2 TBDPSCl, DMAP, TEA, CH2Cl2, r.t. 35% 
3 TBDPSCl, DMAP, TEA, CH2Cl2, reflux Decomposition 
4 TBDPSOTf, 2,6-lutidine, CH2Cl2 47% 
 
Having protected the alcohol, albeit in moderate yield, it was found that the 
N-alkylation, towards 229, took place far more effectively. When standard basic conditions 
were employed, as described previously, the desired product was obtained in a much improved 
yield of 69% (Scheme 77). This took the structure to within a few steps of the key 
intramolecular lactamisation reaction. All that was required was removal of the t-butyl ester 
and the 2,5-dimethylpyrrole before the two ends of the molecule could be coupled together. 
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Scheme 77: TBDPS Protection and N-Alkylation 
 
 In the first instance, the removal of the 2,5-DMP group was attempted using standard 
conditions with hydroxylamine and TEA, as reported in the literature (Scheme 78).
172
 
Unfortunately, this reaction did not occur and the starting material 229 was recovered. The 
reaction was performed using slightly different conditions – treating with hydroxylamine and 
KOH in a mixture of methanol and water – but to no avail.178 
 
Scheme 78: Attempted Removal of 2,5-DMP Group 
 
As an alternative approach, it was decided to deprotect the t-butyl ester and then 
remove the 2,5-dimethylpyrrole group (Scheme 79). The t-butyl ester was removed under 
acidic conditions without incident in quantitative yield, furnishing 231. The TBDPS ether 
survived this transition without any problems, proving the validity of its selection as the 
protecting group in this case. Subsequently, removal of the 2,5-dimethylpyrrole was attempted 
using the same series of conditions as before. Again, there was no indication of any reaction 
and when the reaction constituents were separated after work up, the target amine 232 was not 
isolated. 
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Scheme 79: Alternative Approach to 2,5-DMP Removal 
 
 This was an unexpected difficulty in the synthesis and unfortunately it was one that 
was difficult to circumvent. The most obvious solution was to replace the 2,5-DMP protected 
amine with a more appropriate group The amine either had to be protected in a different 
manner, or replaced with a functional group that could be converted into the amine later in the 
synthesis. The latter approach was chosen because of the difficulties that had been experienced 
with two different protecting groups already. The approach that was chosen was one in which 
the amine was masked as a tosylate, which would be displaced with an azide at an appropriate 
stage in the synthesis followed by reduction to the primary amine. 
Starting once again with racemic glycidol, the tosylated epoxide 233 was synthesised 
in high yield by reaction with p-toluenesulfonyl chloride in the presence of TEA (Scheme 80). 
The epoxide was opened with the alkyne to give the secondary alcohol, again using n-BuLi 
with BF3·THF at –78 °C affording the product 234 in a moderate 66% yield. This particular 
yield is dependent on the quantity of recovered starting material. The reaction is best carried 
out by recycling unused starting material as it never progresses to full conversion. After 
allowing the reaction to progress as far as possible, it was then fairly simple to purify both the 
unreacted starting material and the product by chromatography. The starting material is then 
recycled in a repeat reaction. This made maximum use of the available material and gave a 
respectable overall yield. The nitrogen was then alkylated using t-butyl bromoacetate in the 
presence of K2CO3 to furnish 235 in a modest yield. 
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Scheme 80: Towards the Synthesis of the Cyclisation Precursor 
 
At this stage, efforts were made to protect the secondary alcohol as before (Scheme 81) 
with the expectation that the yield of the alkylation could be improved. Several attempts were 
made to install the TBDPS ether at this position but they were unsuccessful and returned only 
starting materials. This may be caused by the presence of the bulky tosyl group, located α to 
the secondary alcohol, blocking the approach of the similarly bulky silylating reagent. Having 
been unsuccessful in protecting the hydroxyl group, the synthesis was continued with the free 
alcohol. It was felt that a 46% yield was sufficient to obtain reasonable quantities of the final 
product for testing. 
 
Scheme 81: Attempted Protection of Secondary Alcohol 
 
The final two stages in this section of the synthesis were accomplished without 
incident. The tosyl group was displaced successfully using sodium azide, giving the desired 
target 237 in excellent yield (91%). The azide was then reduced using Staudinger conditions, 
giving the amine 238 in a good 78% yield. The final stage was the cleavage of the t-Bu ester 
which was performed under acidic conditions using TFA in CH2Cl2 as a 1:1 mixture. This 
gave the amino alcohol salt 239 in quantitative yield. This compound was very insoluble in 
CHCl3 and so dissolution in deuterated methanol was required for characterisation by NMR 
spectroscopy. 
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Scheme 82: Final Steps in Cyclisation Precursor Synthesis 
 
2.3.3 Testing of Amide Coupling Conditions 
The next stage required the coupling of the amine and carboxylic acid groups to give 
10-membered lactam 212 required for the model target (Scheme 83). There are various 
coupling agents in the literature for formation of amide bonds so there was no shortage of 
options. 
 
Scheme 83: Towards the Synthesis of 10-Membered Lactam Model 
 
The reaction conditions that were tested are displayed in Table 15. This was a difficult 
reaction to monitor by TLC because the TFA salt 239 is very polar and occupies the base line 
of a chromatography plate, regardless of eluent polarity. This made it very difficult to 
ascertain whether any of the starting material had been consumed. In the first attempt to 
perform lactamisation BOP  was utilised as the coupling reagent and the reaction was carried 
out over the course of 20 hours in the presence of HOBt and DIPEA (entry 1), but the reaction 
showed no progression at all. EDCI was then used as an alternative coupling reagent, this time 
with DMAP and reacting for 20 hours, with similarly poor results (entry 2). At this stage a 
report in the literature was found showing that pentafluorophenyl diphenylphosphinate and 
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (FDPP and DMTMM 
respectively) are useful amide coupling reagents for the synthesis of peptide containing 
macrolactams,
179
 therefore these reagents were utilised for the subsequent test reactions 
(entries 3 and 4). In both of these cases, reactions were carried out over periods of 3-4 days 
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and there was formation of a new product as detected by TLC analysis. The new product was 
formed in greater amounts when using FDPP and it was isolated in both cases. Unfortunately, 
NMR analysis of the product proved to be inconclusive and it was clear that it was not the 
desired ring system. In a final attempt to close the ring, PyBOP was utilised alongside DIPEA 
(entry 5). This reaction was carried out over 3 days and in this case a new product was 
detected by TLC analysis. This product was again isolated for NMR studies, but was found to 
be an undesired side product. The NMR spectra for all three of these decomposition products 
were complex and showed large broad peaks in the upfield regions. The structures of these 
products could not be determined but it was clear that the cyclisation reactions were not 
producing the desired target. 
 
Table 15: Screening of Coupling Conditions for Lactamisation 
Entry Reaction Conditions Reaction Outcome 
1 BOP, HOBt, DIPEA 
CH2Cl2/DMF 
No Reaction 
2 EDCI, DMAP 
CH2Cl2/DMF 
No Reaction 
3 FDPP, DIPEA 
DMF 
Decomposition 
4 DMTMM, DIPEA 
DMF 
Slight Decomposition 
5 PyBOP, DIPEA 
DMF 
Decomposition 
 
 Due to the high polarity of compound 239, the starting material could not be reisolated 
at the end of each test reaction and so it had to be synthesised several times as these reactions 
were carried out. All of the test reactions were performed at 0.25 mM concentration to prevent 
dimerisation couplings. 
Having explored the use of a variety of standard coupling reagents to perform 
cyclisation to give the medium-sized lactam, it was decided that an alternative approach might 
be more useful. One possible reason for the low reactivity is the strain induced by the triple 
bond in the ring. In the linear precursor 239, the alkyne is most likely making it more difficult 
for the two reactive centres to approach one another. Unfortunately, none of the attempts to 
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perform the cyclisation reaction revealed any of the desired product. Even trace yields of 
product were elusive. A possible solution for this problem would be to find a way to lower the 
transition state energy for the cyclisation reaction. 
 
2.3.4 Cobalt Complex Approach to Lactam 
In the literature it has been reported that complexation of dicobalt octabarbonyl to an 
alkyne in a chiral compound allows diastereomers to be separated.
180
 The cobalt was easy to 
install, robust under a variety of reaction conditions and straightforward to remove. It also had 
the effect of giving the alkyne triple bond more double bond character. This was a perfect 
avenue for exploration in this system and could provide the solution to the difficulties 
mentioned previously. To this end, the synthesis of cobalt complex 240 was accomplished by 
direct treatment of the alkyne with dicobalt octacarbonyl (Scheme 84). Initially, this reaction 
was attempted using the deprotected salt 239. However, it was quickly realised that this 
approach was not appropriate because there was no readily apparent method to purify the 
resulting complex. The yields of the complex were greater than 100% due to the slight excess 
of dicobalt octacarbonyl complex that was still present after reaction workup. In addition, due 
to the charged nature of both the starting material and the target product, there was no 
conclusive way to prove that all of the starting material had been consumed. 
 
 
Scheme 84: Attempt to Complex Deprotected Precursor 
 
It was decided that an alternative approach to the preparation of the cobalt complex 
was more appropriate in order to obtain better control over its purity. It was believed that 
better results would be obtained during the subsequent cyclisation reactions if the cobalt 
complex was of higher purity. It was entirely possible that excess cobalt may interfere with the 
reaction outcome or that only a partial conversion to the complex had in fact taken place. 
By carrying out the reaction with dicobalt octacarbonyl complex prior to removal of 
the t-butyl ester, purification of the resulting complex 241 was easier (Scheme 85). It was not 
possible to characterise the metal complexes using NMR techniques, possibly due to the 
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paramagnetic nature of cobalt. Upon obtaining a sample of the cobalt complex, it was filtered 
through a layer of Celite
®
 in an effort to remove excess cobalt and prepare the sample for 
NMR spectroscopy. Unfortunately, in the case of complex 241 this was unsuccessful and 
NMR data was inconclusive. The presence of the cobalt complex was suggested instead by 
TLC analysis in conjunction with IR studies to determine the abundance of carbonyl 
functionality. Curiously, the reaction to install the cobalt complex gave relatively low yield 
when compared to the high yield reported by the literature. Initial attempts to perform this 
reaction gave on average 30% yield after purification. These reactions were performed on the 
scale of 20-30 mg of alkyne. It was then found that when carrying the reaction out on a 
slightly larger scale, the yields were significantly improved and when the reaction was 
performed on a 700 mg scale a yield of 52% was obtained. This yield still does not approach 
those reported in the literature but it was good enough for us to proceed with the subsequent 
lactamisation reactions. 
 
 
Scheme 85: Synthesis of Cobalt Complex Before Deprotection 
  
 Once the cobalt complex had been installed and the material had been purified, it was a 
straightforward matter to cleave the t-butyl ester under acidic conditions (Scheme 86). This 
deprotection reaction provided the carboxylic acid 240 in quantitative yield. The final step 
involved cyclisation of the linear precursor using amide coupling chemistry. Initial attempts at 
this transformation were unsuccessful and so a series of reaction conditions had to be 
screened. 
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Scheme 86: Use of Cobalt Complex in Cyclisation Reaction 
 
 The use of reagents such as PyBOP, EDCI and FDPP all gave no reaction as judged by 
TLC analysis (Table 16, entries 1-3). Even after extended reaction times of 2 to 3 days, there 
was no indication of product formation. This was a disheartening result, but the screening of 
reaction conditions was continued with DMTMM as the coupling reagent (entry 4). This set of 
conditions does not deliver the required product either but instead gave small traces of 
decomposition products. In an attempt to identity these trace products they were purified and 
analysed by NMR spectroscopy. However, the resulting spectra showed large overlapping 
peaks in the alkyl region and could not be adequately interpreted. The process was further 
complicated by the limited quantities of the decomposition products that were isolated from 
the reaction. 
All of the test reactions were performed in DMF, which necessitated the work up of 
any TLC samples by dilution with water and organic extraction. The DMF solvent blanketed 
the region on the TLC plate that coincided with the starting materials making it impossible to 
determine if they had been consumed at all, while the solvent was present. 
 Finally, the reaction was attempted using BOP in CH2Cl2, and this led to a slightly 
more promising outcome (entry 5). A new product was isolated in very small quantities. The 
identity of the product could not be accurately verified by NMR analysis because of the same 
difficulties in removing cobalt contaminants that were encountered previously. The cobalt 
complex also complicated analysis by mass spectrometric methods. If the material was indeed 
the cyclised target, the yield would have been 35%, a very respectable outcome considering 
the difficulties that had been encountered thus far in forming the lactam. 
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Table 16: Screening of Coupling Conditions for Cobalt Complex Lactamisation 
Entry Reaction Conditions Reaction Outcome 
1 PyBOP, DIPEA 
DMF 
No Reaction 
2 EDCI, DIPEA 
DMF 
No Reaction 
3 FDPP, DIPEA 
DMF 
No Reaction 
4 DMTMM, DIPEA 
DMF 
Slight Decomposition 
5 BOP, DIPEA 
CH2Cl2 
Possible Product 
 
 It was decided that the most effective approach to verify the identity of the product was 
to remove the cobalt complex and regenerate the alkyne functionality. This process has been 
well described in the literature and assuming it was the desired product that was isolated from 
the BOP coupling reaction there should have been no difficulty in removing the cobalt. 
 Published procedures required the use of N-methylmorpholine-N-oxide (NMO) to 
decomplex cobalt and restore the triple bond. This standard approach was applied to the 
suspected lactam product 242 (Scheme 87). Literature examples suggested that, by carrying 
the reaction out in CH2Cl2 at room temperature, it should take about one hour to completely 
remove the cobalt. However, when the reaction was performed under these conditions, no 
progress was observed at all: starting material remained and there was no sign of reaction or 
decomposition. The mixture was stirred for several more hours, but to no avail. The mixture 
was worked up and analysed by NMR spectroscopy to confirm that no reaction had taken 
place. Unfortunately, the only conclusion that could be drawn is that the required lactam 
complex was not the product that had been isolated from the previous reaction. This rendered 
all attempts to cyclise the cobalt complex 240 unsuccessful. 
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Scheme 87: Attempt to Remove Cobalt From Suspected Lactam Product 
 
2.3.5 Diphenylphosphine Tether Approach to Lactam 
The failure of the approach described above was disappointing and attention was 
focused on an alternative method to synthesise the desired model compound. Further study of 
the literature in this area revealed a novel approach to the synthesis of medium-sized 
lactams.
181,182 
A procedure had been reported in which a diphenylphosphine tether had been 
attached to the carboxylic acid end of the structure. This was then coupled with an azide which 
resulted in ring-closure by a Staudinger reaction. The unwanted atoms were excised during 
this process to give nitrogen gas and the phosphine oxide derivative of the tether as 
by-products alongside the desired lactam product (Scheme 88). 
 
 
Scheme 88: Staudinger Approach to Lactamisation 
 
The first step required the synthesis of the relevant diphenylphosphine tether before it 
could be reacted with the desired carboxylic acid centre. This was accomplished using a 
reported literature procedure (Scheme 89).
183 
Initially, diphenylphosphine was treated with 
borane dimethylsulfide, to provide diphenylphosphine borane. This was then treated with 
formaldehyde to install the hydroxymethyl group and furnish 243 in quantitative yield. The 
primary alcohol was then mesylated in the presence of TEA, providing 244, followed by 
displacement using thioacetic acid to produce thioacetate 245 in good yield. Finally, the 
thioester group was cleaved, leaving the thiol group ready for reaction in the next stages of the 
synthesis; compound 246 was isolated in 70% yield.
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Scheme 89: Synthesis of Diphenylphosphine Tether 
 
 With the thiol available, the alkyne fragment had to be prepared for coupling and 
cyclisation. Due to the requirement of an azide coupling partner, fragment 237 was chosen as 
the ideal starting point for this procedure (Scheme 90). The t-butyl ester was cleaved under 
acidic conditions to provide carboxylic acid 247 in quantitative yield, while retaining the azide 
functionality. The next step required the coupling of 247 with thiol fragment 246. Initially, 
EDCI was used as the coupling agent, as suggested in the literature, giving the required 
product in a reasonable 63% yield. It was felt that this yield could be improved and so DCC 
was used as an alternative coupling reagent. Under these conditions compound 248 was 
isolated with a markedly improved yield (85%). 
 
 
Scheme 90: Formation of Cyclisation Precursor 
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 Following installation of the diphenylphosphine tether, the Staudinger mediated 
cyclisation reaction was attempted using standard literature conditions. This involved 
treatment of precursor 248 with DABCO in THF at reflux. The reaction was performed over 
the course of 20 hours and MgCl2 and HgCl2 were then added to scavenge triphenylphosphine 
oxide by-product. After completion of the work-up, the product mixture was carefully 
separated by column chromatography. NMR analysis was used to determine if any of the 
component products was the desired product 212. Unfortunately, the reaction was not 
successful. TLC analysis of the crude mixture indicated that a significant amount of starting 
material remained but several potential products were also visible. These appeared to be trace 
decomposition products. A subsequent attempt to perform the reaction over a more prolonged 
period (48 hours), gave similarly negative results. 
 
Scheme 91: Attempted Cyclisation Reaction 
 
2.3.6 Further Cobalt Complex Experiments 
Having exhausted several avenues of investigation for the cyclisation, attention 
returned to the cyclisation of the cobalt complexed substrates. It was postulated that the linear 
precursor had the potential to cyclise onto the alcohol, which would have resulted in the 
lactone product. This 9-membered ring would lack the strong trans preference that is 
associated with amide bonding units. Most of the reaction towards the lactam product showed 
either no progress or resulted in small amounts of decomposition by-products. It was possible 
that if the lactamisation was competing with lactone formation, then the lactone intermediate 
might be decomposing to give the by-products that were seen in the reaction. To this end, it 
was decided that it might be worthwhile protecting the secondary alcohol prior to cyclisation 
using standard amide coupling conditions. 
 Having already attempted to protect the secondary alcohol with no success (cf. Scheme 
81), attention was focused on alternative approaches. The first attempt to perform protection 
had been carried out with the tosylate group in the α position to the alcohol and this was 
believed to be a factor that contributed to its failure. The tosylate is in close proximity to the 
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reacting hydroxyl group and it has a great deal of freedom to rotate, so it was suggested that 
this was blocking the approach of reagents. 
 Of course, during our proposed synthetic sequence, the tosylate group is displaced by 
an azide, which is then reduced to give a primary amine. This provides two further 
opportunities to protect the alcohol but with less bulky groups in close proximity. The first 
attempt was carried out after the azide was installed and is illustrated in Scheme 92. This 
reaction was ineffective and did not progress at all. It appeared that the azide in the α position 
was unsuitable for approach by the silylating reagent. The fact that no product was isolated at 
all discouraged further attempts using the more reactive TBDPSOTf and 2,6-lutidine. Previous 
experience had shown that in cases where TBDPSCl gave a low yield of the silyl ether, 
TBDPSOTF gave much improved yields. The fact that in this case there was no reaction at all 
did not bode well for the success of the triflate in carrying out the same transformation. Due to 
the difficulty in obtaining the triflate, it was decided that it would be better to use it to silylate 
the subsequent primary amine substrate, pending the success with the silyl chloride.  
 
Scheme 92: Attempted Protection of Secondary Alcohol 
 
 With this approach in mind, the same protection reaction was performed on the 
primary amine alternative 238, towards 250. The reaction was carried out as before using 
TBDPSCl as shown in Scheme 93. In this instance, the reaction was somewhat more 
successful, giving a very low yield (9%). Unfortunately, both the starting material and the 
product in this reaction were very polar and it was very difficult to purify the material using 
silica gel chromatography. Thus, when purifying the material, especially when the reaction 
was performed on small scale and with such a low yield, it was very difficult to obtain a pure 
sample of the product. 
 
Scheme 93: Protection of Alcohol Adjacent to Primary Amine 
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 Following the successful reaction with the silyl chloride, and despite the low yield 
obtained, an alternative silylation reaction was performed involving treatment of the alcohol 
with TBDPSOTf in the presence of 2,6-lutidine. Unfortunately, this reaction was not as 
successful as hoped – a similarly poor yield of the product was obtained and large quantities of 
starting material were recovered. 
 As a consequence of the disappointing results obtained, there was no choice but to 
attempt the following reaction to prepare the protected cobalt complex 251. The reaction was 
carried out under the same conditions as before, using dicobalt octacarbonyl in CH2Cl2 
(Scheme 94). The reaction was unsuccessful and there was no evidence of any reaction upon 
TLC analysis. This result was very disappointing and a little surprising as the reaction to 
generate the cobalt is usually very straightforward and tolerates a wide variety of functional 
groups as reported in the literature. 
 
Scheme 94: Cobalt Complexation Reaction with Protected Alcohol 
 
 Having explored several routes to prepare the desired lactam, there were no positive 
results. The cyclisation reaction refused to take place regardless of the conditions used and the 
model compounds based on the desired peptidomimetic targets remain elusive. Due to the lack 
of progress made towards these model structures, the more complex targets remain out of 
reach. Of course there are multiple avenues for further investigation that should be considered 
for future research. (See Future Work Chapter 3.2) 
 In theory, the ynamide and alkyne macrocycles are feasible structures that do not differ 
a great deal from the actual peptide systems. The distances involved between the two 
H-bonding groups in the natural systems are approximately the same as the average bond 
distances along the covalent linker that would close the mimetic macrocycle. Thus, it was 
reasonable to expect that the ring could be effectively synthesised. This is the case even 
although there is an amide bonding unit involved, as this factor does not discourage the turn 
that is found naturally in leu-enkephalin. Hopefully, future investigation can overcome low 
propensity for the substrates to undergo cyclisation that has been encountered during the 
project. 
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Chapter 3 
Conclusions and Future Work 
 
3.1 Conclusions 
In conclusion, several approaches to the synthesis of β-turn mimetics based on 
leu-enkephalinamide have been investigated. The use of an ynamide unit as a covalent linker 
was explored first. Intramolecular coupling of an amide with an appropriate alkyne unit and 
intermolecular coupling with subsequent ring closure by lactamisation were investigated. In 
both approaches the synthesis of the ynamide was the problematic step and this could not be 
overcome, despite the use of numerous different reaction conditions. 
An alternative system was investigated in which a proline residue was used to bring the 
reacting functional groups into close proximity during intramolecular coupling, but this was 
similarly unsuccessful. The intermolecular approach to ynamide formation did not provide any 
of the ynamide product either. 
Studies were carried out to optimise the Hsung second generation protocol for ynamide 
synthesis. This was demonstrated on a glycine-containing system and a yield of 72% was 
achieved following the addition of Ni(II), compared to a literature yield of 70%. The 
application of the newly optimised conditions to the target system did not yield any of the 
target ynamide, prompting an alteration to the proposed mimetic structures, namely the 
replacement of the ynamide with an alkyne. 
Research progressed onto the alkyne tethered mimetic system. This structure was 
approached with the intention of using amide coupling chemistry to close the 10-membered 
lactam. The penultimate structure was prepared but the ring system could not be constructed 
even after several attempts.  
Further methods utilised a cobalt complex to ease the strain induced by the alkyne unit 
on the transition state, as well as an alternative approach involving a diphenylphosphine tether 
to close the ring via Staudinger chemistry. Neither of these approaches was successful. 
Unfortunately, the core ring systems for both the alkyne and ynamide mimetics could not be 
prepared and their synthesis remains unsolved. 
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Having attempted a number of approaches to the target ring system, some simple 3D 
model structures were constructed using computational methods. The purpose of this was to 
evaluate how closely the covalent linker resembles the hydrogen bond from the natural 
system. The hydrogen bond that holds the natural β-turn together will not be linear as the 
interaction between the amine hydrogen and the carbonyl oxygen is directed towards one of 
the oxygen lone pairs. This has the potential to give the pseudo-ring structure a more open, 
less strained conformation. As a result, it is possible that the hydrogen bonded system is 
slightly less strained than the 10-membered ynamide or alkyne ring. The linear conformation 
that is imposed by the triple bond could increase the strain in the ring system sufficiently to 
render the structure highly unfavourable. 
It was hoped that construction of a 3D model at this stage would provide a definitive 
explanation for the inability of the target structures to cyclise. The four model structures are 
illustrated in figure 52 alongside the X-ray structure of leu-enkephalin originally published in 
1978.
37,184,185 
Visual comparisons of the models and the X-ray structure show that they are 
similar in terms of the ring systems that are at their core. 
In each of the 3D structures, the alkyne and ynamide units are not entirely linear. 
Instead they show a slight bend that is induced by the overall ring system. This may more 
closely resemble the hydrogen bond that is in the natural system, but it also suggests that the 
ring is very strained. Clearly the triple bonded system would prefer to adopt a linear 
conformation. It is possible that the mimetic system is simply too strained to be formed in this 
case and that the natural β-turn system has more freedom to relieve this strain. 
However, the intermolecular reactions that were carried out in Scheme 48 suggest that 
there is a reactivity problem at both the amide and the alkynyl bromide centre. This would 
imply that the problems encountered in forming the ynamide targets are more complex than 
simple ring strain of the product. 
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Figure 52: 3D Model Structures of Target Compounds and X-Ray Structure of 
Leu-Enkephalin 
 
These models appear to support the goals of the project, by suggesting that the ring 
system would resemble the natural turn fairly closely. There is some variation in the 
orientation of the side chains, but the core of the structure is very similar and this helps to 
validate the initial targets that were designed as leu-enkephalin mimetics. This also suggests 
that continued investigation of these targets, or similar structures, is worthwhile for future 
research. 
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Future Work 
Throughout this project there has been immeasurable difficulty in achieving the cyclic 
cores of the various mimetic structures that have been proposed. Despite numerous attempts 
and various different approaches to the issue, none of the reactions met with any success. 
There are some approaches that may be worth trying in future however and if these are 
unsuccessful, alternative structures must then be considered. 
Returning to the ynamide core model, there are several approaches to this synthesis 
that were not utilised, including the use of triiodonium triflate salts that was discussed earlier. 
Alternatively, there is a procedure that was published recently that uses CuI2 in an oxygen 
atmosphere to couple a terminal alkyne with an amide (Scheme 95). This approach may have 
more success than the various amidation protocols utilising an alkynyl bromide. 
 
Scheme 95: Stahl Oxidative Amidation of Terminal Alkyne 
 
 It may also be worthwhile to investigate other approaches to ynamide synthesis, such 
as the elimination approach. This type of reaction has been reported previously by several 
groups, however, the most appropriate for this system has also been suggested by Hsung and 
co-workers. This group has shown that by refluxing the corresponding enamide with bromine 
in 1,2-DCE the desired β-bromoenamide can be isolated. HBr is then eliminated by treatment 
with KOt-Bu at room temperature to give the desired ynamide. This approach has the added 
benefit of installing the 10-membered ring before introducing the problematic triple bond 
system. Unfortunately, the use of the olefin bond itself as the covalent tether in the actual 
mimetic would introduce too much freedom to the ring and would most likely render the 
structure unsuitable for its intended function. 
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Scheme 96: Elimination Approach to Ynamide 
 
 Alternatively, the alkyne system could be probed further with the screening of a 
diverse array of peptide coupling reagents (Scheme 97). The number of compounds that can 
be used in this transformation is extensive and screening of these may be the best way to 
approach the difficult lactamisation reaction that was attempted in this project. Of course, if 
this approach is taken towards the lactam ring, the same variety of coupling reagents can be 
applied to the cobalt complex system that was investigated earlier as well. While this approach 
did not yield any positive results, the principles behind it are still valid and should not be 
dismissed. 
 
 
Scheme 97: Screening of Lactamisation Conditions 
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Chapter 4 
Experimental 
 
 4.1 General Conditions 
 All reagents were purchased from commercial suppliers and used without further 
purification unless otherwise stated. Reactions involving air-sensitive agents and dry solvents 
were performed in glassware that had been flame dried prior to use and were carried out under 
an argon atmosphere. Organic solvents were dried using a Pure Solv
TM
 solvent purification 
system. Reactions were monitored by thin layer chromatography (TLC) on Merck silica gel 60 
covered aluminium plates F254. TLC plates were developed under UV light and/or with a 
KMnO4 solution (3 g of KMnO4, 20 g K2CO3, 5 mL 5% NaOH (aq) and 300 mL H2O) or 
acidic ethanolic anisaldehyde solution (formed by dissolving 15 g of anisaldehyde in 250 mL 
ethanol and 2.5 mL conc. sulfuric acid). Liquid reagents were distilled prior to use if 
necessary. Column chromatography was performed under pressure (forced flow) using silica 
gel (Fluorochem LC60A, 35-70 micron, 60A) as solid support and HPLC-grade solvents as 
eluent. Petroleum ether used for column chromatography was 40-60 °C fraction. 
 IR spectra were recorded using a type IIa diamond single reflection element on a 
Shimadzu FTIR-8400 instrument. The IR spectrum of the compound (solid or liquid) was 
directly detected as a thin layer at ambient temperature. 
 
1
H NMR spectra were recorded on a Bruker 400 MHz or 500 MHz Spectrospin 
spectrometer (
1
H NMR at 400 MHz and 500 MHz and 
13
C NMR at 100 MHz). Chemical 
shifts are reported in ppm. 
1
H NMR spectra were recorded with CDCl3 as solvent using 
(δ = 7.26) as internal standard or CD3OD using (δ = 4.87, 3.31) as internal standard. For 
13
C 
NMR spectra, the chemical shifts are reported relative to the central resonance of CDCl3 
(δ = 77.2) or CD3OD (δ = 49.1). Signals in NMR spectra are described as singlet (s), doublet 
(d), triplet (t), quartet (q), multiplet (m), broad (br) or a combination of these, which refers to 
the spin-spin coupling pattern observed. DEPT 135 and two-dimensional (COSY, HSQC) 
NMR spectroscopy were used where appropriate to assist the assignment of signals in the 
1
H 
and 
13
C NMR spectra. 
Experimental 
 136 
High resolution mass spectra (HRMS) were recorded under EI, CI and FAB conditions 
by the analytical services at the University of Glasgow. Elemental analyses were carried out 
using an Exeter Analytical Elemental Analyser EA 440. Melting points were recorded with an 
Electrothermal IA 9100 apparatus. Optical rotations were determined on solutions of samples 
and irradiating with the sodium D line (λ = 589 nm) using an Autopol V polarimeter. [α]D 
values are given in units 10
-1
 deg cm
2
 g
-1
. 
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 4.2 Experimental Procedures and Characterisation 
 
L-Phenylalanine tert-butyl ester 155 
 
To a stirred solution of L-phenylalanine (500 mg, 3.03 mmol) in tert-butyl acetate (20 mL) at 
0 C was added HClO4 (70% w/w, 0.640 mL, 4.46 mmol) dropwise. The resulting solution 
was allowed to warm to room temperature and stirred continuously for 16 hours. The reaction 
mixture was then washed with water (30 mL) and 1M HCl (30 mL). The aqueous layer was 
adjusted to pH 9 using a saturated aqueous solution of K2CO3 before extracting with CH2Cl2 
(3  50 mL). The combined organic extracts were dried (MgSO4), filtered and concentrated in 
vacuo. Flash column chromatography on silica gel (petroleum ether-ethyl acetate, 1:1) 
afforded tert-butyl ester 155 as a colourless oil (608 mg, 91%). 
Rf = 0.12 (petroleum ether-ethyl acetate, 1:1); [α]
28
D +8.0 (c = 0.91, CHCl3) {Lit. [α]
27
D +10.1 
(c = 1.01, CHCl3)}
186
; max 3377, 2978, 1725, 846, 740, 699 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3)  7.22–7.13 (5H, m, CH-Arom), 3.53 (1H, dd, J = 7.8, 5.4 Hz, CH-C2), 2.96 (1H, dd, 
J = 13.4, 5.4 Hz, CH2-C3a), 2.76 (1H, dd, J = 13.4, 7.8 Hz, CH2-C3b), 1.40 (2H, s, NH2), 1.35 
(9H, s, CH3-tBu); 
13
C NMR (100 MHz, CDCl3)  174.3 (C-C1), 137.5 (C-C4), 129.4 (CH-
Arom), 128.5 (CH-Arom), 126.7 (CH-Arom), 81.2 (C-tBu), 56.2 (CH-C2), 41.2 (CH2-C3), 
28.0 (CH3-tBu); HRMS (CI, Me3CH) [M+H]
+
 calcd for C13H20NO2 222.1494, found 
222.1493, [ –0.6 ppm]; LRMS (CI, Me3CH) m/z (intensity) 223.1 (16%), 222.1 (100%),  
209.1 (12%). 
 
(S)-tert-Butyl 2-(2-(tert-butoxycarbonylamino)acetamido)-3-phenylpropanoate 
160 
 
A solution of Boc-glycine (174 mg, 0.993 mmol) and HOBt (135 mg, 0.999 mmol) in CH2Cl2 
(2 mL) and DMF (0.5 mL) was prepared and cooled to 0 C. DCC (308 mg, 1.49 mmol) was 
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added and the mixture stirred for 1 hour at 0 C. A solution of L-phenylalanine tert-butyl ester 
155 (221 mg, 0.999 mmol) and TEA (140 L, 1.00 mmol) in CH2Cl2 (1 mL) was added to the 
reaction. The resulting mixture was stirred for 1 hour at 0 C, warmed to room temperature 
and stirred for a further 16 hours. The solution was concentrated in vacuo and the residue was 
suspended in ethyl acetate (15 mL). This solution was filtered and the resulting filtrate was 
washed with 5% aqueous citric acid (15 mL), 5% aqueous NaHCO3 (15 mL) and brine (15 
mL). The organic phase was dried (MgSO4), filtered and concentrated in vacuo. Protected 
dipeptide 160 was isolated by flash column chromatography (petroleum ether-ethyl acetate 
3:1) as a clear oil (199 mg, 53%). 
Rf = 0.30 (petroleum ether-ethyl acetate 3:1); [α]
27
D +34.6 (c = 1.01, CHCl3) {Lit. [α]
27
D +47.2 
(c = 1.10, CHCl3)}
187
; max 3321, 2978, 1735, 1671, 1508, 741, 701 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3)  7.21–7.12 (3H, m, CH-Arom), 7.09–7.07 (2H, m, CH-Arom), 6.68 (1H, d, J = 7.0 
Hz, NH-N3), 5.22 (1H, br s, NH-N6), 4.68 (1H, dt, J = 7.0, 6.1 Hz, CH-C2), 3.75 (1H, dd, J = 
16.5, 5.0 Hz, CH2-C5a), 3.67 (1H, dd, J = 16.5, 5.2 Hz, CH2-C5b) 3.01 (2H, d, J = 6.1 Hz, 
CH2-C10), 1.37 (9H, s, CH3-tBu), 1.32 (9H, s, CH3-C9); 
13
C NMR (100 MHz, CDCl3)  169.1 
(C-C1), 167.8 (C-C4), 154.7 (C-C7), 134.8 (C-C11), 128.3 (C-Arom), 127.1 (C-Arom), 125.7 
(C-Arom), 81.2 (C-C8), 78.8 (C-tBu), 52.3 (CH-C2), 42.9 (CH2-C6), 36.8 (CH2-C10), 27.0 
(CH3-C9), 26.7 (CH3-tBu); HRMS (EI+) [M]
+
 calcd for C20H30N2O5 378.2155, found 
378.2158, [Δ +0.8 ppm]; LRMS (EI+) m/z (intensity) 379.2 (28%), 378.2 (100%). 
 
Glycine tert-butyl ester 158 
 
Ammonia (20 mL) was condensed into a flask cooled to –40 C and diluted with dry Et2O 
(15 mL). A solution of tert-butyl bromoacetate (3.20 mL, 21.7 mmol) in dry Et2O (5 mL) was 
added slowly, maintaining the temperature at –40 C. The reaction was stirred at this 
temperature for 2 hours before warming to room temperature and stirring, open to the air, for 
16 hours. The solution was filtered and concentrated in vacuo. Flash column chromatography 
on silica gel (petroleum ether- ethyl acetate 1:1) afforded tert-butyl ester 158 as a clear oil 
(2.08 g, 73%). 
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Rf = 0.28 (petroleum ether-ethyl acetate 1:1); max 3336, 2983, 2923, 1731, 746 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3)  3.27 (2H, s, CH2-C2), 1.89 (2H, s, NH2), 1.40 (9H, s, CH3-tBu); 
13
C 
NMR (100 MHz, CDCl3)  171.1 (C-C1), 81.3 (C-tBu), 50.9 (CH2-C2), 28.1 (CH3-tBu). 
 
3-(Trimethylsilyl)prop-2-yn-1-ol 163 
 
A solution of propargyl alcohol (570 μL, 10.0 mmol) in THF (50 mL) was prepared and 
cooled to –78 °C. n-BuLi (8.80 mL of a 2.5M solution in hexane, 22.0 mmol) was added to the 
solution dropwise and the mixture stirred for 30 minutes. Finally, TMSCl (2.86 mL, 
22.5 mmol) was added and the mixture was warmed to room temperature. 1M HCl (50 mL) 
was added and the reaction was stirred for 1 hour. After this time, the aqueous layer was 
extracted with ethyl acetate (3 × 20 mL) and the combined organic extracts were washed with 
saturated aqueous NaHCO3 (20 mL) and brine (20 mL). The extracts were then dried 
(MgSO4), filtered and concentrated in vacuo. The TMS acetylene 163 was isolated after flash 
column chromatography on silica gel (petroleum ether-ethyl acetate, 19:1) as a colourless oil 
(880 mg, 69%). 
Rf = 0.31 (petroleum ether-ethyl acetate, 9:1); max 3333, 2963, 2176, 756, 648 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3) δ 4.09 (2H, s, CH2-C1), 2.04 (1H, s, OH), 0.00 (9H, s, TMS); 
13
C NMR 
(100 MHz, CDCl3) δ 104.1 (C-C2), 90.8 (C-C3), 51.7 (CH2-C1), 0.0 (CH3-TMS); HRMS (CI, 
Me3CH) [M+H]
+
 calcd for C6H13OSi 129.0736, found 129.0733, [ –0.3 ppm]; LRMS (CI, 
Me3CH) m/z (intensity) 129.1 (18%), 95.2 (100%); Anal. calcd for C6H12OSi: C, 56.19%; H, 
9.43%. Found: C, 55.81%; H, 9.62%. 
 
3-(Trimethylsilyl)prop-2-yn-1-al 157 
 
A suspension of PCC (3.51 g, 16.3 mmol) in CH2Cl2 (30 mL) was prepared and cooled to 
0 °C. 3-(Trimethylsilyl)prop-2-yn-1-ol, 163, (1.28g, 10.0 mmol) was added dropwise over a 
period of 10 minutes and the resulting mixture was stirred for 2 hours at room temperature. 
The reaction mixture was then filtered through a pad of silica washing with dichloromethane, 
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simultaneously removing the chromium residues and purifying the mixture, to give the target 
aldehyde 157 as a clear, colourless oil (675 mg, 54%). 
Rf = 0.69 (petroleum ether-ethyl acetate, 9:1); νmax 3317, 2965, 2858, 2154, 1667, 625cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 8.99 (1H, s, CH-C1), 0.08 (9H, s, CH3-TMS); 
13
C NMR (100 
MHz, CDCl3) δ 177.7 (CH-C1), 104.0 (C-C2), 103.1 (C-C3), 0.0 (CH3-TMS). 
 
tert-Butyl 2-(3-(trimethylsilyl)prop-2-ynylamino)acetate 164 
 
A solution was prepared containing glycine tert-butyl ester 158 (310 mg, 2.36 mmol) and 
3-(trimethylsilyl)prop-2-yn-1-al 157 (298 mg, 2.36 mmol) in dry THF (20 mL) at room 
temperature. Sodium triacetoxyborohydride (763 mg, 3.60 mmol) was then added and the 
reaction mixture was stirred for 16 hours. A further 0.5 equivalents of glycine tert-butyl ester 
(155 mg, 1.18 mmol) was added to assist in driving the reaction to completion. After a further 
2 hours reaction time, the mixture was quenched by the addition of aqueous 3M NaOH 
solution (10 mL) and the aqueous layer was extracted with Et2O (3 × 10 mL). The organic 
extracts were dried (MgSO4), filtered and concentrated in vacuo. Amine 164 was isolated by 
flash column chromatography on silica gel (petroleum ether-ethyl acetate, 3:1) as a clear 
colourless oil (56 mg, 10%). 
Rf = 0.43 (petroleum ether-ethyl acetate, 1:1); νmax 3338, 2962, 2931, 2868, 2167, 1733, 840, 
759, 698 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 3.31 (2H, s, CH2-C2), 3.22 (2H, s, CH2-C3), 
1.61 (1H, s, NH), 1.31 (9H, s, CH3-tBu), 0.00 (9H, s, CH3-TMS); 
13
C NMR (100 MHz, 
CDCl3) δ 171.2 (C-C1), 103.5 (C-C4), 88.4 (C-C5), 81.4 (C-tBu), 50.2 (CH2-C2), 38.7 (CH2-
C3), 28.1 (CH3-tBu), 0.0 (CH3-TMS); HRMS (CI, Me3CH) [M+H]
+
 calcd for C12H24NO2Si 
242.1576, found 242.1580, [ +0.3 ppm]; LRMS (CI, Me3CH) m/z (intensity) 243.2 (19%), 
242.2 (100%). 
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4-Methyl-N-(prop-2-ynyl)benzenesulfonamide 165 
 
A flask was charged with TsCl (9.70 g, 51.0 mmol) before the addition of THF (40 mL) and 
pyridine (4.30 mL, 53.2 mmol). The solution was cooled to 0 C and propargylamine 
(3.20 mL, 50.0 mmol) was added dropwise. The reaction mixture was stirred for 18 hours, 
allowing it to reach room temperature slowly. Aqueous 2M NaOH solution (10 mL) was 
added and the resulting solution was stirred for a further 45 minutes. The aqueous layer was 
separated and extracted with EtOAc (3 × 50 mL). The combined organic extracts were washed 
with brine (50 mL), dried (MgSO4), filtered and concentrated in vacuo. Sulfonamide 165 was 
isolated after flash column chromatography on silica gel (petroleum ether-ethyl acetate, 3:1) to 
give a white solid (8.2 g, 78%). 
Rf = 0.41 (petroleum ether-ethyl acetate, 2:1); m.p. = 73.5–74 °C {Lit. m.p. 73–74 °C}
188; νmax 
3271, 2924, 2863, 2129, 810, 664 cm 
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.81 (2H, d, J = 8.1 
Hz, CH-C5), 7.35 (2H, d, J = 8.1 Hz, CH-C6), 4.69 (1H, t, J = 5.8 Hz, NH), 3.86 (2H, dd, J = 
5.8, 2.6 Hz, CH2-C3), 2.47 (3H, s, CH3-C8), 2.14 (1H, t, J = 2.6 Hz, CH-C1); 
13
C NMR (100 
MHz, CDCl3) δ 142.8 (C-Arom), 135.5 (C-Arom), 128.7 (CH-C6), 126.4 (CH-C5), 76.9 (C-
C2), 72.0 (CH-C1), 31.8 (CH2-C3), 20.5 (CH3-C8); HRMS (CI, Me3CH) [M+H]
+
 calcd for 
C10H12NO2S 210.0589, found 210.0589, [ +0.3 ppm]; LRMS (CI, Me3CH) m/z (intensity) 
211.1 (12%), 210.1 (100%); Anal. calcd for C10H11NO2S: C, 57.42%; H, 5.26%; N, 6.70%. 
Found: C, 57.45%; H, 5.31%; 6.69%. 
 
tert-Butyl 2-(4-methyl-N-(prop-2-ynyl)phenylsulfonamido)acetate 166 
 
To a solution of sulfonamide 165 (800 mg, 3.83 mmol) in acetone (10 mL) was added 
anhydrous K2CO3 (1.60 g, 11.6 mmol) followed by vigorous stirring at room temperature for 
18 hours. The suspension was filtered and washed with acetone and the filtrate was 
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concentrated in vacuo. Ester 166 was isolated after flash column chromatography using silica 
gel (petroleum ether-ethyl acetate, 9:1) as a white solid (1.16 g, 94%). 
Rf = 0.26 (petroleum ether-ethyl acetate 9.1); m.p. = 47–49 °C; νmax 3280, 2983, 1735, 700, 
685 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.65 (2H, d, J = 8.2 Hz, CH-C7), 7.22 (2H, d, J = 8.2 
Hz, CH-C8), 4.19 (2H, d, J = 2.4 Hz, CH2-C3), 3.94 (2H, s, CH2-C2), 2.34 (3H, s, CH3-C10), 
2.08 (1H, t, J = 2.4 Hz, CH-C5), 1.35 (9H, s, CH3-tBu); 
13
C NMR (100 MHz, CDCl3) δ 167.4 
(C-C1), 143.7 (C-Arom), 136.3 (C-Arom), 129.6 (CH-C8), 127.5 (CH-C7), 82.3 (C-tBu), 76.6 
(CH-C5), 74.1 (C-C4), 47.4 (CH2-C2), 37.3 (CH2-C3), 28.0 (CH3-tBu), 21.5 (CH3-C10); 
HRMS (FAB) [M+H]
+
 calcd for C16H22NO4S 324.1270, found 324.1269, [Δ –0.3 ppm]; 
LRMS (FAB) m/z (intensity) 325.1 (20%), 324.1 (100%); Anal calcd for C16H21NO4S: C, 
59.44%; H, 6.50%; N, 4.33%. Found: C, 59.65%; H, 6.59%; N, 4.46%. 
 
2-(4-Methyl-N-(prop-2-ynyl)phenylsulfonamido)acetic acid 169 
 
A solution of the tert-butyl ester 166 (594 mg, 1.84 mmol) in CH2Cl2 (5 mL) was prepared, to 
which was added TFA (5 mL) at room temperature. The reaction mixture was stirred for 
2 hours followed by concentration in vacuo. A small volume of toluene was added to the 
residue before concentrating in vacuo once again. This was repeated a further two times to 
ensure complete removal of trace amounts of TFA. After further drying under high vacuum, 
carboxylic acid 169 was isolated as an off-white solid (490 mg, 100%). 
Rf = 0.61 (dichloromethane-methanol, 9:1); m.p. = 100–101 °C; νmax 3262, 3050, 2969, 2554, 
2120, 1732, 1707, 1599, 816, 766 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 10.90 (1H, br s, OH), 
7.65 (2H, d, J = 8.2 Hz, CH-C7), 7.24 (2H, d, J = 8.2 Hz, CH-C8), 4.18 (2H, d, J = 2.2 Hz, 
CH2-C3), 4.07 (2H, s, CH2-C2), 2.36 (3H, s, CH3-C10), 2.09 (1H, t, J = 2.2 Hz, CH-C5); 
13
C 
NMR (100 MHz, CDCl3) δ 174.3 (C-C1), 144.2 (C-Arom), 135.7 (C-Arom), 129.7 (CH-C8), 
127.5 (CH-C7), 76.1 (CH-C5), 74.7 (C-C4), 46.6 (CH2-C2), 37.5 (CH2-C3), 21.6 (CH3-C10); 
HRMS (CI, Me3CH) [M+H]
+
 calcd for C12H14NO4S 268.0644, found 268.0650 [Δ +2.4 ppm]; 
LRMS (CI, Me3CH) m/z (intensity) 285.1 (17%), 284.1 (100%), 168.1 (47%); Anal calcd for 
C12H13NO4S: C, 53.92%; H, 4.90%; N, 5.24%. Found: C, 54.05%; H, 5.09%; N, 5.06%. 
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(S)-Methyl 2-(2-(tert-butoxycarbonylamino)acetamido)-3-phenylpropanoate 167 
 
A solution of Boc-glycine (960 mg, 5.49 mmol) and HOBt (675 mg, 5.00 mmol) was prepared 
in CH2Cl2 (10 mL) and DMF (2.5 mL) and cooled to 0 °C. DCC (1.13 g, 5.49 mmol) was 
added and the reaction stirred for 30 minutes. A solution of L-phenylalanine methyl ester 
hydrochloride (1.10 g, 5.09 mmol) and TEA (700 μL, 5.03 mmol) in CH2Cl2 was added to the 
reaction mixture followed by a further 30 minutes of stirring at 0 °C and 18 hours at room 
temperature. The mixture was concentrated and the white residue was suspended in EtOAc 
(15 mL) and filtered. The filtrate was washed with 5% aqueous citric acid (15 mL), 5% 
aqueous NaHCO3 (15 mL) and brine (15 mL). The organic layer was dried (MgSO4), filtered 
and concentrated in vacuo. Dipeptide 167 was isolated by flash column chromatography using 
silica gel (petroleum ether-ethyl acetate, 1:1) as a colourless oil (1.4 g, 92%). 
Rf = 0.28 (petroleum ether-ethyl acetate, 1:1); [α]
27
D +47.8 (c = 1.05, CHCl3); νmax 3403, 3311, 
2978, 1743, 1717, 1666, 1506, 743, 700 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.24–7.17 (3H, 
m, CH-Arom), 7.03–7.02 (2H, m, CH-Arom), 6.46 (1H, d, J = 7.1 Hz, NH-N3), 5.02 (1H, br s, 
NH-N6), 4.82 (1H, ddd, J = 7.1, 5.9, 5.8 Hz, CH-C2), 3.79-3.61 (2H, m, CH2-C5), 3.65 (3H, s, 
CH3-Me), 3.08 (1H, dd, J = 13.9, 5.8 Hz, CH2-C10a), 3.03 (1H, dd, J = 13.9, 5.9 Hz, CH2-
C10b), 1.37 (9H, s, CH3-C9); 
13
C NMR (100 MHz, CDCl3) δ 171.8 (C-C1), 169.3 (C-C4), 
156.0 (C-C6), 135.7 (C-C11), 129.3 (CH-Arom), 128.6 (CH-Arom), 127.2 (CH-Arom), 80.1 
(C-C8), 53.1 (CH-C2), 52.4 (CH3-Me), 44.1 (CH2-C5), 37.9 (CH2-C10), 28.3 (CH3-C9); 
HRMS (CI, Me3CH) [M+H]
+
 calcd for C17H25N2O5 337.1763, found 337.1760 [Δ –1.1 ppm]; 
LRMS (CI, Me3CH) m/z (intensity) 338.2 (20%), 337.2 (100%); Anal calcd for C17H24N2O5: 
C, 60.70%; H, 7.19%; N, 8.33%. Found: C, 60.70%; H, 7.15%; N, 8.33%. 
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(S)-Methyl 2-(2-aminoacetamido)-3-phenylpropanoate TFA salt 168 
 
A solution of carbamate 167 (233 mg, 0.693 mmol) was prepared in CH2Cl2 (2 mL) before 
addition of TFA (2 mL) at room temperature followed by stirring for 2 hours. After this time, 
the mixture was concentrated in vacuo. A small volume of toluene was added to the residue 
and it was concentrated in vacuo once again. This was repeated a further two times to remove 
trace amounts of TFA. Finally with drying under high vacuum, the target amine 168 was 
isolated as its TFA salt as a fluffy white solid (242 mg, 100%). 
M.p. = 61–63 °C; [α]27D +9.6 (c = 1.13, CHCl3); νmax 3032, 2955, 2855, 2654, 1736, 1667, 
1551, 833, 702 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.74 (3H, br s, NH3
+
), 7.32 (1H, d, J = 7.9 
Hz, NH), 7.15–7.07 (3H, m, CH-Arom), 6.97–6.95 (2H, m, CH-Arom), 4.67 (1H, ddd, J = 7.9, 
7.3, 5.6 Hz, CH-C2), 3.70 (1H, d, J = 15.2 Hz, CH2-C4a), 3.55 (1H, d, J = 15.2 Hz, CH2-C4b), 
3.54 (3H, s, CH3-Me), 2.96 (1H, dd, J = 14.0, 5.6 Hz, CH2-C5a), 2.85 (1H, dd, J = 14.0, 7.3 
Hz, CH2-C5b); 
13
C NMR (100 MHz, CDCl3) δ 172.1 (C-C1), 166.1 (C-C3), 161.3 (q, 
2
JF-C = 
30.4, C-TFA), 135.3 (C-C6), 129.0 (CH-Arom), 128.7 (CH-Arom), 127.3 (CH-Arom), 115.6 
(q, 
1
JF-C = 229.8 Hz, CF3-TFA), 54.0 (CH-C2), 52.6 (CH3-Me), 40.9 (CH2-C4), 37.4 (CH2-
C5); HRMS (CI, Me3CH) [M+H]
+
 calcd for C12H17N2O3 237.1239, found 237.1240, [ +0.4 
ppm]; LRMS (CI, Me3CH) m/z (intensity) 238.1 (16%), 237.1 (100%). 
 
Methyl 2-(2-(2-(4-methyl-N-(prop-2-
ynyl)phenylsulfonamido)acetamido)acetamido)-3-phenylpropanoate 170 
 
A solution of carboxylic acid 169 (100 mg, 0.374 mmol) and HOBt (51.0 mg, 0.377 mmol), in 
CH2Cl2 (3 mL) and DMF (1 mL) was prepared and cooled to 0 °C. DCC (83.0 mg, 
0.402 mmol) was added to the solution and it was stirred at 0 °C for 30 minutes. A solution of 
TFA salt 168 (132 mg, 0.377 mmol) in CH2Cl2 (2 mL) with TEA (52.3 μL, 0.376 mmol) was 
prepared separately and added to the reaction mixture. The resulting mixture was stirred for 
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1 hour at 0 °C and a further 16 hours at room temperature. The reaction was concentrated and 
the resulting white residue was suspended in ethyl acetate (20 mL). The suspension was 
filtered and the filtrate was washed with 5% aqueous citric acid solution (10 mL), 5% aqueous 
NaHCO3 solution (10 mL) and brine (10 mL). The organic layer was dried (MgSO4), filtered 
and concentrated in vacuo. Tripeptide 170 was isolated after flash column chromatography on 
silica gel (dichloromethane-methanol, 19:1) as a white solid (159 mg, 88%). 
Rf = 0.43 (dichloromethane-methanol, 19:1); m.p. = 47–48 °C; [α]
26
D +30.7 (c = 1.00, CHCl3); 
νmax 3364, 3295, 1744, 1659, 1520, 910, 810, 733, 656 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
7.64 (2H, d, J = 8.2 Hz, CH-C18), 7.26 (2H, d, J = 8.2 Hz, CH-C19), 7.23 – 7.13 (4H, m, CH-
Arom and NH-N6), 7.07–7.06 (2H, m, CH-Arom), 6.74 (1H, d, J = 7.8 Hz, NH-N3), 4.78 (1H, 
ddd, J = 7.8, 6.7, 5.8 Hz, CH-C2), 4.06 (2H, d, J = 2.5 Hz, CH2-C9), 3.94 (1H, dd, J = 16.9, 
6.0 Hz, CH2-C5a), 3.85 (1H, dd, J = 16.9, 5.8 Hz, CH2-C5b), 3.74 (2H, d, J = 2.4 Hz, CH2-
C8), 3.62 (3H, s, CH3-Me), 3.07 (1H, dd, J = 13.9, 5.8 Hz, CH2-C12a), 2.98 (1H, dd, J = 13.9, 
6.7 Hz, CH2-C12b), 2.37 (3H, s, CH3-C21), 2.01 (1H, t, J = 2.5 Hz, CH-C11); 
13
C NMR (100 
MHz, CDCl3) δ 171.7 (C-C1), 168.3 (C-C4), 168.2 (C-C7), 144.8 (C-Arom), 135.8 (C-Arom), 
133.7 (C-C13), 129.9 (CH-C19), 129.3 (CH-Arom), 128.6 (CH-Arom), 128.0 (CH-C18), 
127.1 (CH-Arom),  75.7 (CH-C11), 75.2 (C-C10), 53.4 (CH-C2), 52.4 (CH3-Me), 50.2 (CH2-
C8), 42.8 (CH2-C5), 39.3 (CH2-C9), 37.8 (CH2-C12), 21.6 (CH3-C21); HRMS (FAB) [M+H]
+
 
calcd for C24H28N3O6S 486.1699, found 486.1707 [Δ +1.6 ppm]; LRMS (FAB) m/z (intensity) 
488.2 (12%), 487.1 (30.7%), 486.2 (100%). 
 
Bromination of Tripeptidic Alkyne 
 
To a solution of tripeptide 170 (100 mg, 0.206 mmol) in dry acetone (3 mL) at room 
temperature, was added AgNO3 (3.50 mg, 0.0206 mmol) and the mixture was stirred for 
15 minutes. NBS (34.9 mg, 0.196 mmol) was then added and the mixture was stirred at room 
temperature for a period of 4.5 hours. The mixture was diluted with acetone and filtered, 
before concentration in vacuo to give a yellow oil. Attempts to isolate possible products 
identified by TLC analysis, using flash column chromatography on silica gel 
(dichloromethane-methanol 37:3), provided polybrominated products. This approach was 
abandoned in favour of an alternate route to the alkynyl bromide. 
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tert-Butyl 2-(N-(3-bromoprop-2-ynyl)-4-methylphenylsulfonamido)acetate 172 
 
To a solution of alkyne 166 (1.60 g, 4.95 mmol) in acetone (5 mL) was added silver nitrate 
(168 mg, 0.988 mmol) and the reaction vessel was covered with aluminium foil. After stirring 
for 30 minutes, NBS (979 mg, 5.50 mmol) was added. The reaction mixture was stirred for a 
subsequent 18 hours. The suspension was filtered and washed with EtOAc and the filtrate was 
concentrated in vacuo. Bromide 172 was isolated by flash column chromatography using silica 
gel (petroleum ether-ethyl acetate, 4:1), giving a white solid (1.7 g, 88%). 
Rf = 0.48 (petroleum ether-ethyl acetate, 3:1); m.p. = 93–94 °C; νmax 2980, 2214, 1922, 1744, 
1599, 813, 623, 602 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.64 (2H, d, J = 8.2 Hz, CH-C7), 
7.24 (2H, d, J = 8.2 Hz, CH-C8), 4.20 (2H, s, CH2-C3), 3.89 (2H, s, CH2-C2), 2.35 (3H, s, 
CH3-C10), 1.36 (9H, s, CH3-tBu); 
13
C NMR (100 MHz, CDCl3) δ 167.3 (C-C1), 143.9 (C-
Arom), 135.9 (C-Arom), 129.6 (CH-C8), 127.6 (CH-C7), 82.5 (C-tBu), 73.0 (C-C4), 47.7 
(CH2-C2), 45.5 (C-C5), 38.5 (CH2-C3), 28.0 (CH3-tBu), 21.6 (CH3-C10); HRMS (FAB) 
[M+H]
+
 calcd for C16H21BrNO4S 402.0375, found 402.0372 [Δ –0.7 ppm]; LRMS (FAB) m/z 
(intensity) 404.0 (10%), 402.0 (12%), 345.9 (100%); Anal calcd for C16H20BrNO4S: C, 
47.77%; H, 5.01%; N, 3.48%. Found: C, 47.62; H, 5.00%; N, 3.53%. 
 
2-(N-(3-Bromoprop-2-ynyl)-4-methylphenylsulfonamido)acetic acid 173 
 
A solution of tert-butyl ester 172 (50.0 mg, 0.124 mmol) in CH2Cl2 (2 mL) was prepared. TFA 
(2 mL) was added to the solution and it was stirred for 3 hours at room temperature. After this 
time the reaction was concentrated in vacuo. A small volume of toluene was added to the 
residue, which was then concentrated in vacuo once again. This procedure was repeated a 
further two times to remove traces of TFA, followed by a period of drying under high vacuum. 
The carboxylic acid 173 was isolated as an off white solid without further purification (43 mg, 
100%). 
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Rf = 0.23 (petroleum ether-ethyl acetate, 3:1); m.p. = 125–127 °C; νmax 2969, 2920, 1729, 
1710, 1599, 812, 691, 664, 636 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 9.82 (1H, br s, OH), 7.65 
(2H, d, J = 8.2 Hz, CH-C7), 7.26 (2H, d, J = 8.2 Hz, CH-C8), 4.19 (2H, s, CH2-C3), 4.04 (2H, 
s, CH2-C2), 2.37 (3H, s, CH3-C10); 
13
C NMR (100 MHz, CDCl3) δ 173.4 (C-C1), 143.3 (C-
Arom), 134.3 (C-Arom), 128.7 (CH-C8), 126.5 (CH-C7), 71.4 (C-C4), 45.8 (CH2-C2), 45.3 
(C-C5), 37.6 (CH2-C3), 20.6 (CH3-C10); HRMS (CI, Me3CH) [M+H]
+
 calcd for 
C12H13BrNO4S 345.9749; found 345.9750 [Δ +0.3 ppm]; LRMS (CI, Me3CH) m/z (intensity) 
348.0 (100%), 347.0 (15%), 346.0 (93%); Anal calcd for C12H12BrNO4S: C, 41.63%; H, 
3.49%; N, 4.05%. Found: C, 42.10%; H, 3.56%; N, 4.13%. 
 
(S)-Methyl 2-(2-(2-(N-(3-bromoprop-2-ynyl)-4-
methylphenylsulfonamido)acetamido)acetamido)-3-phenylpropanoate 171 
 
A solution of carboxylic acid 173 (169 mg, 0.488 mmol) was prepared in CH2Cl2 (6 mL). 
HOBt (53.6 mg, 0.397 mmol) and DMF (1 mL) were added to the solution, which was then 
cooled to 0 °C. After stirring for 30 minutes, a solution of TFA salt 168 (139 mg, 0.397 mmol) 
and TEA (110 μL, 0.794 mmol) in CH2Cl2 (2 mL) was added. The reaction was stirred at 0 °C 
for 1 hour and a further 16 hours at room temperature. The mixture was concentrated and the 
residue was suspended in EtOAc (20 mL). This was then filtered and the filtrate was washed 
with 5% aqueous citric acid (20 mL), 5% aqueous NaHCO3 (20 mL) and brine (20 mL). The 
organic layer was dried (MgSO4), filtered and concentrated in vacuo. Tripeptide 171 was 
isolated by flash column chromatography using silica gel (dichloromethane-methanol, 19:1) to 
give a white solid (160 mg, 58%). 
Rf = 0.32 (dichloromethane-methanol, 19:1); m.p. = 49–50 °C; [α]
26
D +47.8 (c = 0.99, CHCl3); 
νmax 3358, 3066, 2950, 2215, 1741, 1659, 1518, 803, 747, 701, 662, 625 cm
-1
; 
1
H NMR (500 
MHz, CDCl3) δ 7.65 (2H, d, J = 8.2 Hz, CH-C18), 7.29 (2H, d, J = 8.2 Hz, CH-C19), 7.25–
7.16 (3H, m, CH-Arom), 7.06–7.04 (2H, m, CH-Arom), 6.99 (1H, dd, J = 6.0, 5.8 Hz, NH-
N6), 6.40 (1H, d, J = 7.8 Hz, NH-N3), 4.88 (1H, ddd, J = 7.8, 6.4, 5.8 Hz, CH-C2), 4.11 (1H, 
d, J = 18.3 Hz, CH2-C9a), 4.06 (1H, d, J = 18.3 Hz, CH2-C9b), 3.94 (1H, dd, J =16.7, 6.0 Hz, 
CH2-C5a), 3.87 (1H, dd, J = 16.7, 5.8 Hz, CH2-C5b), 3.72 (2H, s, CH2-C8), 3.66 (3H, s, CH3-
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Me), 3.09 (1H, dd, J = 13.9, 5.8 Hz, CH2-C12a), 3.01 (1H, dd, J = 13.9, 6.4 Hz, CH2-C12b), 
2.39 (3H, s, CH3-C21); 
13
C NMR (100 MHz, CDCl3) δ 171.6 (C-C1), 168.1 (C-C4), 168.0 (C-
C7), 144.8 (C-Arom), 135.7 (C-Arom), 133.7 (C-Arom), 129.9 (CH-C19), 129.3 (CH-Arom), 
128.6 (CH-Arom), 128.1 (CH-C18), 127.2 (CH-Arom), 77.2 (C-C10), 72.1 (C-C11), 53.3 
(CH-C2), 52.4 (CH3-Me), 50.4 (CH2-C8), 42.8 (CH2-C5), 40.2 (CH2-C9), 37.8 (CH2-C12), 
21.6 (CH3-C21); HRMS (FAB) [M+H]
+
 calcd for C24H27BrN3O6S 564.0804, found 564.0801 
[Δ –0.6 ppm]; LRMS (FAB) m/z (intensity) 567.1 (30%), 566.1 (100%), 565.1 (29%), 564.1 
(97%). 
 
Hsung 2
nd
 Generation Coupling Using Potassium Carbonate 
 
 
 
To a solution of alkynyl bromide 171 (15.0 mg, 0.0266 mmol) in toluene (2 mL) was added, 
sequentially, CuSO4·5H2O (0.700 mg, 0.00280 mmol), 1,10-phenanthroline (1.00 mg, 0.00555 
mmol) and K2CO3 (7.30 mg, 0.528 mmol). The reaction mixture was heated to 70 °C and 
stirred for 41 hours. The mixture was diluted with EtOAc and filtered through a pad of 
Celite
®
, before concentration in vacuo. Analysis of the residue indicated that no reaction had 
taken place; the starting material was recovered using flash column chromatography on silica 
gel (petroleum ether-ethyl acetate 4:1). 
 
Hsung 2
nd
 Generation Coupling Using Potassium Phosphate 
 
 
A solution of tripeptide 171 (21.0 mg, 0.0372 mmol) in toluene (10 mL) was prepared, before 
the sequential addition of CuSO4·5H2O (1.90 mg, 0.00761 mmol), 1,10-phenanthroline 
(2.70 mg, 0.0150 mmol) and K3PO4 (15.0 mg, 0.0707 mmol). The reaction mixture was heated 
to reflux and stirred continuously for 48 hours. The reaction was allowed to cool to room 
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temperature before concentration in vacuo.  TLC analysis indicated traces of new products and 
so the mixture was separated using flash column chromatography on silica gel 
(dichloromethane-methanol, 19:1). Analysis of the new products using NMR methods 
revealed them to be trace decomposition products rather than the desired macrocycle. 
 
Zhang Iron Catalysed Coupling 
 
 
A solution of tripeptide 171 (20.0 mg, 0.0354 mmol) was prepared in toluene (5 mL), before 
the sequential addition of FeCl3·6H2O (0.960 mg, 0.00355 mmol), DMEDA (0.630 mg, 
0.00715 mmol) and K2CO3 (9.70 mg, 0.0702 mmol). The mixture was heated to 90 °C and 
stirred for a period of 22 hours. TLC analysis indicated no progression of reaction or 
consumption of starting material. The reaction mixture was filtered and concentrated in vacuo. 
The starting material was successfully recovered from the reaction mixture using flash column 
chromatography on silica gel (dichloromethane-methanol, 19:1). 
 
Danheiser Coupling Protocol 
 
A solution of tripeptide 171 (20.0 mg, 0.0354 mmol) and pyridine (0.1 mL) in THF (10 mL) 
was prepared and cooled to 0 °C. KHMDS (70.0 μL of a 0.5 M solution in toluene, 
0.0350 mmol) was added dropwise and the resulting mixture was stirred for 15 minutes. CuI 
(6.70 mg, 0.0352 mmol) was added and the reaction mixture was allowed to warm to room 
temperature. After stirring for 20 hours, the reaction was diluted with Et2O (10 mL) and 
washed with a 2:1 solution of brine and saturated aqueous NH4Cl (3 × 20 mL). The aqueous 
washings were then extracted with Et2O (3 × 20 mL) and the combined extracts were dried 
(Na2SO4), filtered and concentrated in vacuo. TLC analysis of the residue indicated no 
consumption of starting material and no progression of reaction. 
Experimental 
 150 
Hsung 1
st
 Generation Protocol 
 
A solution of tripeptide 171 (20.0 mg, 0.0354 mmol) in toluene (0.5 mL) was prepared before 
the addition of K3PO4 (15.0 mg, 0.0707 mmol) and CuCN (0.160 mg, 0.00179 mmol). Finally, 
DMEDA (0.380 μL, 0.00353 mmol) was added to the mixture and the reaction was heated to 
90 °C. After stirring at this temperature for 48 hours, the reaction mixture was allowed to cool 
to room temperature. The mixture was filtered through a pad of silica and concentrated in 
vacuo. Analysis of the residue indicated that the desired product had not formed and that there 
was no consumption of the starting material. 
 
Intramolecular Approach Using Hsung 2
nd
 Generation Protocol 
 
 
To a solution of protected dipeptide 167 (50.0 mg, 0.149 mmol) in toluene (3 mL) was added 
CuSO4·5H2O (3.70 mg, 0.0148 mmol), 1,10-phenanthroline (5.40 mg, 0.0300 mmol) and 
K3PO4 (63.0 mg, 0.297 mmol). Finally, alkynyl bromide 172 (66.0 mg, 0.164 mmol) was 
added to the reaction mixture, before heating it to 75 °C. The reaction was stirred for 24 hours, 
after which time TLC analysis revealed that reaction had not taken place. The reaction mixture 
was concentrated in vacuo and the starting materials were recovered by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate 4:1). 
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Intramolecular Approach Using Danheiser Stoichiometric Protocol 
 
A solution of dipeptide 167 (17.0 mg, 0.0505 mmol) in pyridine (0.13 mL) was prepared and 
cooled to 0 °C. KHMDS (0.100 mL of a 0.5 M solution in toluene, 0.0500 mmol) was added 
dropwise and the resulting mixture was stirred for 15 minutes. A solution of CuI (9.50 mg, 
0.0499 mmol) in pyridine (0.12 mL) was added and the reaction mixture was allowed to warm 
to room temperature, followed by another 2 hours of stirring. Finally, a solution of alkynyl 
bromide 172 (40.0 mg, 0.0994 mmol) in THF (0.25 mL) was added slowly to the mixture, 
before stirring for 20 hours. The mixture was diluted with Et2O (15 mL) and washed with a 
2:1 mixture of brine and saturated aqueous NH4Cl (3 × 15 mL). The combined aqueous 
washings were extracted with Et2O (3 × 15 mL). The combined organic extracts were washed 
with brine (10 mL), dried (MgSO4), filtered and concentrated in vacuo. TLC analysis did not 
indicate product formation, and so the starting materials were recovered from the residue using 
flash column chromatography on silica gel (petroleum ether-ethyl acetate, 4:1). 
 
(R)-4-Phenyloxazolidin-2-one 178 
 
A 2 neck round-bottomed flask with attached distillation condenser was flame dried under 
vacuum. After cooling, the flask was charged with (R)-(–)-2-phenylglycinol (2.00 g, 
14.6 mmol), dried K2CO3 (201 mg, 1.46 mmol) and diethyl carbonate (3.50 mL, 28.9 mmol). 
The flask was lowered into a pre-heated oil bath at 135 °C. The reaction was stirred at this 
temperature, allowing ethanol by-product to be distilled into a separate flask. The reaction was 
complete upon cessation of ethanol formation, at which point the reaction was cooled and 
diluted with CH2Cl2 (1 L). The solution was washed with water (500 mL) and the organic 
layer was dried (MgSO4), filtered and concentrated yielding a yellow solid. The product was 
washed with Et2O and filtered to give a clean white solid. Further product crystallised out of 
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the Et2O washings upon cooling. This was also filtered and collected, giving oxazolidinone 
178 as a white solid (887 mg, 37%). 
Rf = 0.23 (petroleum ether-ethyl acetate, 1:1); m.p. = 127–129 °C
 
{Lit. m.p. = 129–131 °C}189; 
[α]26D –55.3 (c = 1.05, CHCl3) {Lit. [α]
20
D –54.0 (c = 1.00, CHCl3)}
190; νmax 3237, 3140, 1736, 
1701, 748, 694 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.38–7.26 (5H, m, CH-Arom), 5.71 (1H, 
s, NH), 4.89 (1H, dd, J = 8.6, 7.0 Hz, CH-C3), 4.67 (1H, dd, J = 8.6, 8.6 Hz, CH2-C2a), 4.12 
(1H, dd, J = 8.6, 7.0 Hz, CH2-C2b); 
13
C NMR (100 MHz, CDCl3) δ 159.7 (C-C1), 139.5 (C-
C4), 129.2 (CH-Arom), 128.9 (CH-Arom), 126.1 (CH-Arom), 72.5 (CH2-C2), 59.4 (CH-C3); 
HRMS (CI, Me3CH) [M+H]
+
 calcd for C9H10NO2 164.0712, found 164.0709 [Δ –1.3 ppm]; 
LRMS m/z (intensity) 165.1 (10%), 164.1 (100%); Anal. calcd for C9H9NO2: C, 66.25%; H, 
5.56%; N, 8.58%. Found C, 66.27%; H, 5.51%; N, 8.55%. 
 
Alkynyl Bromide Fragment Test Reaction 
 
To a solution of oxazolidinone 178 (100 mg, 0.613 mmol) in toluene (10 mL) was added, 
sequentially, CuSO4·5H2O (15.3 mg, 0.0613 mmol), 1,10-phenanthroline (22.1 mg, 
0.123 mmol) and K3PO4 (260 mg, 1.22 mmol). Finally, alkynyl bromide 172 (271 mg, 
0.674 mmol) was added and the reaction mixture was heated to 75 °C for 48 hours. The 
reaction mixture was then concentrated in vacuo. TLC analysis indicated that reaction had not 
occurred and so the starting materials were recovered by flash column chromatography on 
silica gel (petroleum ether-ethyl acetate, 3:1). 
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Amide Fragment Test Reaction 
 
To a solution of dipeptide 167 (169 mg, 0.502 mmol) in toluene (10 mL) was added 
CuSO4·5H2O (12.5 mg, 0.0501 mmol), 1,10-phenanthroline (18.1 mg, 0.100 mmol) and 
K3PO4 (213 mg, 1.00 mmol). Finally, phenyl acetylene bromide 179 (100 mg, 0.552 mmol) 
was added and the mixture was heated to 75 °C. After stirring for 20 hours, analysis of the 
reaction mixture by TLC indicated the formation of a new product. The reaction mixture was 
allowed to cool to room temperature before it was filtered, washing through with excess 
dichloromethane and methanol. The filtrate was then concentrated in vacuo. The reaction 
mixture was purified by flash column chromatography on silica gel (petroleum ether-ethyl 
acetate, 2:3) and the new product was analysed using NMR spectroscopy. This new material 
was not the desired ynamide and there was strong evidence that it was, in fact, the alkynyl 
dimer product. 
 
(R)-4-Phenyl-3-(phenylethynyl)oxazolidin-2-one 183 
 
A vial was charged with (R)-4-phenyloxazolidin-2-one, 178 (25.0 mg, 0.153 mmol), 
CuSO4·5H2O (3.80 mg, 0.0152 mmol), 1,10-phenanthroline (5.50 mg, 0.0306 mmol) and 
dried potassium phosphate (65.0 mg, 0.307 mmol). A solution of phenylacetylene bromide 
179 (30.0 mg, 0.166 mmol) in dry toluene (0.2 mL) was added to the vial, which was then 
heated to 75 °C. The reaction was stirred for 3 days before cooling to room temperature The 
mixture was filtered and washed with EtOAc and the filtrate was concentrated in vacuo. The 
target ynamide 183 was isolated by flash column chromatography on silica gel (petroleum 
ether-ethyl acetate, 2:1) giving a white solid (17.3 mg, 43%). 
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Rf = 0.63 (petroleum ether-ethyl acetate, 1:1); m.p. = 140–143 °C {Lit. m.p. 139–141 °C}
122
; 
[α]26D –180.3 (c = 1.00, CHCl3) {Lit. [α]
20
D –208.5 (c = 1.00, CH2Cl2)}
122; νmax 2979, 2252, 
1746, 702, 692, 642 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.37–7.30 (5H, m, CH-Arom), 7.18–
7.12 (5H, m, CH-Arom), 5.05 (1H, dd, J = 8.6, 7.2 Hz, CH-C3), 4.69 (1H, dd, J = 9.0, 8.6 Hz, 
CH-C2a), 4.21 (1H, dd, J = 9.0, 7.2 Hz, CH2-C2b); 
13
C NMR (100 MHz, CDCl3) δ 155.6 (C-
C1), 136.1 (C-Arom), 131.5 (CH-Arom), 129.5 (CH-Arom), 129.3 (CH-Arom), 128.2 (CH-
Arom), 128.1 (CH-Arom), 126.9 (CH-Arom), 122.1 (C-Arom), 78.1 (C-C8), 72.8 (C-C9), 
70.8 (CH2-C2), 62.2 (CH-C3); HRMS (CI, Me3CH) [M+H]
+
 calcd for C17H14NO2 264.1025, 
found 264.1024 [Δ –0.1 ppm]; LRMS (CI, Me3CH) m/z (intensity) 265.1 (20%), 264.1 
(100%). 
 
(R)-4-Phenyl-3-(phenylethynyl)oxazolidin-2-one (183) Using Evano Approach 
 
A vial was charged with oxazolidinone 178 (16.0 mg, 0.0981 mmol), 1,1-dibromoalkene 189 
(39.0 mg, 0.149 mmol), Cs2CO3 (130 mg, 0.399 mmol) and CuI (2.30 mg, 0.0121 mmol). Dry 
dioxane (0.3 mL) and DMEDA (1.60 mg, 0.0182 mmol) were added to the vessel and the 
mixture was heated to 60 °C with stirring. The reaction mixture was stirred for 18 hours and 
then cooled to room temperature and filtered through a pad of Celite
®
. The filtrate was then 
concentrated in vacuo. The target ynamide 183 was isolated by flash column chromatography 
on silica gel (petroleum ether-ethyl acetate, 3:2) to give a white solid (10 mg, 39%). 
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Evano Test Reaction Using Dipeptide Fragment 
 
To a solution of dipeptide 167 (33.0 mg, 0.981 mmol) in dioxane (0.5 mL) was added 
1,1-dibromoalkene 189 (39.0 mg, 0.149 mmol), CuI (2.30 mg, 0.0121 mmol) and Cs2CO3 
(130 mg, 0.399 mmol). Finally, DMEDA (1.60 mg, 0.0182 mmol) was added and the reaction 
was heated to 60 °C with stirring. After 24 hours, there appeared to have been no reaction and 
so further portions of CuI (2.30 mg, 0.0121 mmol) and DMEDA (1.60 mg, 0.0182 mmol) 
were added to the mixture and the temperature was raised to 75 °C. The reaction was then 
stirred for a further 24 hours, during which time no reaction was observed. The mixture was 
allowed to cool to room temperature, before filtering through a pad of Celite
® 
and 
concentrating in vacuo. The starting materials were recovered by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, 4:1). 
 
Coupling of Methyl Ester Analogue of Glycine Using Hsung 2
nd
 Generation Protocol 
 
To a solution of carbamate 192 (19.0 mg, 0.100 mmol) in toluene (1 mL) was added alkynyl 
bromide 179 (20.0 mg, 0.110 mmol), CuSO4·5H2O (5.00 mg, 0.0200 mmol), 
1,10-phenanthroline (7.20 mg, 0.0400 mmol) and K3PO4 (42.0 mg, 0.198 mmol). The mixture 
was heated to 80 °C and stirred for a period of 48 hours before being cooled to room 
temperature. The reaction mixture was filtered through Celite
® 
and concentrated in vacuo. 
TLC analysis indicated that the reaction had not taken place and so purification was 
abandoned.  
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Coupling of Methyl Ester Analogue of Glycine Using Evano Protocol 
 
A vial was charged with carbamate 192 (19.0 mg, 0.100 mmol), 1,1-dibromoalkene 189 
(39.0 mg, 0.149 mmol), Cs2CO3 (130 mg, 0.399 mmol) and CuI (2.30 mg, 0.0121 mmol). 
Dioxane (0.5 mL) was added to the vessel, followed by DMEDA (1.60 mg, 0.0182 mmol) and 
the mixture was heated to 65 °C with stirring. The mixture was stirred for 24 hours and then 
filtered through a pad of Celite
®
 and concentrated in vacuo. TLC analysis showed that reaction 
had not occurred and so further purification and characterisation of the mixture was 
abandoned. 
 
Ethyl 2-(tert-butoxycarbonylamino)acetate 190 
  
To a solution of glycine ethyl ester hydrochloride (2.00 g, 14.3 mmol) in acetonitrile (68 mL) 
was added NaHCO3 (3.60 g, 42.9 mmol). The mixture was cooled to 0 °C followed by 
addition of di-tert-butyl dicarbonate (3.10 g, 14.2 mmol). The reaction mixture was warmed to 
room temperature and stirred continuously for 18 hours. Upon completion, it was concentrated 
in vacuo and the residue was suspended in a mixture of CH2Cl2 (70 mL) and H2O (70 mL). 
The layers were separated and the aqueous layer was extracted with CH2Cl2 (2 × 70 mL). The 
combined organic layers were washed with H2O (70 mL) followed by drying (MgSO4), 
filtration and concentration in vacuo to yield the ester 190 as a colourless oil (2.7 g, 94%). 
Rf = 0.46 (petroleum ether-ethyl acetate, 17:3); νmax 3372, 2978, 1697, 1512 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3) δ 5.02 (1H, br s, NH), 4.23 (2H, q, J = 7.2 Hz, CH2-Et), 3.92 (2H, d, J = 
5.4 Hz, CH2-C2), 1.48 (9H, s, CH3-C5), 1.30 (3H, t, J = 7.2 Hz, CH3-Et); 
13
C NMR (100 
MHz, CDCl3) δ 170.4 (C-C1), 155.7 (C-C3), 80.0 (C-C4), 61.3 (CH2-Et), 42.5 (CH2-C2), 28.3 
(CH3-C5), 14.2 (CH3-Et); HRMS, (CI, Me3CH) [M+H]
+
 calcd for C9H18NO4 204.1236, found 
204.1234 [Δ –1.1 ppm]; LRMS (CI, Me3CH) m/z (intensity) 205.1 (13%), 204.1 (100%). 
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Ethyl 2-(tert-butoxycarbonyl(phenylethynyl)amino)acetate 191 
 
A sealed vial was charged with carbamate 190 (37.0 mg, 0.182 mmol) and phenylacetylene 
bromide 179 (27.0 mg, 0.149 mmol) in toluene (1 mL), that had been degassed with argon. 
Freshly ground K3PO4 (95.0 mg, 0.448 mmol) was added to the reaction mixture, followed by 
CuSO4·5H2O (7.50 mg, 0.0300 mmol), 1,10-phenanthroline (10.8 mg, 0.0600 mmol) and 
Ni(acac)2 (4.00 mg, 0.0156 mmol). The reaction was heated to 80 °C and stirred for 48 hours. 
The crude mixture was cooled to room temperature and filtered through a pad of Celite
®
, 
washing it through with Et2O. The filtrate was concentrated in vacuo and the residue was 
purified by flash column chromatography using silica gel (petroleum ether-ethyl acetate, 
17:3). Ynamide 191 was isolated as a white solid (33 mg, 73%). 
Rf = 0.53 (petroleum ether-ethyl acetate, 17:3); m.p. = 76–77 °C; νmax 2978, 2253, 1751, 1713, 
694, 633 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 7.34–7.28 (2H, m, CH-Arom), 7.22–7.16 (3H, 
m, CH-Arom), 4.19 (2H, q, J = 7.0 Hz, CH2-Et), 4.16 (2H, s, CH2-C2), 1.48 (9H, s, CH3-C11), 
1.23 (3H, t, J = 7.0 Hz, CH3-Et); 
13
C NMR (100 MHz, CDCl3) δ 167.9 (C-C1), 153.8 (C-C9), 
130.8 (CH-Arom), 128.2 (CH-Arom), 127.3 (CH-Arom), 123.4 (C-C5), 83.6 (C-C3), 83.2 (C-
C10), 69.8 (C-C4), 61.5 (CH2-Et), 51.0 (CH2-C2), 27.9 (CH3-C11), 14.2 (CH3-Et); HRMS 
(EI+) [M]
+
 calcd for C17H21NO4 303.1471, found 303.1469 [Δ –0.7 ppm]; LRMS (EI+) m/z 
(intensity) 305.0 (28%), 303.1 (17%), 247.0 (100%); Anal. calcd for C17H21NO4: C, 67.31%; 
H, 6.98%; N, 4.62%. Found: C, 67.28%; H, 7.02%; N, 4.70%. 
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Application of Optimised Hsung Conditions to Intramolecular Coupling 
 
 
To a solution of tripeptide 171 (56.0 mg, 0.0992 mmol) in dry, degassed toluene (10 mL) was 
added CuSO4·5H2O (5.00 mg, 0.0200 mmol), 1,10-phenanthroline (7.10 mg, 0.0394 mmol) 
and freshly ground K3PO4 (42.0 mg, 0.198 mmol). Finally, Ni(acac)2 (2.55 mg, 
0.00993 mmol) was added, and the mixture was heated to 80 °C with stirring. There was no 
evidence of reaction after 20 hours and so further amounts of CuSO4 (5.00 mg, 0.0200 mmol) 
and 1,10-phenanthroline (7.10 mg, 0.0394 mmol) were added with an extended period of 
stirring. After the reaction had progressed for a total of 48 hours, TLC analysis showed that 
formation of new products and consumption of the tripeptide starting material had not 
occurred. The reaction was allowed to cool to room temperature, filtered and concentrated in 
vacuo. The residue was purified using flash column chromatography on silica gel 
(dichloromethane-methanol, 19:1) and pure starting material was recovered. 
 
(S)-Methyl 2-(2-(1,3-dioxoisoindolin-2-yl)acetamido)-3-phenylpropanoate 194 
 
A vessel was flame dried with attached Dean-Stark condenser. The apparatus was charged 
with TFA salt 168 (70.0 mg, 0.200 mmol) and toluene (2.4 mL). Phthalic anhydride (30.0 mg, 
0.203 mmol) and TEA (30.0 μL, 0.216 mmol) were added to the reaction mixture and it was 
heated to reflux for 4 hours forming water (~4 μL) as byproduct, which was isolated as the 
reaction progressed. The reaction mixture was cooled to room temperature and concentrated in 
vacuo. Phthalimide 194 was isolated by flash column chromatography using silica gel 
(dichloromethane-methanol, 99:1) as a colourless solid (28 mg, 38%). 
Rf = 0.57 (dichloromethane-methanol, 19:1); m.p. = 169–170 °C {Lit. m.p. 174–175 °C}
191
; 
[α]25D +88.6 (c = 1.01, CHCl3) {Lit. [α]
21
D +91.6 (c = 1.00, EtOAc)}
189; νmax 3310, 2947, 
1720, 1659, 1543, 702, 648 cm
-1
; 
1H NMR δ (500 MHz, CDCl3) δ 7.82 (2H, dd, J = 5.5, 3.1 
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Hz, CH-Phthalimide), 7.69 (2H, dd, J = 5.5, 3.1 Hz, CH-Phthalimide), 7.18–7.13 (3H, m, CH-
Arom), 7.02–7.00 (2H, m, CH-Arom), 6.14 (1H, d, J = 7.5 Hz, NH), 4.81 (1H, ddd, J = 7.5, 
5.8, 5.1 Hz, CH-C2), 4.32 (1H, d, J = 16.1 Hz, CH2-C9a), 4.24 (1H, d, J = 16.1 Hz, CH2-C9b), 
3.67 (3H, s, CH3-Me), 3.11 (1H, dd, J = 13.9, 5.8 Hz, CH2-C3a), 3.05 (1H, dd, J = 13.9, 5.1 
Hz, CH2-C3b); 
13
C NMR (100 MHz, CDCl3) δ 171.7 (C-C1), 167.9 (C-C8), 165.8 (C-C10), 
135.5 (C-Arom), 134.2 (CH-Phthalimide), 132.0 (C-C11), 129.4 (CH-Arom), 128.6 (CH-
Arom), 127.1 (CH-Arom), 123.6 (CH-Phthalimide), 53.4 (CH-C2), 52.5 (CH3-Me), 40.6 
(CH2-C9), 37.6 (CH2-C3); HRMS (CI, Me3CH) [M+H]
+
 calcd for C20H19N2O5 367.1294, 
found 367.1296 [Δ +0.6 ppm]; LRMS (CI, Me3CH) m/z (intensity) 368.1 (23%), 367.1 
(100%). 
 
Optimised Conditions Test Reaction 
 
A solution of protected dipeptide 194 (35.0 mg, 0.0993 mmol) and freshly ground K3PO4 
(51.0 mg, 0.240 mmol) was prepared in toluene (0.5 mL) that was first purged with argon. 
Alkynyl bromide 179 (14.0 mg, 0.0773 mmol), CuSO4·5H2O (4.00 mg, 0.0160 mmol), 
1,10-phenanthroline (6.00 mg, 0.0333 mmol) and Ni(acac)2 (2.00 mg, 0.00778 mmol) were 
added and the mixture was heated to 80 °C with stirring. After 24 hours, the mixture was 
allowed to cool to room temperature and then filtered through Celite
® 
before being 
concentrated in vacuo. TLC analysis found that no new compounds had been formed and 
starting material had not been consumed. Consequently, the reaction was abandoned. 
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Diethyl (1S,2S)-cyclohexane-1,2-diyldicarbamate 198 
 
A solution of NaOH (3.80 g, 95.0 mmol) in water (18 mL) was prepared, followed by addition 
of (±)-trans-1,2-diaminocyclohexane 197 (2.40 mL, 20.0 mmol). The reaction mixture was 
cooled to 0 °C and stirred for 10 minutes. Ethyl chloroformate (4.00 mL, 42.2 mmol) was 
added as a solution in toluene (18 mL) by addition funnel over a period of 30 minutes. The 
reaction mixture was warmed to room temperature and stirred for 2.5 hours. It was then 
filtered and concentrated in vacuo. The target carbamate 198 was isolated by flash column 
chromatography using silica gel (petroleum ether-ethyl acetate, 2:1) as a white solid (3.1 g, 
60%). 
Rf = 0.61 (petroleum ether-ethyl acetate, 2:1); m.p. = 144–147 °C; νmax 3314, 2930, 1678, 
1533 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 4.94 (2H, br s, NH), 4.19–4.06 (4H, m, CH2-Et), 
3.39–3.37 (2H, m, CH-C3), 2.11–2.07 (2H, m, CH2-C2a), 1.78–1.75 (2H, m, CH2-C1a), 1.36–
1.30 (2H, m, CH2-C1b), 1.27–1.22 (2H, m, CH2-C2b), 1.25 (6H, t, J = 7.0 Hz, CH3-Et); 
13
C 
NMR (100 MHz, CDCl3) δ 157.1 (C-C4), 60.8 (CH2-Et), 55.4 (CH-C3), 32.9 (CH2-C2), 24.8 
(CH2-C1), 14.6 (CH3-Et); HRMS (CI, Me3CH) [M+H]
+
 calcd for C12H23N2O4 259.1658, found 
159.1659 [Δ +0.5 ppm]; LRMS (CI, Me3CH) m/z (intensity) 260.2 (14%), 259.2 (100%). 
 
(1S,2S)-N1,N2-Dimethylcyclohexane-1,2-diamine, 196 
 
A suspension of LiAlH4 (2.80 g, 73.7 mmol) in dry THF (100 mL) was prepared in a 
three-necked flask fitted with a condenser. The suspension was cooled to 0 °C before addition 
of dicarbamate 198 (3.10 g, 12.0 mmol) portionwise. The reaction was stirred at room 
temperature for 1 hour and then at reflux for 18 hours. The mixture was cooled to 0 °C 
followed by careful sequential addition of water (3 mL), 15% aqueous NaOH (3 mL) and a 
further quantity of water (11 mL). The suspension was filtered, washing through with THF 
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(2 × 50 mL) and the filtrate was concentrated in vacuo. The residue was acidified with 1M 
HCl until pH 2 and then extracted with CH2Cl2 (3 × 40 mL). The aqueous layer was adjusted 
to pH 13 with saturated aqueous NaOH solution and extracted with CH2Cl2 (3 × 80 mL). 
These extracts were dried (MgSO4), filtered and concentrated in vacuo to yield the pure 
diamine 196 as a yellow liquid (1.5 g, 88%). 
Rf = 0.47 (dichloromethane-methanol, 9:1); νmax 3243, 2933, 727 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 2.33 (6H, s, CH3-C4), 2.06–2.02 (2H, m, CH2-C2a), 1.98–1.94 (2H, m, CH-C3), 
1.68–1.64 (2H, m, CH2-C1a), 1.54 (2H, s, NH), 1.19–1.13 (2H, m, CH2-C1b), 0.94–0.84 (2H, 
m, CH2-C2b); 
13
C NMR (100 MHz, CDCl3) δ 63.3 (CH-C3), 33.7 (CH3-C4), 30.8 (CH2-C2), 
25.0 (CH2-C1); HRMS (CI, Me3CH) [M+H]
+
 calcd for C8H19N2 143.1549, found 143.1544 [Δ 
–3.1 ppm]; LRMS (CI, Me3CH) m/z (intensity) 143.2 (100%). 
 
Linear Alkynyl Dimer 199 
 
A flask was charged with alkynyl bromide 171 (100 mg, 0.177 mmol), CuTC (2.40mg, 
0.0126 mmol) and freshly ground K3PO4 (75.0 mg, 0.354 mmol).  The flask was evacuated 
and flushed with argon three times. The mixture was dissolved in toluene (0.75 mL) that had 
been degassed with argon. Finally, diamine 196 (3.80 mg, 0.0268 mmol) was added and the 
reaction was heated to 85 °C. The vessel was covered with aluminium foil for the duration of 
the reaction. The reaction mixture was stirred for 24 hours, at which point it was cooled to 
room temperature. Water (10 mL) was added and the solution was extracted with EtOAc 
(3 × 5 mL). The combined organic extracts were washed with brine (10 mL), dried (MgSO4), 
filtered and concentrated in vacuo. The residue was purified by flash column chromatography 
using silica gel (dichloromethane-methanol, 19:1). The dialkyne 199 was isolated as a slightly 
yellow oil (41 mg, 24%). 
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Rf = 0.40 (dichloromethane-methanol, 40:3); [α]
23
D +30.1 (c = 1.00, CHCl3); νmax 3343, 3302, 
3063, 2926, 2359, 1744, 1663, 1526, 816, 752, 702 cm
-1
;
 1
H NMR (500 MHz, CDCl3) δ 7.61 
(4H, d, J = 8.2 Hz, CH-C18), 7.26 (4H, d, J = 8.2 Hz, CH-C19), 7.23–7.15 (6H, m, CH-
Arom), 7.12 (2H, dd, J = 5.7, 5.7 Hz, NH-N6), 7.06–7.04 (4H, m, CH-Arom), 6.61 (2H, d, J = 
7.7 Hz, NH-N3), 4.78 (2H, ddd, J = 7.7, 6.6, 5.7 Hz, CH-C2), 4.12 (2H, d, J = 18.5 Hz, CH2-
C9a), 4.07 (2H, d, J = 18.5 Hz, CH2-C9b), 3.90 (2H, dd, J = 16.7, 5.7 Hz, CH2-C5a), 3.83 
(2H, dd, J = 16.7, 5.7 Hz, CH2-C5b), 3.72 (2H, d, J = 17.1 Hz CH2-C8a), 3.64 (2H, d, J = 17.1 
Hz, CH2-C8b), 3.64 (6H, s, CH3-Me), 3.08 (2H, dd, J = 13.9, 5.7 Hz, CH2-C12a), 2.99 (2H, 
dd, J = 13.9, 6.6 Hz, CH2-C12b), 2.37 (6H, s, CH3-C21); 
13
C NMR (100 MHz, CDCl3) δ 171.8 
(C-C1), 168.1 (C-C4), 167.9 (C-C7), 145.0 (C-Arom), 135.7 (C-Arom), 133.7 (C-Arom), 
130.0 (CH-C19), 129.3 (CH-Arom), 128.6 (CH-Arom), 127.9 (CH-C18), 127.2 (CH-Arom), 
71.6 (C-C10), 70.0 (C-C11), 53.4 (CH-C2), 52.5 (CH3-Me), 50.4 (CH2-C8), 42.7 (CH2-C5), 
39.5 (CH2-C9), 37.7 (CH2-C12), 21.7(CH3-C21); HRMS (FAB) [M+H]
+
 calcd for 
C48H53N6O12S2 969.3163, found 969.3171 [Δ +0.8 ppm]; LRMS (FAB) m/z (intensity) 969.3 
(100%). 
 
Cyclic dimer 200 
 
To a solution of alkynyl bromide 171 (100 mg, 0.177 mmol) in toluene that had been degassed 
with argon (40 mL) was added CuTC (2.40 mg, 0.0126 mmol) and freshly ground K3PO4 
(75.0 mg, 0.354 mmol). Finally diamine 196 (3.80 mg, 0.0268 mmol) was added and the 
reaction mixture was heated to 85 °C. The flask was wrapped in aluminium foil and the 
reaction was stirred for 40 hours before cooling to room temperature and diluting with water 
(40 mL). The aqueous layer was extracted with EtOAc (3 × 30 mL) and the combined organic 
extracts were washed with brine (40 mL), dried (MgSO4), filtered and concentrated in vacuo. 
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The residue was separated by flash column chromatography using silica gel (dichloromethane-
methanol, 49:1). Cyclic ynamide 200 was isolated as a colourless oil (21 mg, 10%). 
Rf = 0.47 (dichloromethane-methanol, 24:1); [α]
23
D +0.77 (c = 0.39, CHCl3); νmax 2961, 2922, 
2854, 2359, 2342, 1684, 1559, 756, 669 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.59 (4H, d, J = 
8.2 Hz, CH-C16), 7.28 (4H, d, J = 8.2 Hz, CH-C17), 7.21–7.17 (6H, m, CH-Arom), 7.01–6.99 
(4H, m, CH-Arom), 5.94 (2H, d, J = 7.5 Hz, NH), 4.73 (2H, ddd, J = 7.5, 5.5, 5.3 Hz, CH-C2), 
4.64 (2H, d, J = 16.5 Hz, CH2-C4a), 4.58 (2H, d, J = 16.5 Hz, CH2-C4b), 3.94 (4H, s, CH2-
C7), 3.91 (2H, d, J = 13.0 Hz, CH2-C6a), 3.86 (2H, d, J = 13.0 Hz, CH2-C6b), 3.65 (6H, s, 
CH3-Me), 3.05 (2H, dd, J = 13.7, 5.5 Hz, CH2-C10a), 3.00 (2H, dd, J = 13.7, 5.3 Hz, CH2-
C10b), 2.37 (6H, s, CH3-C19); 
13
C NMR (100 MHz, CDCl3) δ 171.4 (C-C1), 166.4 (C-C3), 
165.4 (C-C5), 144.8 (C-Arom), 135.4 (C-Arom), 135.0 (C-Arom), 130.1 (CH-C17), 129.3 
(CH-Arom), 128.7 (CH-Arom), 127.8 (CH-C16), 127.3 (CH-Arom), 90.7 (C-C9), 77.2 (C-
C8), 53.3 (CH-C2), 52.5 (CH3-Me), 50.4 (CH2-C6), 49.0 (CH2-C4), 47.4 (CH2-C7), 37.7 
(CH2-C10), 21.6 (CH3-C19). 
 
1-(tert-Butoxycarbonyl)pyrrolidine-2-carboxylic acid 204 
 
A solution of L-proline 206 (1.15 g, 10.0 mmol) was prepared in a 1:1 mixture of dioxane and 
water (10 mL). Saturated aqueous NaHCO3 (20 mL) was added to the solution, which was 
then cooled to 0 °C. Di-tert-butyl dicarbonate (4.30 g, 19.7 mmol) was added portionwise and 
the mixture was stirred vigorously for 18 hours. The pH was adjusted to pH 3 by addition of 
1M aqueous HCl solution and the mixture was extracted with EtOAc (3 × 60 mL). The 
combined organic extracts were dried (Na2SO4) and concentrated in vacuo to give a colourless 
oil. Boc-protected proline 204 was isolated by flash column chromatography using silica gel 
(petroleum ether-ethyl acetate, 1:1) as a white solid (1.7 g, 79%). This compound was isolated 
as a mixture of rotamers. 
Rf = 0.25 (petroleum ether-ethyl acetate, 1:1); m.p. = 132–133 °C {Lit. m.p. 133 °C}
192
; [α]27D 
–98.0 (c = 1.02, CHCl3) {Lit. [α]
27
D –57.0 (c = 1.00, CHCl3)}
193; νmax 2970, 2893, 2716, 1736, 
1636, 725 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 11.45 (2H, br s, OH), 4.29 (1H, dd, J = 8.2, 2.3 
Hz, CH-C2a), 4.17 (1H, dd, J = 8.2, 4.2 Hz, CH-C2b), 3.52–3.28 (4H, m, CH2-C5), 2.25–1.96 
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(4H, m, CH2-C3), 1.93–1.78 (4H, m, CH2-C4), 1.41 (9H, s, CH3-C8a), 1.35 (9H, s, CH3-C8b); 
13
C NMR (100 MHz, CDCl3) δ 178.9 (C-C1a), 176.1 (C-C1b), 155.9 (C-C6a), 153.9 (C-C6b), 
81.0 (C-C7a), 80.4 (C-C7b), 59.0 (CH-C2), 46.9 (CH2-C5a), 46.3 (CH2-C5b), 30.8 (CH2-C3a), 
29.0 (CH2-C3b), 28.4 (CH3-C8a), 28.3 (CH3-C8b), 24.3 (CH2-C4a), 23.6 (CH2-C4b); HRMS 
(CI, Me3CH) [M+H]
+
 calcd for C10H18NO4 216.1236, found 216.1234 [Δ –1.0 ppm]; LRMS 
(CI, Me3CH) m/z (intensity) 217.1 (18%), 216,1 (100%); Anal. calcd for C10H17NO4: C, 
55.80%; H, 7.96%; N, 6.51%. Found: C, 55.71%; H, 8.03%; N, 6.53%. 
 
(S)-tert-Butyl 2-(2-methoxy-2-oxoethylcarbamoyl)pyrrolidine-1-carboxylate 207 
 
A solution of Boc-proline 204 (344 mg, 1.60 mmol), and glycine methyl ester hydrochloride 
(200 mg, 1.59 mmol) was prepared in CH2Cl2 (16 mL). BOP (707 mg, 1.60 mmol) and 
DIPEA (835 μL, 4.80 mmol) were added to the solution, and the mixture was stirred for 
18 hours at room temperature. The mixture was then concentrated in vacuo and the residue 
was dissolved in EtOAc (25 mL). This solution was washed with 1M aqueous KHSO4 
(3 × 25 mL), 10% aqueous Na2CO3 (3 × 25 mL) and brine (3 × 25 mL). The organic layer was 
dried (Na2SO4), filtered and concentrated in vacuo. The target dipeptide 207 was isolated after 
flash column chromatography using silica gel (dichloromethane-methanol, 19:1) as a 
colourless solid (323 mg, 71%). This compound was isolated as a mixture of rotamers. 
Rf = 0.54 (dichloromethane-methanol, 9:1); m.p. = 67–68 °C {Lit. m.p. 70–71 °C}
194
; [α]27D –
4.3 (c = 1.03, CHCl3) {Lit. [α]
27
D –16.0 (c = 1.00, CHCl3)}
195; νmax 3306, 2976, 1755, 1666, 
1530, 731 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.24 (1H, br s, NHa), 6.49 (1H, br s, NHb), 
4.28–4.20 (2H, m, CH-C5), 4.00 (2H, dd, J = 18.3, 5.6 Hz, CH2-C3a), 3.99–3.96 (2H, m, CH2-
C3b), 3.68 (6H, s, CH3-C1), 3.40–3.28 (4H, m, CH2-C8), 2.27–2.09 (4H, m, CH2-C6), 1.84–
1.80 (4H, m, CH2-C7), 1.40 (18H, s, CH3-C11); 
13
C NMR (100 MHz, CDCl3) δ 173.0 (C-
C2a), 172.4 (C-C2b), 170.2 (C-C4), 155.8 (C-C9a), 154.6 (C-C9b), 80.5 (C-C10), 61.1 (CH-
C5a), 59.9 (CH-C5b), 52.3 (CH3-C1), 47.1 (CH2-C8), 41.1 (CH2-C3), 31.0 (CH2-C6), 28.3 
(CH3-C11), 24.5 (CH2-C7a), 23.7 (CH2-C7b); HRMS (CI, Me3CH) [M+H]
+
 calcd for 
C13H23N2O5 287.1607, found 287.1608 [Δ +0.5 ppm]; LRMS (CI, Me3CH) m/z (intensity) 
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288.2 (15%), 287.2 (100%); Anal. calcd for C13H22N2O5: C, 54.53%; H, 7.74%; N, 9.78%. 
Found: C, 54.36%; H, 7.76%; N, 9.61%. 
 
(S)-Methyl 2-(pyrrolidine-2-carboxamido)acetate TFA Salt 208 
 
A solution of Boc-protected dipeptide 207 (1.00 g, 3.50 mmol) in dry CH2Cl2 (3 mL) was 
prepared. TFA (3 mL) was added to the solution followed by continuous stirring at room 
temperature for 4 hours. The mixture was then concentrated in vacuo. A small volume of 
toluene was added to the residue and it was concentrated in vacuo. This was repeated another 
two times followed by a period of drying under high vacuum to remove any traces of excess 
TFA from the product. The TFA salt of the target dipeptide 208 was isolated as a pale yellow 
oil (1.05 g, 100%). This compound was isolated as a mixture of rotamers. 
[α]23D –20.5 (c = 0.98, CHCl3); νmax 3287, 3094, 2963, 1744, 1667, 1559, 702 cm
-1
;
 1
H NMR 
(400 MHz, CDCl3) δ 10.54 (1H, s, NH-N10a), 10.44 (1H, s, NH-N10b), 7.91 (2H, dd, J = 6.0, 
5.4 Hz, NH-N4), 4.80 (2H, br s, CH-C6), 4.14 (1H, dd, J = 17.9, 6.0 Hz, CH2-C3a), 4.04 (1H, 
dd, J = 17.9, 5.4 Hz, CH2-C3b), 3.78 (3H, s, CH3-C1), 3.51 (2H, br s, CH2-C9), 2.57–2.47 
(1H, m, CH2-C7a), 2.21–2.13 (3H, m, CH2-C7b and CH2-C8); 
13
C NMR (100 MHz, CDCl3) δ 
170.0 (C-C2), 169.5 (C-C5), 59.7 (CH-C6), 52.4 (CH3-C1), 46.8 (CH2-C9), 41.4 (CH2-C3), 
30.1 (CH2-C7), 24.3 (CH2-C8); HRMS (CI, Me3CH) [M+H]
+
 calcd for C8H15N2O3 187.1083, 
found 187.1086 [Δ +1.6 ppm]; LRMS (CI, Me3CH) m/z (intensity) 187.1 (100%). 
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Methyl 2-(1-(2-(N-(3-bromoprop-2-ynyl)-4-
methylphenylsulfonamido)acetyl)pyrrolidine-2-carboxamido)acetate 202 
 
A solution of TFA salt 208 (694 mg, 2.31 mmol) and carboxylic acid 173 (800 mg, 
2.31 mmol) in CH2Cl2 (23 mL) was prepared at room temperature. Coupling reagent BOP 
(1.02 g, 2.31 mmol) and DIPEA (1.20 mL, 6.90 mmol) were added and the solution was 
stirred for 24 hours. The reaction was concentrated in vacuo upon completion and the residue 
was redissolved in ethyl acetate (100 mL). The solution was washed with 1M aqueous KHSO4 
(3 × 50 mL), 10% aqueous Na2CO3 (3 × 50 mL) and brine (50 mL). The washed solution was 
dried (Na2SO4), filtered and concentrated in vacuo. Tripeptide 202 was isolated by flash 
column chromatography using silica gel (dichloromethane-methanol, 19:1) as a white solid 
(728 mg, 61%). This compound was isolated as a mixture of rotamers. 
Rf = 0.40 (dichloromethane-methanol, 19:1); m.p. = 60–62 °C; [α]
26
D –62.4 (c = 0.985, 
CHCl3); νmax 3310, 2955, 2214, 1751, 1651, 1528, 810, 664, 602 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) δ 7.67 (2H, d, J = 8.2 Hz, CH-C15), 7.26 (2H, d, J = 8.2 Hz, CH-C16), 7.20 (1H, dd, J 
= 5.9, 5.4 Hz, NH), 4.55 (1H, dd, J = 8.2, 2.3 Hz, CH-C5), 4.24 (1H, d, J = 18.3 Hz, CH2-
C11a), 4.18 (1H, d, J = 18.3 Hz, CH2-C11b), 4.00 (1H, d, J = 15.8 Hz, CH2-C10a), 3.96 (1H, 
dd, J = 18.1, 5.9 Hz, CH2-C3a), 3.94 (1H, d, J = 15.8 Hz, CH2-C10b), 3.88 (1H, dd, J = 18.1, 
5.4 Hz, CH2-C3b), 3.69–3.62 (1H, m, CH2-C8a), 3.66 (3H, s, CH3-C1), 3.50 (1H, td, J = 9.3, 
7.2 Hz, CH2-C8b), 2.37 (3H, s, CH3-C18), 2.32–2.29 (1H, m, CH2-C6a), 2.10–2.04 (1H, m, 
CH2-C7a), 1.99–1.93 (1H, m, CH2-C7b), 1.91–1.83 (1H, m, CH2-C6b); 
13
C NMR (100 MHz, 
CDCl3) δ 171.1 (C-C2), 170.1 (C-C4), 167.2 (C-C9), 144.1 (C-Arom), 135.1 (C-Arom), 129.7 
(CH-C16), 127.8 (CH-C15), 72.9 (C-C12), 60.2 (CH-C5), 52.3 (CH3-C1), 48.6 (CH2-C10), 
47.2 (CH2-C8), 45.6 (C-C13), 41.2 (CH2-C3), 38.9 (CH2-C11), 27.5 (CH2-C6), 25.1 (CH2-
C7), 21.6 (CH3-C18); HRMS (FAB) [M+H]
+
 calcd for C20H25BrN3O6S 514.0647, found 
514.0650 [Δ –0.5 ppm]; LRMS (FAB) m/z (intensity) 517.1 (23%), 516.1 (100%), 515.1 
(16%), 514.1 (96%); Anal. calcd for C20H24BrN3O6S: C, 46.70%; H, 4.70%; N, 8.17%. Found: 
C, 46.61; H, 4.68%; N, 8.04%. 
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Cyclisation Using Hsung 2
nd
 Generation Protocol 
 
 
The tripeptide 202 (50.0 mg, 0.0972 mmol) and freshly ground K3PO4 (41.0 mg, 0.193 mmol) 
were dissolved in dry toluene (20 mL) that had been bubbled through with argon. To this 
solution was added CuSO4·5H2O (4.90 mg, 0.0196 mmol) and 1,10-phenanthroline (7.00 mg, 
0.0388 mmol), and the mixture was heated to 75 °C with stirring. After 20 hours, the reaction 
mixture was cooled to room temperature and filtered. The filtrate was concentrated in vacuo 
and a new compound was detected by TLC analysis of the residue. The new compound was 
isolated by flash column chromatography using silica gel (dichloromethane-methanol 24:1) 
and found to be a decomposition product following NMR analysis. 
 
Cyclisation using CuTC conditions 
 
A dried flask was charged with tripeptide 202 (50.0 mg, 0.0972 mmol), CuTC (1.30 mg, 
0.00682 mmol) and freshly ground K3PO4 (41.0 mg, 0.193 mmol). The flask was evacuated 
and charged with argon several times before addition of dry toluene (25 mL) that was first 
saturated with argon. Finally, (S,S)-(+)-N,N'-dimethyl-1,2-cyclohexanediamine ligand 196 
(2.10 mg, 0.0148 mmol) was added to the mixture and the reaction vessel was then wrapped in 
aluminium foil. The mixture was then heated to 85 °C and stirred at this temperature for 24 
hours. After this time, the mixture was allowed to cool to room temperature and water (20 mL) 
was added. The mixture was then extracted with EtOAc (3 × 15 mL) and the combined 
extracts were washed with brine (20 mL), dried (MgSO4), filtered and concentrated in vacuo. 
The residue was purified by flash column chromatography on silica gel (dichloromethane-
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methanol, 39:1) to afford a single product. Analysis of this material suggested that it was the 
dimer formed by coupling of two alkyne units. 
 
Intermolecular Reaction With Proline Dipeptide 
O
MeO
H
N
O
N
Boc
O
t-BuO
N
Ts
Br
O
MeO
N
O
N
Boc
N
Ts
Ot-Bu
O
209
172207
 
A dried vessel was charged with dipeptide 207 (50.0 mg, 0.175 mmol), CuTC (2.30 mg, 
0.0121 mmol) and freshly ground K3PO4 (74.0 mg, 0.349 mmol). The vessel was then 
evacuated and charged with argon several times. Dry toluene (1 mL), that had been 
deoxygenated with argon, was added followed by (S,S)-(+)-N,N'-dimethyl-1,2-
cyclohexanediamine ligand 196 (3.70 mg, 0.0260 mmol). Finally, alkynyl bromide 172 
(119 mg, 0.296 mmol) was added to the reaction mixture and the reaction vessel was wrapped 
in aluminium foil. The mixture was then heated to 85 °C and stirred at this temperature for 24 
hours. TLC analysis showed the development of traces of a new material and so the mixture 
was stirred for another 24 hours to allow the reaction to progress. The mixture was cooled to 
room temperature, diluted with water (10 mL) and then extracted with EtOAc (3 × 5 mL). The 
combined extracts were washed with brine (10 mL), dried (MgSO4), filtered and concentrated 
in vacuo. The crude product was purified by flash column chromatography on silica gel 
(petroleum ether-ethyl acetate, 4:1) to give an unwanted decomposition product. 
 
N-(4-Methoxybenzyl)-4-methylbenzenesulfonamide 219 
 
A solution of p-anisaldehyde (2.40 mL, 19.7 mmol) was prepared in CH2Cl2 (60 mL). 
p-Toluenesulfonamide (4.40 g, 25.7 mmol) and TEA (8.30 mL, 59.7 mmol) were added 
sequentially and the reaction was cooled to 0 °C before dropwise addition of distilled TiCl4 
(2.90 mL, 26.3 mmol) as a solution in CH2Cl2 (15 mL). The reaction progressed over 5 hours 
at which point it was quenched by the addition of saturated aqueous NaHCO3 (30 mL). The 
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aqueous layer was extracted with CH2Cl2 (3 × 50 mL). The combined organic extracts were 
washed with brine (50 mL) before being dried (Na2SO4), filtered and concentrated in vacuo. 
The crude imine product 218 was used without further purification by dissolving in MeOH 
(60 mL), followed by portionwise addition of NaBH4 (760 mg, 20.0 mmol) at 0 °C. The 
reaction was allowed to warm to room temperature and it was stirred for 16 hours. The 
reaction was quenched with water (60 mL) and extracted with Et2O (3 × 60 mL). The 
combined organic extracts were dried (Na2SO4), filtered and concentrated in vacuo. 
Sulfonamide 219 was isolated by flash column chromatography using silica gel (petroleum 
ether-ethyl acetate, 3:1) as a white solid (3.3 g, 57%). 
Rf = 0.53 (petroleum ether-ethyl acetate, 3:2); m.p. = 120–121 °C {Lit. m.p. 121–123 °C}; 
νmax 3248, 3024, 2924, 1929, 1613, 1512, 810 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.78 (2H, 
d, J = 8.2 Hz, CH-C8), 7.33 (2H, d, J = 8.2 Hz, CH-C9), 7.13 (2H, d, J = 8.6 Hz, CH-Arom), 
6.82 (2H, d, J = 8.6 Hz, CH-Arom), 4.61 (1H, t, J = 6.0 Hz, NH), 4.07 (2H, d, J = 6.0 Hz, 
CH2-C6), 3.80 (3H, s, CH3-C1), 2.46 (3H, s, CH3-C11); 
13
C NMR (100 MHz, CDCl3) δ 159.3 
(C-Arom), 143.5 (C-Arom), 136.9 (C-Arom), 129.7 (CH-C9), 129.3 (CH-Arom), 128.3 (C-
Arom), 127.2 (CH-C8), 114.1 (CH-Arom), 55.3 (CH3-C1), 46.8 (CH2-C6), 21.6 (CH3-C11); 
HRMS (EI+) [M]
+
 calcd for C15H17NO3S 291.0929, found 291.0925 [Δ –1.3 ppm]; LRMS 
(EI+) m/z (intensity) 292.1 (20%), 291.1 (100%); Anal. calcd for C15H17NO3S: C, 61.83%; H, 
5.88%; N, 4.81%. Found: C, 61.41%; H, 5.90%; N, 4.83%. 
 
N-(4-Methoxybenzyl)-4-methyl-N-(prop-2-ynyl)benzenesulfonamide 220 
 
A solution of sulfonamide 219 (200 mg, 0.687 mmol) was prepared in acetone (4 mL), to 
which was added anhydrous K2CO3 (190 mg, 1.38 mmol) and 80% propargyl bromide in 
toluene (92.0 μL, 0.825 mmol). The reaction was stirred vigorously at 60 °C for 16 hours. 
Water (20 mL) was added to the reaction mixture and it was then extracted with Et2O 
(3 × 10 mL). The combined organic extracts were dried (Na2SO4), filtered and concentrated. 
Flash column chromatography with silica gel (petroleum ether-ethyl acetate, 3:1) isolated the 
alkyne 220 as a white solid (192 mg, 85%). 
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Rf = 0.42 (petroleum ether-ethyl acetate, 3:1); m.p. = 91–92 °C; νmax 3248, 2924, 2839, 2122, 
1605, 1512, 810, 656 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.72 (2H, d, J = 8.1 Hz, CH-C11), 
7.25 (2H, d, J = 8.1 Hz, CH-C12), 7.20 (2H, d, J = 8.7 Hz, CH-Arom), 6.79 (2H, d, J = 8.7 
Hz, CH-Arom), 4.22 (2H, s, CH2-C4), 3.86 (2H, d, J = 2.5 Hz, CH2-C3), 3.73 (3H, s, CH3-
C9), 2.37 (3H, s, CH3-C14), 1.93 (1H, t, J = 2.5 Hz, CH-C1); 
13
C NMR (100 MHz, CDCl3) δ 
159.5 (C-Arom), 143.6 (C-Arom), 136.0 (C-Arom), 130.2 (CH-Arom), 129.5 (CH-C12), 
127.9 (CH-C11), 126.7 (C-Arom), 114.1 (CH-Arom), 76.4 (C-C2), 74.0 (CH-C1), 55.3 (CH3-
C9), 49.2 (CH2-C4), 35.3 (CH2-C3), 21.6 (CH3-C14); HRMS (EI+)  [M]
+
 calcd for 
C18H19NO3S 329.1086, found 329.1089 [Δ +0.9 ppm]; LRMS (EI+) m/z (intensity) 330.1 
(21%), 329.1 (100%). 
 
2-(Oxiran-2-ylmethyl)isoindoline-1,3-dione 221 
 
A solution of phthalic anhydride (294 mg, 2.00 mmol) in dry THF (5 mL) was prepared, 
followed by addition of PPh3 (524 mg, 2.00 mmol) and glycidol (150 μL, 2.26 mmol). Finally 
DEAD (0.310 mL, 1.97 mmol) was added and the solution was stirred for 18 hours. The 
resulting mixture was concentrated in vacuo and diluted with Et2O (15 mL) before stirring for 
a further 2 hours. The mixture was filtered and concentrated in vacuo. Phthalimide 221 was 
isolated by flash column chromatography (petroleum ether-ethyl acetate, 4:1) as a colourless 
solid (222 mg, 48%). 
Rf = 0.41 (petroleum ether-ethyl acetate, 3:2); m.p. = 96–98 °C {Lit. m.p. 99 °C}
196; νmax 
3215, 3085, 2940, 1771, 1710, 746 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.89 (2H, dd, J = 5.4, 
3.0 Hz, CH-Arom), 7.76 (2H, dd, J = 5.4, 3.0 Hz, CH-Arom), 3.98 (1H, dd, J = 14.4, 5.0 Hz, 
CH2-C3a), 3.83 (1H, dd, J = 14.4, 5.0 Hz, CH2-C3b), 3.26 (1H, dddd, J = 5.0, 5.0, 4.3, 2.6 Hz, 
CH-C2), 2.83 (1H, dd, J =4.9, 4.3 Hz, CH2-C1a), 2.71 (1H, dd, J = 4.9, 2.6 Hz, CH2-C1b); 
13
C 
NMR (100 MHz, CDCl3) δ 168.0 (C-C4), 134.2 (CH-Arom), 132.0 (C-C5), 123.5 (CH-Arom), 
49.1 (CH-C2), 46.1 (CH2-C1), 39.7 (CH2-C3); HRMS (CI, Me3CH) [M+H]
+
 calcd for 
C11H10NO3 204.0661, found 204.0656 [Δ –2.1 ppm]; LRMS (CI, Me3CH) m/z (intensity) 
205.1 (12%), 204.1 (100%); Anal. calcd for C11H9NO3: C, 65.02%; H, 4.46%; N, 6.89%. 
Found: C, 64.66%; H, 4.44%; N, 6.95%. 
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Attempted Epoxide Opening Using PMB Protected Sulfonamide 
 
A solution of alkyne 220 (132 mg, 0.401 mmol) in toluene (1 mL) was prepared and cooled to 
0 °C. n-BuLi (150 μL of a 2.5 M solution in hexanes, 0.375 mmol) was added to the solution, 
dropwise, and the mixture was stirred for 15 minutes. Et2AlCl (390 μL of a 1M solution in 
hexanes, 0.390 mmol) was added dropwise, and the mixture was stirred for a further 1 hour. 
Finally, a solution of epoxide 221 (41.0 mg, 0.202 mmol) in toluene (1.5 mL) was added to the 
mixture, which was stirred for another hour, maintaining the temperature at 0 °C throughout. 
The reaction was quenched with saturated aqueous NH4Cl (2 mL) and the mixture was 
allowed to warm to room temperature. The biphasic mixture was extracted with CH2Cl2 
(3 × 20 mL) and the combined extracts were dried (Na2SO4), filtered and concentrated in 
vacuo. The residue was purified by flash column chromatography on silica gel (petroleum 
ether-ethyl acetate, 7:3) to afford a mixture of unreacted starting material and traces of 
decomposition products. 
 
2-(2-Hydroxy-5-(trimethylsilyl)pent-4-ynyl)isoindoline-1,3-dione 223 
 
A solution of TMS-acetylene (73.0 μL, 0.518 mmol) in THF (3.6 mL) was prepared and 
cooled to –78 °C. n-BuLi (160 μL of a 2.5 M solution in hexanes, 0.400 mmol) was added 
dropwise with continuous stirring. After 10 minutes BF3·OEt2 (76.0 μL, 0.599 mmol) was 
added. The mixture was stirred for a further 10 minutes before addition of a solution of 
epoxide 221 (81.0 mg, 0.399 mmol) in THF (0.4 mL). The reaction continued for 2.5 hours, 
maintaining the temperature at –78 °C. Excess n-BuLi was quenched by addition of saturated 
aqueous NH4Cl (5 mL), and the mixture was then extracted with EtOAc (3 × 20 mL). The 
combined organic extracts were washed with brine (20 mL) before drying (MgSO4), filtering 
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and concentrating in vacuo. Flash column chromatography using silica gel (petroleum ether-
ethyl acetate, 2:1) delivered the target alcohol 223 as a clear, colourless oil (31 mg, 26%).  
Rf = 0.53 (dichloromethane-methanol, 49:1); νmax 3472, 2963, 2901, 2176, 1775, 1712, 1613, 
718, 640 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.72 (2H, dd, J = 5.5, 3.1 Hz, CH-Arom), 7.59 
(2H, dd, J = 5.5, 3.1 Hz, CH-Arom), 3.96–3.91 (1H, m, CH-C4), 3.77 (1H, dd, J = 14.2, 7.2 
Hz, CH2-C5a), 3.74 (1H, dd, J = 14.2, 4.3 Hz, CH2-C5b), 2.56 (1H, d, J = 6.8 Hz, OH), 2.43 
(1H, dd, J = 17.0, 5.9 Hz, CH2-C3a), 2.37 (1H, dd, J = 17.0, 5.5 Hz, CH2-C3b), 0.00 (9H, s, 
CH3-TMS); 
13
C NMR (100 MHz, CDCl3) δ 168.8 (C-C6), 134.2 (CH-Arom), 132.0 (C-C7), 
123.5 (CH-Arom), 101.5 (C-C1), 88.7 (C-C2), 68.3 (CH-C4), 43.3 (CH2-C5), 26.7 (CH2-C3), 
0.0 (CH3-TMS); HRMS (CI, Me3CH) [M+H]
+
 calcd for C16H20NO3Si 302.1212, found 
302.1215 [Δ +0.3 ppm]; LRMS (CI, Me3CH) m/z (intensity) 303.1 (21%), 302.1 (89%), 284.1 
(100%). 
 
2,5-Dimethyl-1-(oxiran-2-ylmethyl)-1H-pyrrole 224 
 
A suspension of 60% NaH dispersed on mineral oil (600 mg, 15.0 mmol) in anhydrous DMF 
(15 mL) was prepared followed by addition of 2,5-dimethylpyrrole (1.00 mL, 9.84 mmol) in 
anhydrous DMF (15 mL). This mixture was stirred for 18 hours before cooling to 0 °C. 
Epibromohydrin (940 μL, 11.0 mmol) was added dropwise and the mixture was stirred for a 
further 7 hours at 0 °C. The reaction was quenched by careful addition of H2O (20 mL) before 
extraction with Et2O (4 × 30 mL). The combined extracts were washed with brine (30 mL), 
dried (MgSO4) filtered and concentrated in vacuo. Flash column chromatography using silica 
gel (petroleum ether-ethyl acetate, 9:1) afforded the pyrrole 224 as a cloudy oil (864 mg, 
58%). 
Rf = 0.40 (petroleum ether-ethyl acetate, 17:3); νmax 3050, 2934, 1521, 747, 723, 709 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 5.80 (2H, s, CH-C6), 4.09 (1H, dd, J = 15.7, 3.2 Hz, CH2-C3a), 
3.95 (1H, dd, J = 15.7, 4.4 Hz, CH2-C3b), 3.16 (1H, dddd, J = 4.4, 4.0, 3.2, 2.5 Hz, CH-C2), 
2.79 (1H, dd, J = 4.9, 4.0 Hz, CH2-C1a), 2.42 (1H, dd, J = 4.9, 2.5 Hz, CH2-C1b), 2.25 (6H, s, 
CH3-C5); 
13
C NMR (100 MHz, CDCl3) δ 128.1 (C-C4), 105.5 (CH-C6), 51.2 (CH-C2), 45.2 
(CH2-C1), 44.4 (CH2-C3), 12.6 (CH3-C5); HRMS (CI, Me3CH) [M+H]
+
 calcd for C9H14NO 
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152.1075, found 152.1074 [Δ –0.8 ppm]; LRMS (CI, Me3CH) m/z (intensity) 153.1 (12%), 
152.1 (100%). 
 
N-(6-(2,5-Dimethyl-1H-pyrrol-1-yl)-5-hydroxyhex-2-ynyl)-N-(4-methoxybenzyl)-4-
methylbenzenesulfonamide 225 
 
A solution of alkyne 220 (165 mg, 0.502 mmol) in THF (3.5 mL) was prepared and cooled to 
–78 °C. n-BuLi (260 μL  of a 2.5 M solution in hexanes, 0.650 mmol) was added dropwise 
and the resulting mixture was stirred for 30 minutes. Subsequently, BF3·THF (72.0 μL, 
0.652 mmol) was added followed by a further 15 minutes of stirring. Finally, epoxide 224 
(91.0 mg, 0.602 mmol) was added as a solution in THF (0.5 mL). The mixture was stirred for 
2 hours, maintaining the temperature at –78 °C, and the reaction was quenched by the addition 
of saturated aqueous NH4Cl (4 mL). The resulting biphasic mixture was extracted with Et2O 
(3 × 10 mL) and the combined extractions were washed with brine (10 mL). The organic 
solution was dried (MgSO4), filtered and concentrated in vacuo. The residue was purified by 
flash column chromatography using silica gel (petroleum ether-ethyl acetate, 2:1) to give 
alcohol 225 as a colourless oil (83 mg, 34%). 
Rf = 0.29 (petroleum ether-ethyl acetate, 7:3); νmax 3470, 2974, 2913, 1611, 835, 658 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 7.72 (2H, d, J = 8.2 Hz, CH-C17), 7.24 (2H, d, J = 8.2 Hz, CH-
C18), 7.17 (2H, d, J = 8.6 Hz, CH-Arom), 6.78 (2H, d, J = 8.6 Hz, CH-Arom), 5.72 (2H, s, 
CH-C15), 4.21 (2H, s, CH2-C6), 3.85 (2H, s, CH2-C7), 3.72 (3H, s, CH3-C1),  3.70–3.64 (1H, 
m, CH-C11), 3.61 (1H, dd, J = 14.5, 4.4 Hz, CH2-C12a), 3.60 (1H, dd, J = 14.5, 8.0 Hz, CH2-
C12b), 2.32 (3H, s, CH3-C20), 2.12 (6H, s, CH3-C14), 2.13–2.11 (2H, m, CH2-C10), 1.90 (1H, 
d, J = 3.9 Hz, OH); 
13
C NMR (100 MHz, CDCl3) δ 159.5 (C-Arom), 143.7 (C-Arom), 136.2 
(C-Arom), 130.0 (CH-Arom), 129.5 (CH-C18), 128.0 (C-C13), 127.9 (CH-C17), 126.9 (C-
Arom), 114.1 (CH-Arom), 105.9 (CH-C15), 81.5 (C-C9), 75.8 (C-C8), 69.5 (CH-C11), 55.3 
(CH3-C1), 49.4 (CH2-C6), 48.5 (CH2-C12), 35.7 (CH2-C7), 24.9 (CH2-C10), 21.5 (CH3-C20), 
12.8 (CH3-C14); HRMS (EI) [M+]
+
 calcd for C27H32N2O4S 480.2083, found 480.2084 [Δ +0.3 
ppm]; LRMS (EI) m/z (intensity) 481.2 (35%), 480.2 (100%). 
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Attempted PMB Deprotection Using Pd/C 
 
To a solution of alkyne 225 (80.0 mg, 0.166 mmol) in methanol (15 mL) was added 10% Pd/C 
(2.80 mg, 0.00263 mmol) and ammonium formate (105 mg, 1.67 mmol). The mixture was 
heated to reflux and stirred at this temperature for 2.5 hours. The mixture was filtered through 
a pad of Celite
®
 and the filtrate was concentrated in vacuo. The residue was dissolved in 
CH2Cl2 (10 mL) and washed with water (10 mL). The organic phase was dried (Na2SO4), 
filtered and concentrated in vacuo. TLC analysis revealed that no reaction had taken place. 
 
Attempted PMB Deprotection Using α-Chloroethyl Chloroformate  
 
A solution of alkyne 225 (48.0 mg, 0.0999 mmol) in dichloromethane (1 mL) was prepared 
and cooled to 0 °C. α-Chloroethyl chloroformate (14.0 μL, 0.130 mmol) was added slowly to 
the solution of the alkyne and the mixture was stirred at 0 °C for 1 hour. The mixture was 
allowed to reach room temperature before being concentrated in vacuo. Residual material was 
redissolved in methanol (2 mL) and the solution was heated at reflux for 1 hour. The reaction 
mixture was concentrated in vacuo but TLC analysis of the residue indicated that the reaction 
had not taken place. 
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N-(6-(2,5-Dimethyl-1H-pyrrol-1-yl)-5-hydroxyhex-2-ynyl)-4-
methylbenzenesulfonamide 226 
 
A solution of alkyne 165 (2.10 g, 10.0 mmol) in THF (120 mL) was prepared before cooling 
to –78 °C. n-BuLi (9.20 mL  of a 2.5 M solution in hexanes, 23.0 mmol) was added dropwise 
followed by 30 minutes of stirring. Subsequently, BF3·THF (1.40 mL, 12.6 mmol) was added 
followed by a further 15 minutes of stirring. Finally, a solution of epoxide 224 (1.80 g, 
11.9 mmol) in THF (2 mL) was added and the reaction was stirred for 5 hours, maintaining the 
temperature at –78 °C. Excess n-BuLi was quenched by the addition of saturated aqueous 
NH4Cl (120 mL). The resulting biphasic solution was extracted with Et2O (3 × 60 mL) and the 
combined extracts were washed with brine (60 mL). The Et2O solution was dried (MgSO4), 
filtered and concentrated in vacuo. Alcohol 226 was isolated by column chromatography using 
silica gel (petroleum ether-ethyl acetate, 3:2) as a colourless oil (2.1 g, 58%). 
Rf = 0.18 (petroleum ether-ethyl acetate, 3:2); νmax 3387, 3113, 2901, 1732, 1597, 814 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.79 (2H, d, J = 8.3 Hz, CH-C4), 7.33 (2H, d, J = 8.3 Hz, CH-
C3), 5.80 (2H, s, CH-C14), 4.71 (1H, t, J = 5.9 Hz, NH), 3.88–3.86 (1H, m, CH-C10), 3.82 
(2H, dt, J = 5.9, 2.2 Hz, CH2-C6), 3.76 (1H, dd, J = 14.6, 4.4 Hz, CH2-C11a), 3.73 (1H, dd, J 
= 14.6, 7.8 Hz, CH2-C11b), 2.43 (3H, s, CH3-C1), 2.27 (2H, dd, J = 5.6, 2.2 Hz, CH2-C9), 
2.25 (1H, br s, OH), 2.22 (6H, s, CH3-C13); 
13
C NMR (100 MHz, CDCl3) δ 143.8 (C-Arom), 
136.7 (C-Arom), 129.7 (CH-C3), 128.1 (C-C12), 127.4 (CH-C4), 105.8 (CH-C14), 80.6 (C-
C8), 77.4 (C-C7), 69.5 (CH-C10), 48.5 (CH2-C11), 33.2 (CH2-C6), 24.9 (CH2-C9), 21.5 (CH3-
C1), 12.8 (CH3-C13); HRMS (CI, Me3CH) [M+H]
+
 calcd for C19H25N2O3S 361.1586, found 
361.1583 [Δ –0.8 ppm]; LRMS (CI, Me3CH) m/z (intensity) 362.2 (23%), 361.2 (100%). 
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N-(5-(tert-Butyldiphenylsilyloxy)-6-(2,5-dimethyl-1H-pyrrol-1-yl)hex-2-ynyl)-4-
methylbenzenesulfonamide 228 
 
To a solution of alcohol 226 (72.0 mg, 0.200 mmol) in dry CH2Cl2 (0.2 mL) was added 
2,6-lutidine (33.0 μL, 0.296 mmol) followed by dropwise addition of TBDPSOTf (78.0 μL, 
0.231 mmol). The mixture was stirred for 18 hours and then diluted with EtOAc (10 mL). The 
resulting solution was washed with saturated aqueous NaHCO3 (10 mL) and brine (10 mL). 
The EtOAc solution was then dried (Na2SO4), filtered and concentrated in vacuo. The residue 
was purified by flash column chromatography using silica gel (petroleum ether-ethyl acetate, 
9:1) to give silyl ether 228 as a colourless oil (56 mg, 47%). 
Rf = 0.46 (petroleum ether-ethyl acetate, 4:1); νmax 3264, 3048, 2932, 2855, 2245, 1713, 1597, 
810, 702, 617 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.62 (2H, d, J = 8.2 Hz, CH-C4), 7.60–7.58 
(2H, m, CH-Arom), 7.39–7.24 (8H, m, CH-Arom), 7.17 (2H, d, J = 8.2 Hz, CH-C3), 5.65 (2H, 
s, CH-C14), 4.31 (1H, t, J = 5.8 Hz, NH), 3.86–3.81 (1H, m, CH-C10), 3.65 (1H, dd, J = 14.7, 
6.6 Hz, CH2-C11a), 3.62 (1H, dd, J = 14.7, 7.1 Hz, CH2-C11b), 3.54 (2H, dt, J = 5.8, 2.3 Hz, 
CH2-C6), 2.30 (3H, s, CH3-C1), 1.92 (6H, s, CH3-C13), 1.92–1.90 (2H, m, CH2-C9), 0.93 (9H, 
s, CH3-C24); 
13
C NMR (100 MHz, CDCl3) δ 143.6 (C-Arom), 136.6 (C-Arom), 135.9 (CH-
Arom), 135.9 (CH-Arom), 133.8 (C-Arom), 132.7 (C-Arom), 130.0 (CH-Arom), 130.0 (CH-
Arom), 129.6 (CH-C3), 128.1 (C-Arom), 127.8 (CH-Arom), 127.8 (CH-Arom), 127.3 (CH-
C4), 105.6 (CH-C14), 81.1 (C-C8), 76.4 (C-C7), 70.4 (CH-C10), 48.8 (CH2-C11), 33.2 (CH2-
C6), 26.8 (CH3-C24), 25.1 (CH2-C9), 21.5 (CH3-C1), 19.1 (C-C23), 12.7 (CH3-C13); HRMS 
(EI) [M+]
+ 
calcd for C35H42N2O3SSi 598.2685, found 598.2679 [Δ –1.0 ppm]; LRMS (EI) m/z 
(intensity) 600.3 (20%), 599.3 (47%), 598.3 (100%). 
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tert-Butyl 2-(N-(5-(tert-butyldiphenylsilyloxy)-6-(2,5-dimethyl-1H-pyrrol-1-yl)hex-
2-ynyl)-4-methylphenylsulfonamido)acetate 229 
 
To a solution of sulphonamide 228 (88.0 mg, 0.147 mmol) in acetone (2 mL) was added 
K2CO3 (61.0 mg, 0.442 mmol) and tert-butyl bromoacetate (33.0 μL, 0.224 mmol). The 
reaction mixture was stirred at 65 °C for 20 hours, after which it was allowed to cool to room 
temperature. The reaction mixture was filtered, washing through with excess acetone, and 
concentrated in vacuo. The residue was purified by flash column chromatography using silica 
gel (petroleum ether-ethyl acetate, 4:1) to give tert-butyl ester 229 as a colourless oil (72 mg, 
69%). 
Rf = 0.54 (petroleum ether-ethyl acetate, 2:1); νmax 3071, 2931, 1746, 822, 743, 702 cm
-1
; 
1
H 
NMR (500 MHz, CDCl3) δ 7.62–7.59 (2H, m, CH-Arom), 7.61 (2H, d, J = 8.1 Hz, CH-C13), 
7.38–7.22 (8H, m, CH-Arom), 7.14 (2H, d, J = 8.1 Hz, CH-C14), 5.67 (2H, s, CH-C11), 4.11 
(2H, t, J = 2.2 Hz, CH2-C3), 3.89 (2H, d, J = 1.4 Hz, CH2-C2), 3.83 (1H, tdd, J = 6.6, 6.3 4.3 
Hz, CH-C7), 3.65 (2H, d, J = 6.6 Hz, CH2-C8), 2.27 (3H, s, CH3-C16), 1.95 (6H, s, CH3-C10), 
1.89 (1H, ddt, J = 16.8, 6.3, 2.2 Hz, CH2-C6a), 1.84 (1H, ddt, J = 16.8, 4.3, 2.2 Hz, CH2-C6b), 
1.33 (9H, s, CH3-tBu), 0.92 (9H, s, CH3-C26); 
13
C NMR (100 MHz, CDCl3) δ 167.5 (C-C1), 
143.5 (C-Arom), 136.6 (C-Arom), 135.9 (CH-Arom), 135.8 (CH-Arom), 133.8 (C-Arom), 
132.6 (C-Arom), 130.0 (CH-Arom), 130.0 (CH-Arom), 129.5 (CH-C14), 127.9 (C-Arom), 
127.8 (CH-Arom), 127.8 (CH-Arom), 127.5 (CH-C13), 105.7 (CH-C11), 82.2 (C-tBu), 82.2 
(C-C5), 75.5 (C-C4), 70.4 (CH-C7), 48.4 (CH2-C8), 47.2 (CH2-C2), 37.7 (CH2-C3), 28.0 
(CH3-tBu), 26.8 (CH3-C26), 24.7 (CH2-C6), 21.5 (CH3-C16), 19.0 (C-25), 12.8 (CH3-C10); 
HRMS (FAB) [M+H]
+
 calcd for C41H53N2O5SSi 713.3444, found 713.3441, [Δ –0.3 ppm]; 
LRMS (FAB) m/z (intensity) 714.3 (53%), 713.3 (100%). 
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Attempted Removal of 2,5-Dimethylpyrrole 
 
To a solution of protected amine 229 (68.0 mg, 0.0954 mmol) in isopropanol (4 mL) and 
water (1 mL) was added hydroxylamine hydrochloride (134 mg, 1.93 mmol) followed by TEA 
(130 μL, 0.932 mmol). The reaction mixture was heated to reflux and stirred for a period of 4 
hours. The mixture was then cooled to room temperature and NaOH (38.0 mg, 0.950 mmol) 
was added. The mixture was stirred for a period of 20 hours. It was apparent that reaction had 
not taken place and so the mixture was heated to reflux for a further two hours with stirring. 
Upon cooling, the reaction mixture was filtered through Celite
®
 and concentrated in vacuo. 
Reaction had not taken place and the starting material was recovered by flash column 
chromatography on silica gel (petroleum ether-ethyl acetate, 3:1). 
 
Alternative Approach to 2,5-Dimethylpyrrole Removal 
 
To a solution of alkyne 231 (13.0 mg, 0.0198 mmol) in isopropanol (4 mL) and water (1 mL) 
was added hydroxylamine hydrochloride (28.0 mg, 0.441 mmol) followed by TEA (28 μL, 
0.201 mmol). The reaction mixture was heated to reflux and stirred at this temperature for 18 
hours. After this time the mixture was cooled to room temperature and NaOH (8.00 mg, 
0.200 mmol) was added. The mixture was stirred for a further 20 hours, then filtered through a 
pad of Celite
®
 and concentrated in vacuo. TLC analysis of the residual material revealed that 
reaction had not taken place. The starting material could not be recovered by column 
chromatography due to polarity issues relateing to the carboxylic acid. 
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Oxiran-2-ylmethyl 4-methylbenzenesulfonate 233 
 
A solution of glycidol (5.00 mL, 75.5 mmol) in CH2Cl2 (60 mL) was prepared and cooled to 
0 °C. TEA (14.0 mL, 101 mmol) was added, followed by p-toluene sulfonyl chloride (17.3 g, 
89.0 mmol) and the reaction mixture was warmed to room temperature with stirring. After 18 
hours, the reaction mixture was washed with brine (50 mL) and saturated aqueous NaHCO3 
(50 mL). The organic layer was dried (Na2SO4), filtered and concentrated in vacuo. The 
resulting oil was purified by flash column chromatography (petroleum ether-ethyl acetate, 3:1) 
to produce sulfonamide 233 as a colourless oil (15.8 g, 92%). 
Rf = 0.38 (petroleum ether-ethyl acetate, 3:2); νmax 2959, 1597, 957, 808 cm
-1
; 
1
H NMR (400 
MHz, CDCl3) δ 7.82 (2H, d, J = 8.2 Hz, CH-C5), 7.37 (2H, d, J = 8.2 Hz, CH-C6), 4.27 (1H, 
dd, J = 11.4, 3.4 Hz, CH2-C3a), 3.96 (1H, dd, J = 11.4, 6.1 Hz, CH2-C3b), 3.20 (1H, dddd, J = 
6.1, 4.4, 3.4, 2.5 Hz, CH-C2), 2.82 (1H, dd, J = 4.8, 4.4 Hz, CH2-C1a), 2.60 (1H, dd, J = 4.8, 
2.5 Hz, CH2-C1b), 2.47 (3H, s, CH3-C8); 
13
C NMR (100 MHz, CDCl3) δ 145.2 (C-Arom), 
132.7 (C-Arom), 129.9 (CH-C6), 128.0 (CH-C5), 70.5 (CH2-C3), 48.8 (CH-C2), 44.6 (CH2-
C1), 21.7 (CH3-C8); HRMS (EI+) [M]
+
 calcd for C10H12O4S 228.0456 found, 228.0448 [Δ –
3.5 ppm]; LRMS (EI+) m/z (intensity) 229.0 (11%), 228.0 (59%), 83.9 (100%). 
 
2-Hydroxy-6-(phenylsulfonamido)hex-4-ynyl 4-methylbenzenesulfonate, 234 
 
A solution of alkyne 165 (2.10 g, 10.0 mmol) in dry THF (120 mL) was prepared and cooled 
to –78 °C. n-BuLi (9.20 mL of a 2.5 M solution in hexanes, 23.0 mmol) was added dropwise 
and the mixture was stirred for 30 minutes. BF3·THF (1.40 mL, 12.7 mmol) was added and the 
mixture stirred for another 15 minutes. Finally, epoxide 233 (1.80 g, 11.9 mmol) was added as 
a solution in THF (2 mL). The reaction was stirred for 5 hours, maintaining the temperature at 
–78 °C. The reaction was then quenched by careful addition of saturated aqueous NH4Cl 
(120 mL). The mixture was allowed to warm to room temperature and then extracted with 
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Et2O (3 × 60 mL). The combined organic extracts were washed with brine (60 mL) before 
drying (MgSO4), filtration and concentration in vacuo. Alcohol 234 was isolated by flash 
column chromatography using silica gel (petroleum ether-ethyl acetate, 3:2) to give a 
colourless oil (2.1 g, 58%). 
Rf = 0.29 (petroleum ether-ethyl acetate, 1:1); νmax 3448, 3387, 2970, 2360, 1598, 814, 660 cm
-
1
; 
1
H NMR (400 MHz, CDCl3) δ 7.82 (2H, d, J = 8.2 Hz, CH-C13), 7.77 (2H, d, J = 8.2 Hz, 
CH-C4), 7.40 (2H, d, J = 8.2 Hz, CH-C14), 7.33 (2H, d, J = 8.2 Hz, CH-C3), 4.70 (1H. t, J = 
6.0 Hz, NH), 4.01 (1H, dd, J = 10.3, 4.5 Hz, CH2-C11a), 3.95 (1H, dd, J = 10.3, 5.6 Hz, CH2-
C11b), 3.87–3.80 (1H, m, CH-C10), 3.77 (2H, dt, J = 6.0, 2.3 Hz, CH2-C6), 2.49 (3H, s, CH3-
C16), 2.45 (3H, s, CH3-C1), 2.33 (1H, d, J = 6.0 Hz, OH), 2.30 (2H, dt, J = 6.1, 2.3 Hz, CH2-
C9); 
13
C NMR (100 MHz, CDCl3) δ 145.3 (C-Arom), 143.9 (C-Arom), 136.6 (C-Arom), 132.4 
(C-Arom), 130.0 (CH-C14), 129.7 (CH-C3), 128.0 (CH-C13), 127.4 (CH-C4), 79.7 (C-C8), 
77.7 (C-C7), 71.8 (CH2-C11), 67.6 (CH-C10), 33.2 (CH2-C6), 23.5 (CH2-C9), 21.7 (CH3-
C16), 21.5 (CH3-C1); HRMS (CI, Me3CH) [M+H]
+
 calcd for C20H24NO6S2 438.1045, found 
438.1041 [Δ –1.0 ppm]; LRMS (CI, Me3CH) m/z (intensity) 439.1 (27%), 438.1 (100%). 
 
Attempted Protection of Secondary Alcohol Prior to N-Alkylation 
 
To a solution of secondary alcohol 234 (40.0 mg, 0.0914 mmol) in dichloromethane (1 mL) 
was added sequentially DMAP (22.0 mg, 0.180 mmol), TBDPSCl (48.0 μL, 0.185 mmol) and 
TEA (14.0 μL, 0.100 mmol). The mixture was stirred for 18 hours at room temperature before 
the reaction was quenched with saturated aqueous NaHCO3 (10 mL). The aqueous phase was 
separated and extracted with Et2O (3 × 10 mL) and the combined organic extracts were 
washed with brine (10 mL), dried (Na2SO4), filtered and concentrated in vacuo. TLC analysis 
indicated that no reaction had taken place and so the starting material was recovered by flash 
column chromatography using silica gel (petroleum ether-ethyl acetate, 3:2).. 
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tert-Butyl 2-(N-(5-hydroxy-6-(tosyloxy)hex-2-ynyl)-4-
methylphenylsulfonamido)acetate 235 
 
A solution of alcohol 234 (874 mg, 2.00 mmol) was prepared in acetone (7 mL). K2CO3 
(828 mg, 5.99 mmol) was added, followed by tert-butyl bromoacetate (310 μL, 2.10 mmol). 
The reaction was stirred for 18 hours at which point it was filtered and concentrated in vacuo. 
The target ester 235 was isolated by flash column chromatography using silica gel (petroleum 
ether-ethyl acetate, 3:1) as a colourless oil (512 mg, 46%). 
Rf = 0.20 (petroleum ether-ethyl acetate, 7:3); νmax 3525, 3476, 2981, 1741, 1598, 813, 660 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.72 (2H, d, J = 8.2 Hz, CH-C10), 7.62 (2H, d, J = 8.4 
Hz, CH-C15), 7.29 (2H, d, J = 8.2 Hz, CH-C11), 7.21 (2H, d, J = 8.4 Hz, CH-C16), 4.07 (2H, 
s, CH2-C3), 3.89 (1H, dd, J = 10.3, 4.8 Hz, CH2-C8a), 3.87 (2H, s, CH2-C2), 3.84 (1H, dd, J = 
10.3, 5.8 Hz, CH2-C8b), 3.77–3.71 (1H, m, CH-C7), 2.48 (1H, d, J = 5.7 Hz, OH), 2.38 (3H, s, 
CH3-C13), 2.33 (3H, s, CH3-C18), 2.21–2.20 (2H, m, CH2-C6), 1.34 (9H, s, CH3-tBu); 
13
C 
NMR (100 MHz, CDCl3) δ 167.6 (C-C1), 145.3 (C-Arom), 143.8 (C-Arom), 136.2 (C-Arom), 
132.4 (C-Arom), 130.0 (CH-C11), 129.6 (CH-C16), 128.0 (CH-C10), 127.5 (CH-C15), 82.4 
(C-tBu), 80.9 (C-C5), 76.0 (C-C4), 71.8 (CH2-C8), 67.6 (CH-C7), 47.8 (CH2-C2), 37.8 (CH2-
C3), 28.0 (CH3-tBu), 23.5 (CH2-C6), 21.7 (CH3-C13), 21.5 (CH3-C18); HRMS (FAB) 
[M+H]
+
 calcd for C26H34NO8S2 552.1726, found 552.1730, [Δ +0.4 ppm]; LRMS (FAB) m/z 
(intensity) 553.2 (30%), 552.2 (100%); Anal. calcd for C26H33NO8S2: C, 56.61%; H, 6.03%; 
N, 2.54%. Found: C, 56.54%; H, 6.22%; N, 2.59%. 
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tert-Butyl 2-(N-(6-azido-5-hydroxyhex-2-ynyl)-4-
methylphenylsulfonamido)acetate 237 
 
A solution of tosylate 235 (200 mg, 0.363 mmol) in DMF (2.5 mL) was added to a flask 
charged with NaN3 (71.0 mg, 1.09 mmol). The mixture was heated to 80 °C and stirred for 5 
hours. Upon completion of the reaction, the mixture was cooled to room temperature before 
H2O (15 mL) was added. The biphasic solution was extracted with Et2O (3 × 10 mL) and the 
combined organic phases were washed with brine (20 mL). The solution was dried (MgSO4), 
filtered and concentrated in vacuo. The residue was purified by flash column chromatography 
using silica gel (petroleum ether-ethyl acetate, 3:2) to give azide 237 as a colourless solid 
(139 mg, 91%). 
Rf = 0.41 (petroleum ether-ethyl acetate, 3:2); m.p. = 53–54 °C; νmax 3570, 3480, 2981, 2102, 
1744, 1598, 813, 658 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.66 (2H, d, J = 8.1 Hz, CH-C10), 
7.24 (2H, d, J = 8.1 Hz, CH-C11), 4.14 (2H, t, J = 2.0 Hz, CH2-C3), 3.92 (2H, s, CH2-C2), 
3.71–3.65 (1H, m, CH-C7), 3.22 (1H, dd, J = 12.5, 4.5 Hz, CH2-C8a), 3.18 (1H, dd, J = 12.5, 
6.3 Hz, CH2-C8b), 2.37 (3H, s, CH3-C13), 2.24 (2H, dt, J = 6.1, 2.0 Hz, CH2-C6), 2.17 (1H, d, 
J = 5.4 Hz, OH), 1.36 (9H, s, CH3-tBu); 
13
C NMR (100 MHz, CDCl3) δ 167.6 (C-C1), 143.8 
(C-Arom), 136.3 (C-Arom), 129.6 (CH-C11), 127.6 (CH-C10), 82.5 (C-tBu), 81.3 (C-C5), 
76.2 (C-C4), 69.0 (CH-C7), 55.2 (CH2-C8), 47.9 (CH2-C2), 37.8 (CH2-C3), 28.0 (CH3-tBu), 
24.8 (CH2-C6), 21.5 (CH3-C13); HRMS (FAB) [M+H]
+
 calcd for C19H27N4O5S 423.1702, 
found 423.1704, [Δ +0.2 ppm]; LRMS (FAB) m/z (intensity) 423.2 (16%), 366.8 (100%). 
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tert-Butyl 2-(N-(6-amino-5-hydroxyhex-2-ynyl)-4-
methylphenylsulfonamido)acetate 238 
 
To a solution of azide 237 (860 mg, 2.04 mmol) in THF (9 mL) was added PPh3 (561 mg, 
2.14 mmol). The mixture was stirred at room temperature for 3 days. The reaction mixture was 
poured into H2O (22 mL) and extracted with CH2Cl2 (3 × 50 mL). The combined extracts were 
dried (Na2SO4), filtered and concentrated in vacuo. The residue was purified by flash column 
chromatography using silica gel (methanol-dichloromethane, 9:1) to yield the primary amine 
238 as a colourless oil (713 mg, 88%). 
Rf = 0.13 (dichloromethane-methanol, 9:1); νmax 3534, 3372, 2978, 2870, 1744, 1597, 656 cm
-
1
; 
1
H NMR (500 MHz, CDCl3) δ 7.66 (2H, d, J = 8.2 Hz, CH-C10), 7.23 (2H, d, J = 8.2 Hz, 
CH-C11), 4.13 (2H, t, J = 2.0 Hz, CH2-C3), 3.92 (2H, s, CH2-C2), 3.52–3.47 (1H, m, CH-C7), 
2.75 (1H, dd, J = 12.8, 3.6 Hz, CH2-C8a), 2.52 (1H, dd, J = 12.8, 7.7 Hz, CH2-C8b), 2.36 (3H, 
s, CH3-C13), 2.20 (1H, ddt, J = 16.7, 6.2, 2.0 Hz, CH2-C6a), 2.15 (1H, ddt, J = 16.7, 6.1, 2.0 
Hz, CH2-C6b), 2.09 (3H, br s, OH and NH2), 1.35 (9H, s, CH3-tBu); 
13
C NMR (100 MHz, 
CDCl3) δ 167.6 (C-C1), 143.7 (C-Arom), 136.3 (C-Arom), 129.5 (CH-C11), 127.6 (CH-C10), 
82.5 (C-tBu), 82.4 (C-C5), 75.2 (C-C4), 69.9 (CH-C7), 47.7 (CH2-C2), 46.1 (CH2-C8), 37.9 
(CH2-C3), 28.0 (CH3-tBu), 24.8 (CH2-C6), 21.5 (CH3-C13); HRMS (CI, Me3CH) [M+H]
+
 
calcd for C19H29N2O5S 397.1797, found 397.1787 [Δ –2.5 ppm]; LRMS (CI, Me3CH) m/z 
(intensity) 397.2 (64%), 230.2 (100%). 
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2-(N-(6-Amino-5-hydroxyhex-2-ynyl)-4-methylphenylsulfonamido)acetic acid 
TFA salt 239 
 
A solution of tert-butyl ester 238 (98.0 mg, 0.247 mmol) in CH2Cl2 (1.8 mL) was prepared 
and TFA (1.8 mL) was added. The mixture was stirred for 16 hours before concentrating in 
vacuo. The residue was mixed with a small volume of toluene and concentrated in vacuo once 
again. This last procedure was repeated two more times to ensure complete removal of traces 
of TFA, followed by further drying under high vacuum. The TFA salt 239 was isolated as a 
white solid (112 mg, 100%). 
M.p. = 38–39 °C; νmax 3337, 3156, 2928, 2643, 1736, 1670, 799, 671 cm
-1
; 
1
H NMR (500 
MHz, CD3OD) δ 7.59 (2H, d, J = 8.2 Hz, CH-C10), 7.25 (2H, d, J = 8.2 Hz, CH-C11), 4.05 
(2H, t, J = 2.2 Hz, CH2-C3), 3.90 (2H, s, CH2-C2), 3.69–3.64 (1H, m, CH-C7), 2.90 (1H, dd, J 
= 12.8, 3.0 Hz, CH2-C8a), 2.65 (1H, dd, J = 12.8, 9.3 Hz, CH2-C8b), 2.29 (3H, s, CH3-C13), 
2.18 (1H, ddt, J = 16.9, 5.4, 2.2 Hz, CH2-C6a), 2.17 (1H, s, OH), 2.11 (1H, ddt, J = 16.9, 7.1, 
2.2 Hz, CH2-C6b); 
13
C NMR (100 MHz, CD3OD) δ 171.9 (C-C1), 145.4 (C-Arom), 137.6 (C-
Arom), 130.8 (CH-C11), 128.8 (CH-C10), 82.3 (C-C5), 76.8 (C-C4), 67.2 (CH-C7), 48.1 
(CH2-C2), 44.9 (CH2-C8), 38.8 (CH2-C3), 25.9 (CH2-C6), 21.5 (CH3-C13); HRMS (FAB) 
[M
+
] calcd for C15H21N2O5S 341.1171, found 341.1168 [Δ 1.0 ppm];  LRMS (FAB) m/z 
(intensity) 341.1 (17%), 154.1 (100%). 
 
Lactamisation Reaction Using BOP 
 
To a solution of carboxylic acid 239 (30.0 mg, 0.0660 mmol) in dry CH2Cl2 (248 mL) and 
DMF (2.5 mL) was added HOBt (89.0 mg, 0.659 mmol) and DIPEA (230 μL, 1.32 mmol). 
The mixture was cooled to –15 °C and BOP (292 mg, 0.660 mmol) was added. The mixture 
was stirred for 24 hours and during this time it was allowed to warm to room temperature. The 
mixture was concentrated in vacuo to 30 mL and washed sequentially with 2% aqueous citric 
acid solution (2 × 50 mL), 2% saturated aqueous Na2CO3 (2 × 50 mL) and brine (2 × 50 mL). 
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The organic phase was dried (Na2SO4), filtered and concentrated in vacuo. No new products 
were visible upon TLC analysis of the residue. 
 
Lactamisation Reaction Using EDCI 
 
A solution of carboxylic acid 239 (20.0 mg, 0.0440 mmol) in dichloromethane (396 mL) and 
DMF (4 mL) was prepared and cooled to –15 °C. EDCI (211 mg, 1.10 mmol) and DMAP 
(54.0 mg, 0.442 mmol) were added to the mixture, followed by stirring for 20 hours as it 
reached room temperature. The mixture was concentrated in vacuo to 30 mL and then washed 
sequentially with 5% aqueous citric acid solution (2 × 50 mL), 5% aqueous Na2CO3 solution 
(2 × 50 mL) and brine (2 × 50 mL). The organic phase was dried (Na2SO4), filtered and 
concentrated in vacuo. TLC analysis of the crude mixture showed that the desired product had 
not been obtained. 
 
Lactamisation Reaction Using FDPP 
 
To a solution of alkyne 239 (15.0 mg, 0.0330 mmol) in DMF (3 mL) was added FDPP 
(38.0 mg, 0.0989 mmol) and DIPEA (29.0 μL, 0.166 mmol). The mixture was stirred at room 
temperature for 4 days and then acidified to pH 5 by the addition of 1M HCl solution. The 
mixture was partitioned between water (20 mL) and a 3:1 mixture of chloroform/isopropanol 
(20 mL). The biphasic solution was extracted with a 3:1 mixture of chloroform/isopropanol 
(3 × 20 mL) and the combined organic extracts were dried (MgSO4), filtered and concentrated 
in vacuo. The crude material was purified by flash column chromatography on silica gel 
(petroleum ether-ethyl acetate, 1:1), but the new products were found to be decomposition 
products. 
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Lactamisation Reaction Using DMTMM 
 
To a solution of alkyne 239 (15.0 mg, 0.0330 mmol) in DMF (3 mL) was added DMTMM 
(27.0 mg, 0.0976 mmol) and DIPEA (29.0 μL, 0.166 mmol). The mixture was stirred at room 
temperature for 4 days and was then acidified to pH 5 using 1M HCl solution. The mixture 
was partitioned between water (20 mL) and a 3:1 mixture of chloroform/isopropanol (20 mL). 
The resulting biphasic solution was extracted with a 3:1 mixture of chloroform/isopropanol 
(3 × 20 mL) and the organic extracts were dried (MgSO4), filtered and concentrated in vacuo. 
The crude mixture was purified by flash column chromatography on silica gel (petroleum 
ether-ethyl acetate, 3:2) to afford trace amounts of decomposition products and none of the 
desired lactam. 
 
Lactamisation Reaction Using PyBOP 
 
To a solution of alkyne 239 (15.0 mg, 0.0330 mmol) in dry DMF (1 mL) was added PyBOP 
(52.0 mg, 0.0999 mmol) and DIPEA (29.0 μL, 0.166 mmol), and the mixture was then stirred 
at room temperature for 3 days. The solution was acidifed to pH 5 using 1M HCl solution and 
the resulting mixture was partitioned between water (20 mL) and a 3:1 solution of 
chloroform/isopropanol (20 mL). The resulting biphasic mixture was extracted with 3:1 
chloroform/isopropanol (3 × 20 mL) and the combined extracts were dried (MgSO4), filtered 
and concentrated in vacuo. The crude reaction mixture was purified by flash column 
chromatography on silica gel (dichloromethane-methanol, 19:1), to deliver trace amounts of 
decomposition products. 
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Synthesis of the Cobalt Complex 241 
 
To a solution of alkyne 238 (700 mg, 1.77 mmol) in dichloromethane (20 mL) was added 
cobalt octacarbonyl (635 mg, 1.86 mmol) at room temperature. The mixture was stirred for 5 
hours and then concentrated in vacuo. Flash column chromatography on silica gel 
(dichloromethane-methanol, 9:1) delivered the cobalt complex 241 (624 mg, 52%) as a brown 
solid. The purified product was dissolved in a small volume of CH2Cl2 and passed through a 
pad of Celite
®
 to remove any traces of free cobalt in preparation for NMR analysis. This was 
unsuccessful and no useful NMR data could be obtained. Similarly, mass spectrometric data 
was unrevealing. 
 
Deprotection of the Cobalt Complex 
 
To a solution of cobalt complex 241 (624 mg, 0.914 mmol) in dichloromethane (3 mL) was 
added TFA (3 mL). The mixture was stirred at room temperature for 5 hours and then 
concentrated in vacuo. The residue was dissolved in toluene and concentrated once again in 
vacuo. This procedure was performed twice more, followed by drying under high vacuum, to 
ensure complete removal of traces of free TFA. The deprotected product 234 was isolated as a 
brown oil (677 mg, 100%) and used without further purification. Attempts to remove traces of 
cobalt for NMR analysis were unsuccessful and so useful NMR data could not be obtained. 
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Formation of the Cobalt Complex Lactam 
 
To a solution of cobalt complex 240 (20.0 mg, 0.0270 mmol) in dichloromethane (2.7 mL) 
was added DIPEA (9.40 μL, 0.0540 mmol) and BOP (14.0 mg, 0.0317 mmol) The reaction 
mixture was stirred for 2 days at room temperature, after which time it was acidified to pH 5 
using 1M HCl solution. The mixture was partitioned between water (10 mL) and 
dichloromethane (10 mL). The aqueous layer was separated and extracted with 
dichloromethane (3 × 10 mL) and the combined extracts were dried (MgSO4), filtered and 
concentrated in vacuo. A possible product was identified by TLC analysis and this compound 
was isolated by flash column chromatography on silica gel (dichloromethane/methanol, 9:1). 
Attempts to obtain useful NMR data from this compound were unsuccessful and so the next 
step involving removal of the cobalt group was carried out as a means of validating this 
structure. 
 
Attempted Removal of Cobalt Complex 
 
To a solution of the isolated product 242 (5.70 mg, 0.00937 mmol) in dichloromethane (1 mL) 
was added NMO (20.0 mg, 0.171 mmol). The mixture was stirred for 2 hours, before 
partitioning it between Et2O (10 mL) and saturated aqueous NH4Cl (10 mL). The organic layer 
was washed with saturated aqueous NH4Cl (10 mL) and brine (10 mL), then dried (Na2SO4), 
filtered and concentrated in vacuo. The reaction did not show a visible progression by TLC 
analysis, suggesting that the product that was isolated from the previous reaction was not the 
desired lactam. 
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Diphenylphosphino(borane)methyl alcohol 243 
 
Borane-dimethylsulfide (19.0 mL of a 2M solution in THF, 38.0 mmol) was diluted by 
addition of THF (20 mL) before the addition of diphenylphosphine (3.50 mL, 20.1 mmol) and 
the mixture was stirred for 2.5 hours. The reaction was quenched slowly with ice (~20 mL) 
and then diluted with brine (20 mL). The mixture was extracted with EtOAc (3 × 20 mL) and 
the combined extracts were washed with brine (20 mL). The organic solution was dried 
(Na2SO4), filtered and concentrated in vacuo to give the diphenylphosphane borane. This 
product was used without further purification by dissolving in a 37% aqueous solution of 
formaldehyde (15 mL) and THF (10 mL). KOH (2.40 g, 42.9 mmol) was added and the 
reaction was stirred for 2 hours. The mixture was concentrated in vacuo and the remaining 
aqueous solution was extracted with EtOAc (3 × 20 mL). The combined extracts were washed 
with brine (20 mL), dried (Na2SO4), filtered and concentrated. The residue was purified by 
flash column chromatography using silica gel (petroleum ether-ethyl acetate, 3:1) to yield 
alcohol 243 as a white solid (4.6 g, 100%). 
Rf = 0.46 (petroleum ether-ethyl acetate, 3:1); m.p. = 38–40 °C; νmax 3442, 3056, 2972, 2370, 
1587, 734, 703, 690 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.75–7.73 (4H, m, CH-Arom), 7.56–
7.54 (2H, m, CH-Arom), 7.51–7.47 (4H, m, CH-Arom), 4.46 (2H, d, J = 6.0 Hz, CH2-C5), 
2.23 (1H, br s, OH), 1.29–0.90 (3H, m, BH3); 
13
C NMR (100 MHz, CDCl3) δ 132.8 (d, 
3
JP-C = 
9.0 Hz, CH-C2), 131.8 (d, 
4
JP-C  = 2.6 Hz, CH-C1), 129.0 (d, 
2
JP-C = 9.8 Hz, CH-C3), 126.7 (d, 
1
JP-C = 55.0 Hz, C-C4), 60.4 (d, 
1
JP-C = 41.4 Hz, CH2-C5); HRMS (EI+) [M]
+
 calcd for 
C13H13OP 216.0704, found 216.0708 [Δ +1.8 ppm]; LRMS (EI+) m/z (intensity) 217.1 (13%), 
216.1 (100%). 
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Diphenylphosphino(borane)methyl methanesulfonate 244 
 
The alcohol 243 (1.10 g, 4.78 mmol) was dissolved in CH2Cl2 (10 mL) and TEA (1.40 mL, 
10.1 mmol) was added. The solution was cooled to 0 °C before dropwise addition of MsCl 
(580 μL, 7.46 mmol). The reaction was stirred continuously for 18 hours. Upon completion of 
the reaction, the resulting solution was concentrated in vacuo. The residue was purified by 
flash column chromatography (petroleum ether-diethyl ether, 1:1) to give mesylate 244 as a 
white solid (1.4 g, 95%). 
Rf = 0.15 (petroleum ether-ethyl acetate, 1:1); m.p. = 63–65 °C; νmax 3055, 2932, 2330, 1588, 
704, 689 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.80–7.75 (4H, m, CH-Arom), 7.64–7.59 (2H, 
m, CH-Arom), 7.57–7.52 (4H, m, CH-Arom), 4.94 (2H, d, J = 2.2 Hz, CH2-C5), 2.92 (3H, s, 
CH3-Ms), 1.60–0.67 (3H, m, BH3); 
13
C NMR (100 MHz, CDCl3) δ 132.9 (d, 
3
JP-C = 9.9 Hz, 
CH-C2), 132.3 (d, 
4
JP-C = 2.5 Hz, CH-C1), 129.2 (d, 
2
JP-C = 10.7 Hz, CH-C3), 125.1 (d, 
1
JP-C = 
56.9 Hz, C-C4), 64.5 (d, 
1
JP-C = 38.5 Hz, CH2-C5), 37.5 (CH3-Ms). 
 
Diphenylphosphino(borane)methanethiol acetate 245 
 
To a solution of mesylate 244 (150 mg, 0.487 mmol) in dry DMF (1 mL) was added thioacetic 
acid (52.0 μL, 0.731 mmol). The mixture was cooled to –20 °C before addition of Cs2CO3 
(317 mg, 0.975 mmol). The reaction was stirred for 3 days, allowing it to reach room 
temperature. The reaction mixture was then diluted with H2O (10 mL) and extracted with 
EtOAc (3 × 10 mL). The combined extracts were washed with brine (10 mL), dried (MgSO4), 
filtered and concentrated in vacuo. The residue was purified by flash column chromatography 
using silica gel (petroleum ether-ethyl acetate, 4:1) to give thioacetate 245 as a white solid 
(94 mg, 67%).  
Rf = 0.38 (petroleum ether-ethyl acetate, 4:1); m.p. = 52–54 °C; IR νmax 3061, 2960, 2388, 
1694, 1587, 702, 691 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.64–7.60 (4H, m, CH-Arom), 
7.46–7.43  (2H, m, CH-Arom), 7.40–7.36 (4H, m, CH-Arom), 3.64 (2H, d, J = 6.9 Hz, CH2-
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C5), 2.18 (3H, s, CH3-C7), 1.18–0.66 (3H, m, BH3); 
13
C NMR (100 MHz, CDCl3) δ 193.3 (d, 
3
JP-C = 2.8 Hz, C-C6), 132.5 (d, 
3
JP-C = 9.3 Hz, CH-C2), 131.8 (d, 
4
JP-C = 2.5 Hz, CH-C1), 
128.9 (d, 
2
JP-C = 10.1 Hz, CH-C3), 127.6 (d, 
1
JP-C = 55.3 Hz, C-C4), 30.1 (CH3-C7), 23.8 (d, 
1
JP-C = 35.7 Hz, CH2-C5). 
 
Diphenylphosphino(borane)methanethiol 246 
 
A solution of thioacetate 245 (200 mg, 0.694 mmol) in methanol (1.4 mL) was prepared and a 
solution of NaOH (56.0 mg, 1.40 mmol) dissolved in the minimum volume of methanol was 
added. The reaction was stirred for 3 hours before concentration in vacuo. The residue was 
redissolved in EtOAc (20 mL) and washed sequentially with saturated aqueous NH4Cl 
(20 mL), water (20 mL) and brine (20 mL). The solution was then dried (Na2SO4), filtered and 
concentrated. The residue was purified by flash column chromatography using silica gel 
(petroleum ether-ethyl acetate, 4:1) to give thiol 246 as a cloudy oil (119 mg, 70%). 
Rf = 0.39 (petroleum ether-ethyl acetate, 4:1); νmax 3055, 2918, 2379, 2244, 1588, 689, 648 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.65–7.61 (4H, m, CH-Arom), 7.48–7.45 (2H, m, CH-
Arom), 7.43–7.39 (4H, m, CH-Arom), 3.12 (2H, dd, J = 8.1, 6.1 Hz, CH2-C5), 1.82 (1H, td, J 
= 8.1, 6.8 Hz, SH), 1.22–0.67 (3H, m, BH3); 
13
C NMR (100 MHz, CDCl3) δ 132.5 (d, 
3
JP-C = 
7.1 Hz, CH-C2), 131.7 (d, 
4
JP-C = 1.5 Hz, CH-C1), 129.0 (d, 
2
JP-C = 7.9 Hz, CH-C3), 127.8 (d, 
1
JP-C = 44.0 Hz, C-C4), 19.7 (d, 
1
JP-C = 25.7 Hz, CH2-C5). 
 
2-(N-(6-Azido-5-hydroxyhex-2-ynyl)-4-methylphenylsulfonamido)acetic acid 247 
 
To a solution of tert-butyl ester 237 (20.0 mg, 0.0474 mmol) in CH2Cl2 (1 mL) was added 
TFA (1 mL). The reaction was stirred for 18 hours after which it was concentrated in vacuo. 
The residue was mixed with a small volume of toluene and concentrated again in vacuo. This 
last procedure was repeated twice more to remove traces of excess TFA. The sample was 
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further dried under high vacuum. This yielded carboxylic acid 247 as a clear oil (17 mg, 
100%). 
Rf = 0.10 (petroleum ether-ethyl acetate, 3:2); νmax 3063, 2924, 2102, 1728, 1597, 810, 656 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.66 (2H, d, J = 8.2 Hz, CH-C10), 7.26 (2H, d, J = 8.2 
Hz, CH-C11), 4.09 (2H, s, CH2-C3), 4.03 (2H, s, CH2-C2), 3.70 (1H, dtd J = 6.2, 5.7, 4.6 Hz, 
CH-C7), 3.20 (1H, dd, J = 13.0, 4.6 Hz, CH2-C8a), 3.16 (1H, dd, J = 13.0, 6.2 Hz, CH2-C8b), 
2.37 (3H, s, CH3-C13), 2.34 (1H, s, OH), 2.23 (2H, d, J = 5.7 Hz, CH2-C6); 
13
C NMR (100 
MHz, CDCl3) δ 173.0 (C-C1), 144.3 (C-Arom), 135.6 (C-Arom), 129.8 (CH-C11), 127.6 (CH-
C10), 82.1 (C-C5), 75.5 (C-C4), 69.0 (CH-C7), 55.1 (CH2-C8), 47.5 (CH2-C2), 38.3 (CH2-
C3), 24.5 (CH2-C6), 21.5 (CH3-C13); HRMS (CI, Me3CH) [M+H]
+
 calcd for C15H19N4O5S 
367.1076, found 367.1074 [Δ –0.6 ppm]; LRMS (CI, Me3CH) m/z (intensity) 368.1 (22%), 
367.1 (100%). 
 
13-Azido-12-hydroxy-5-oxo-2,2-diphenyl-7-tosyl-4-thia-7-aza-2-phosphonia-1-
boranuidatridec-9-yne, 243 
 
To a solution of azide 247 (8.00 mg, 0.0219 mmol) in CH2Cl2 (1 mL) was added thiol 246 
(5.00 mg, 0.0203 mmol). The solution was cooled to 0 °C and DCC (5.00 mg, 0.0243 mmol) 
was added. The reaction mixture was stirred for 18 hours, allowing it to reach room 
temperature, before concentrating in vacuo. The residue was redissolved in a mixture of ethyl 
acetate and petroleum ether (1:4, 10 mL). The resulting solution was filtered and concentrated 
in vacuo once again. The residue was purified by flash column chromatography using silica 
gel (petroleum ether-ethyl acetate, 3:2) to give thioether 248 as a clear oil (11 mg, 85%). 
Rf = 0.28 (petroleum ether-ethyl acetate, 3:2); νmax 3522, 3059, 2924, 2388, 2102, 1697, 814, 
748, 702, 664 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.62 (2H, d, J = 7.6 Hz, CH-C15), 7.62–
7.59 (4H, m, CH-Arom), 7.48–7.45 (2H, m, CH-Arom), 7.41–7.38 (4H, m, CH-Arom), 7.24 
(2H, d, J = 7.6 Hz, CH-C16), 3.99 (2H, s, CH2-C7), 3.94 (2H, t, J = 2.2 Hz, CH2-C8), 3.65–
3.60 (1H, m, CH-C12), 3.63 (2H, d, J = 6.9 Hz, CH2-C5), 3.17 (1H, dd, J = 12.5, 4.3 Hz, CH2-
C13a), 3.12 (1H, dd, J = 12.5, 6.4 Hz, CH2-C13b), 2.37 (3H, s, CH3-C18), 2.15 (2H, dt, J = 
6.1, 2.2 Hz, CH2-C11), 1.98–1.30 (3H, m, BH3); 
13
C NMR (100 MHz, CDCl3) δ 194.8 (C-C6), 
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144.5 (C-Arom), 135.1 (C-Arom), 132.5 (d, 
3
JP-C = 9.4 Hz, CH-C2), 131.9 (d, 
4
JP-C =  2.4 Hz, 
CH-C1), 129.8 (CH-C16), 129.0 (d, 
2
JP-C = 10.1 Hz, CH-C3), 127.9 (CH-C15), 127.5 (d, 
1
JP-C 
= 54.8, C-C4), 82.5 (C-C10), 75.1 (C-C9), 68.9 (CH-C12), 55.2 (CH2-C13), 54.9 (CH2-C7), 
38.6 (CH2-C8), 24.6 (CH2-C11), 23.3 (d, 
1
JP-C = 34.4 Hz, CH2-C5), 21.6 (CH3-C18). 
 
Cyclisation of Diphenylphosphine Borane Tethered Intermediate 
 
A solution of azide 248 (20.0 mg, 0.0336 mmol) in THF (3 mL) was prepared and heated to 
reflux. DABCO (19.0 mg, 0.169 mmol) was added to the solution and the reaction mixture 
was stirred at reflux for 2 days. The reaction showed no progression after this time and so wet 
THF (2 mL) was added to the mixture and it was heated for a further period of 2 days at 
reflux. The reaction mixture was allowed to cool to room temperature and concentrated in 
vacuo. Residual material was purified by flash column chromatography on silica gel 
(petroleum ether-ethyl acetate, 3:2) which resulted in the recovery of starting material only. 
 
List of References 
 194 
List of References 
 
(1) Chasse, G. A.; Rodriguez, A. M.; Mak, M. L.; Deretey, E.; Perczel, A.; Sosa, C. P.; 
Enriz, R. D.; Csizmadia, I. G. J. Mol. Struct. 2001, 537, 319 
(2) Harris, L. J.; Larson, S. B.; Hasel, K. W.; McPherson, A. Biochemistry 1997, 36, 1581 
(3) Kabsch, W.; Mannherz, H. G.; Suck, D.; Pai, E. F.; Holmes, K. C. Nature 1990, 347, 
37 
(4) Hühne, R. K., F. T.; Sühnel, J. Brief. Funct. Genomic Proteomic 2007, 6, 220 
(5) The Figure was created using the Jmol-based Jena3D Viewer (http://jena3d.fli-
leibniz.de) 
(6) Volk, M. Eur. J. Org. Chem. 2001, 2605 
(7) Anfinsen, C. B. Science 1973, 181, 223 
(8) Johnson, L. N.; Phillips, D. C. Nature 1965, 206, 761 
(9) Blake, C. C. F.; Koenig, D. F.; Mair, G. A.; North, A. C. T.; Phillips, D. C.; Sarma, V. 
R. Nature 1965, 206, 757 
(10) Dobson, C. M.; Sali, A.; Karplus, M. Angew. Chem. Int. Ed. 1998, 37, 868 
(11) This image has been reproduced with the permission of John Wiley and Sons 
Publishers 
(12) Dobson, C. M. Nature 2003, 426, 884 
(13) This image has been reproduced with the permission of the American Association for 
the Advancement of Science 
(14) Fermi, G.; Perutz, M. F.; Shaanan, B.; Fourme, R. J. Mol. Biol. 1984, 175, 159 
(15) Levintha.C J. Chim. Phys. Pcb. 1968, 65, 44 
(16) Kaul, R.; Balaram, P. Bioorg. Med. Chem. 1999, 7, 105 
(17) Bowie, J. U. Curr. Opin. Struct. Biol. 2011, 21, 42 
(18) Phillips, S. E. V. J. Mol. Biol. 1980, 142, 531 
(19) Pauling, L.; Corey, R. B.; Branson, H. R. Proc. Natl. Acad. Sci. USA 1951, 37, 205 
(20) Kendrew, J. C.; Bodo, G.; Dintzis, H. M.; Parrish, R. G.; Wyckoff, H.; Phillips, D. C. 
Nature 1958, 181, 662 
(21) Marcelino, A. M. C.; Gierasch, L. M. Biopolymers 2008, 89, 380 
(22) Sibanda, B. L.; Blundell, T. L.; Thornton, J. M. J. Mol. Biol. 1989, 206, 759 
(23) Tyndall, J. D. A.; Pfeiffer, B.; Abbenante, G.; Fairlie, D. P. Chem. Rev. 2005, 105, 793 
List of References 
 195 
(24) Reprinted (adapted) with permission from Chem. Rev. 2005, 105, 793-826. Copyright 
2005 American Chemical Society 
(25) Venkatac.Cm Biopolymers 1968, 6, 1425 
(26) Hutchinson, E. G.; Thornton, J. M. Protein Sci. 1994, 3, 2207 
(27) Gibbs, A. C.; Bjorndahl, T. C.; Hodges, R. S.; Wishart, D. S. J. Am. Chem. Soc. 2002, 
124, 1203 
(28) Ball, J. B. J. Mol. Recogn. 1990, 3, 55 
(29) Lewis, P. N.; Momany, F. A.; Scheraga, H. A. Biochim. Biophys. Acta 1973, 303, 211 
(30) Waldhoer, M.; Bartlett, S. E.; Whistler, J. L. Annu. Rev. Biochem. 2004, 73, 953 
(31) Lord, J. A. H.; Waterfield, A. A.; Hughes, J.; Kosterlitz, H. W. Nature 1977, 267, 495 
(32) Corbett, A. D.; Henderson, G.; McKnight, A. T.; Paterson, S. J. Brit. J. Pharmacol. 
2006, 147, S153 
(33) Whitby, L. R.; Ando, Y.; Setola, V.; Vogt, P. K.; Roth, B. L.; Boger, D. L. J. Am. 
Chem. Soc. 2011, 133, 10184 
(34) Amodeo, P.; Naider, F.; Picone, D.; Tancred, T.; Temussi, P. A. J. Pept. Sci. 1998, 4, 
253 
(35) Hughes, J.; Smith, T. W.; Kosterlitz, H. W.; Fothergill, L. A.; Morgan, B. A.; Morris, 
H. R. Nature 1975, 258, 577 
(36) Aubry, A.; Birlirakis, N.; Sakarellosdaitsiotis, M.; Sakarellos, C.; Marraud, M. 
Biopolymers 1989, 28, 27 
(37) Smith, G. D.; Griffin, J. F. Science 1978, 199, 1214 
(38) Malicka, J.; Groth, M.; Czaplewski, C.; Wiczk, W.; Liwo, A. Biopolymers 2002, 63, 
217 
(39) Goodman, M.; Zapf, C.; Rew, Y. Biopolymers 2001, 60, 229 
(40) Rew, Y.; Malkmus, S.; Svensson, C.; Yaksh, T. L.; Chung, N. N.; Schiller, P. W.; 
Cassel, J. A.; DeHaven, R. N.; Goodman, M. J. Med. Chem. 2002, 45, 3746 
(41) Gosselin, F.; Tourwe, D.; Ceusters, M.; Meert, T.; Heylen, L.; Jurzak, M.; Lubell, W. 
D. J. Pept. Res. 2001, 57, 337 
(42) Lomize, A. L.; Flippenanderson, J. L.; George, C.; Mosberg, H. I. J. Am. Chem. Soc. 
1994, 116, 429 
(43) Xiong, C. Y.; Zhang, J. Y.; Davis, P.; Wang, W.; Ying, J. F.; Porreca, F.; Hruby, V. J. 
Chem. Commun. 2003, 1598 
(44) Rew, Y.; Goodman, M. J. Org. Chem. 2002, 67, 8820 
List of References 
 196 
(45) Qabar, M.; Urban, J.; Sia, C.; Klein, M.; Kahn, M. Lett. Pept. Sci. 1996, 3, 25 
(46) Hanessian, S.; Auzzas, L. Acc. Chem. Res. 2008, 41, 1241 
(47) Eichler, J. Curr. Opin. Chem. Biol. 2008, 12, 707 
(48) Burgess, K. Acc. Chem. Res. 2001, 34, 826 
(49) Klabunde, T.; Hessler, G. ChemBioChem 2002, 3, 929 
(50) De Wachter, R.; Brans, L.; Ballet, S.; Van den Eynde, I.; Feytens, D.; Keresztes, A.; 
Toth, G.; Urbanczyk-Lipkowska, Z.; Tourwe, D. Tetrahedron 2009, 65, 2266 
(51) Robinson, J. A. Acc. Chem. Res. 2008, 41, 1278 
(52) Farmer, P. S.; Ariens, E. J. Trends Pharmacol. Sci. 1982, 3, 362 
(53) Hirschmann, R. F.; Nicolaou, K. C.; Angeles, A. R.; Chen, J. S.; Smith, A. B. Acc. 
Chem. Res. 2009, 42, 1511 
(54) Belanger, P. C.; Dufresne, C. Can. J. Chem. 1986, 64, 1514 
(55) Olson, G. L.; Cheung, H. C.; Chiang, E.; Madison, V. S.; Sepinwall, J.; Vincent, G. P.; 
Winokur, A.; Gary, K. A. J. Med. Chem. 1995, 38, 2866 
(56) Eguchi, M.; Shen, R. Y. W.; Shea, J. P.; Lee, M. S.; Kahn, M. J. Med. Chem. 2002, 45, 
1395 
(57) Reprinted (adapted) with permission from J. Med. Chem. 2002, 45, 1395-1398. 
Copyright 2002 American Chemical Society 
(58) Blomberg, D.; Hedenstrom, M.; Kreye, P.; Sethson, I.; Brickmann, K.; Kihlberg, J. J. 
Org. Chem. 2004, 69, 3500 
(59) Blomberg, D.; Kreye, P.; Fowler, C.; Brickmann, K.; Kihlberg, J. Org. Biomol. Chem. 
2006, 4, 416 
(60) Roubini, E.; Laufer, R.; Gilon, C.; Selinger, Z.; Roques, B. P.; Chorev, M. J. Med. 
Chem. 1991, 34, 2430 
(61) Hruby, V. J.; Li, G. G.; HaskellLuevano, C.; Shenderovich, M. Biopolymers 1997, 43, 
219 
(62) Ndungu, J. M.; Gu, X. Y.; Gross, D. E.; Cain, J. P.; Carducci, M. D.; Hruby, V. J. 
Tetrahedron Lett. 2004, 45, 4139 
(63) Vagner, J.; Qu, H. C.; Hruby, V. J. Curr. Opin. Chem. Biol. 2008, 12, 292 
(64) Gu, X. Y.; Ying, J. F.; Min, B.; Cain, J. P.; Davis, P.; Willey, P.; Navratilova, E.; 
Yamamura, H. I.; Porreca, F.; Hruby, V. J. Biopolymers 2005, 80, 151 
(65) Gu, X. Y.; Cowell, S.; Ying, J. F.; Tang, X. J.; Hruby, V. J. Tetrahedron Lett. 2003, 
44, 5863 
List of References 
 197 
(66) Gu, X. Y.; Ndungu, J. A.; Qiu, W.; Ying, J. F.; Carducci, M. D.; Wooden, H.; Hruby, 
V. J. Tetrahedron 2004, 60, 8233 
(67) Gu, X. Y.; Ying, J. F.; Agnes, R. S.; Navratilova, E.; Davis, P.; Stahl, G.; Porreca, F.; 
Yamamura, H. I.; Hruby, V. J. Org. Lett. 2004, 6, 3285 
(68) Kanoh, K.; Kohno, S.; Katada, J.; Takahashi, J.; Uno, I.; Hayashi, Y. Bioorg. Med. 
Chem. 1999, 7, 1451 
(69) Clark, B.; Capon, R. J.; Lacey, E.; Tennant, S.; Gill, J. H. J. Nat. Prod. 2005, 68, 1661 
(70) Prakash, K. R. C.; Tang, Y.; Kozikowski, A. P.; Flippen-Anderson, J. L.; Knoblach, S. 
M.; Faden, A. I. Bioorg. Med. Chem. 2002, 10, 3043 
(71) Wyatt, P. G.; Allen, M. J.; Borthwick, A. D.; Davies, D. E.; Exall, A. M.; Hatley, R. J. 
D.; Irving, W. R.; Livermore, D. G.; Miller, N. D.; Nerozzi, F.; Sollis, S. L.; Szardenings, A. 
K. Bioorg. Med. Chem. Lett. 2005, 15, 2579 
(72) Boger, D. L.; Fink, B. E.; Hedrick, M. P. Bioorg. Med. Chem. Lett. 2000, 10, 1019 
(73) Golebiowski, A.; Jozwik, J.; Klopfenstein, S. R.; Colson, A. O.; Grieb, A. L.; Russell, 
A. F.; Rastogi, V. L.; Diven, C. F.; Portlock, D. E.; Chen, J. J. J. Comb. Chem. 2002, 4, 584 
(74) Golebiowski, A.; Klopfenstein, S. R.; Chen, J. J.; Shao, X. Tetrahedron Lett. 2000, 41, 
4841 
(75) Golebiowski, A.; Klopfenstein, S. R.; Shao, X.; Chen, J. J.; Colson, A. O.; Grieb, A. 
L.; Russell, A. F. Org. Lett. 2000, 2, 2615 
(76) Mieczkowski, A.; Kozminski, W.; Jurczak, J. Synthesis 2010, 221 
(77) Reprinted (adapted) with permission from Org. Lett. 2000, 2, 2615-2617. Copyright 
2000 American Chemical Society 
(78) Fustero, S.; Mateu, N.; Albert, L.; Acena, J. L. J. Org. Chem. 2009, 74, 4429 
(79) Harwood, L. M.; Vines, K. J.; Drew, M. G. B. Synlett 1996, 1051 
(80) Shaginian, A.; Whitby, L. R.; Hong, S.; Hwang, I.; Farooqi, B.; Searcey, M.; Chen, J. 
C.; Vogt, P. K.; Boger, D. L. J. Am. Chem. Soc. 2009, 131, 5564 
(81) Padwa, A.; Dent, W. Org. Synth. 1989, 67, 133 
(82) Matsuura, F.; Hamada, Y.; Shioiri, T. Tetrahedron 1994, 50, 265 
(83) Pinsker, A.; Einsiedel, J.; Harterich, S.; Waibel, R.; Gmeiner, P. Org. Lett. 2011, 13, 
3502 
(84) Martinez, L.; Sampedro, A.; Sanna, E.; Costa, A.; Rotger, C. Org. Biomol. Chem. 
2012, 10, 1914 
List of References 
 198 
(85) Zificsak, C. A.; Mulder, J. A.; Hsung, R. P.; Rameshkumar, C.; Wei, L. L. Tetrahedron 
2001, 57, 7575 
(86) Bode, J. Liebigs Ann. Chem. 1892, 267, 268 
(87) Zaugg, H. E.; Swett, L. R.; Stone, G. R. J. Org. Chem. 1958, 23, 1389 
(88) Wolf, V.; Kowitz, F. Liebigs Ann. Chem. 1960, 638, 33 
(89) Viehe, H. G. Angew. Chem. Int. Ed. 1963, 75, 638 
(90) Katritzky, A. R.; Jiang, R.; Singh, S. K. Heterocycles 2004, 63, 1455 
(91) Ishihara, T.; Mantani, T.; Konno, T.; Yamanaka, H. Tetrahedron 2006, 62, 3783 
(92) Murch, P.; Williamson, B. L.; Stang, P. J. Synthesis 1994, 1255 
(93) DeKorver, K. A.; Li, H. Y.; Lohse, A. G.; Hayashi, R.; Lu, Z. J.; Zhang, Y.; Hsung, R. 
P. Chem. Rev. 2010, 110, 5064 
(94) Janousek, Z.; Viehe, H. G.; Collard, J. Angew. Chem. Int. Ed. 1972, 11, 917 
(95) Galy, J. P.; Elguero, J.; Vincent, E. J.; Galy, A. M.; Barbe, J. Synthesis 1979, 944 
(96) Mahamoud, A.; Galy, J. P.; Vincent, E. J.; Barbe, J. Synthesis 1981, 917 
(97) Katritzky, A. R.; Ramer, W. H. J. Org. Chem. 1985, 50, 852 
(98) Wei, L. L.; Mulder, J. A.; Xiong, H.; Zificsak, C. A.; Douglas, C. J.; Hsung, R. P. 
Tetrahedron 2001, 57, 459 
(99) Huang, J.; Xiong, H.; Hsung, R. P.; Rameshkumar, C.; Mulder, J. A.; Grebe, T. P. Org. 
Lett. 2002, 4, 2417 
(100) Saito, N.; Sato, Y.; Mori, M. Org. Lett. 2002, 4, 803 
(101) Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953 
(102) Bruckner, D. Synlett 2000, 1402 
(103) Rodriguez, D.; Castedo, L.; Saa, C. Synlett 2004, 783 
(104) Tracey, M. R.; Zhang, Y. S.; Frederick, M. O.; Mulder, J. A.; Hsung, R. P. Org. Lett. 
2004, 6, 2209 
(105) Rodriguez, D.; Martinez-Esperon, M. F.; Castedo, L.; Saa, C. Synlett 2007, 1963 
(106) Zhdankin, V. V.; Stang, P. J. Tetrahedron 1998, 54, 10927 
(107) Feldman, K. S.; Bruendl, M. M.; Schildknegt, K.; Bohnstedt, A. C. J. Org. Chem. 
1996, 61, 5440 
(108) Witulski, B.; Stengel, T. Angew. Chem. Int. Ed. 1998, 37, 489 
(109) Evano, G.; Coste, A.; Jouvin, K. Angew. Chem. Int. Ed. 2010, 49, 2840 
(110) Balsamo, A.; Macchia, B.; Macchia, F.; Rossello, A.; Domiano, P. Tetrahedron Lett. 
1985, 26, 4141 
List of References 
 199 
(111) Frederick, M. O.; Mulder, J. A.; Tracey, M. R.; Hsung, R. P.; Huang, J.; Kurtz, K. C. 
M.; Shen, L. C.; Douglas, C. J. J. Am. Chem. Soc. 2003, 125, 2368 
(112) Hartwig, J. F. Angew. Chem. Int. Ed. 1998, 37, 2047 
(113) Wolfe, J. P.; Wagaw, S.; Marcoux, J. F.; Buchwald, S. L. Acc. Chem. Res. 1998, 31, 
805 
(114) Kwong, F. Y.; Klapars, A.; Buchwald, S. L. Org. Lett. 2002, 4, 581 
(115) Mulder, J. A.; Kurtz, K. C. M.; Hsung, R. P. Synlett 2003, 1379 
(116) Shen, R. C.; Porco, J. A. Org. Lett. 2000, 2, 1333 
(117) Yamada, K.; Kubo, T.; Tokuyama, H.; Fukuyama, T. Synlett 2002, 231 
(118) Zhang, Y. S.; Hsung, R. P.; Tracey, M. R.; Kurtz, K. C. M.; Vera, E. L. Org. Lett. 
2004, 6, 1151 
(119) Zhang, X. J.; Zhang, Y. S.; Huang, J.; Hsung, R. P.; Kurtz, K. C. M.; Oppenheimer, J.; 
Petersen, M. E.; Sagamanova, I. K.; Shen, L. C.; Tracey, M. R. J. Org. Chem. 2006, 71, 4170 
(120) Coste, A.; Couty, F.; Evano, G. Org. Lett. 2009, 11, 4454 
(121) Hamada, T.; Ye, X.; Stahl, S. S. J. Am. Chem. Soc. 2008, 130, 833 
(122) Yao, B. B.; Liang, Z. J.; Niu, T. M.; Zhang, Y. H. J. Org. Chem. 2009, 74, 4630 
(123) Jouvin, K.; Couty, F.; Evano, G. Org. Lett. 2010, 12, 3272 
(124) Jia, W.; Jiao, N. Org. Lett. 2010, 12, 2000 
(125) de Parrodi, C. A.; Walsh, P. J. Angew. Chem. Int. Ed. 2009, 48, 4679 
(126) Kohnen, A. L.; Mak, X. Y.; Lam, T. Y.; Dunetz, J. R.; Danheiser, R. L. Tetrahedron 
2006, 62, 3815 
(127) Dunetz, J. R.; Danheiser, R. L. J. Am. Chem. Soc. 2005, 127, 5776 
(128) Riddell, N.; Villeneuve, K.; Tam, W. Org. Lett. 2005, 7, 3681 
(129) Mori, M.; Wakamatsu, H.; Saito, N.; Sato, Y.; Narita, R.; Sato, Y.; Fujita, R. 
Tetrahedron 2006, 62, 3872 
(130) Couty, S.; Meyer, C.; Cossy, J. Tetrahedron 2009, 65, 1809 
(131) Robinson, J. A. Curr. Opin. Chem. Biol. 2011, 15, 379 
(132) Grauer, A.; Konig, B. Eur. J. Org. Chem. 2009, 5099 
(133) Rizo, J.; Gierasch, L. M. Annu. Rev. Biochem. 1992, 61, 387 
(134) Leung, D.; Abbenante, G.; Fairlie, D. P. J. Med. Chem. 2000, 43, 305 
(135) Babine, R. E.; Bender, S. L. Chem. Rev. 1997, 97, 1359 
(136) Liu, J.; Brahimi, F.; Saragovi, H. U.; Burgess, K. J. Med. Chem. 2010, 53, 5044 
List of References 
 200 
(137) Koivisto, J. J.; Kumpulainen, E. T. T.; Koskinen, A. M. P. Org. Biomol. Chem. 2010, 
8, 2103 
(138) Qiu, W.; Gu, X. Y.; Soloshonok, V. A.; Carducci, M. D.; Hruby, V. J. Tetrahedron 
Lett. 2001, 42, 145 
(139) Galeazzi, R.; Martelli, G.; Marcucci, E.; Orena, M.; Rinaldi, S.; Lattanzi, R.; Negri, L. 
Amino Acids 2010, 38, 1057 
(140) Maricic, S.; Berg, U.; Frejd, T. Tetrahedron 2002, 58, 3085 
(141) Liskamp, R. M. J.; Rijkers, D. T. S.; Kruijtzer, J. A. W.; Kemmink, J. ChemBioChem 
2011, 12, 1626 
(142) El-Faham, A.; Albericio, F. Chem. Rev. 2011, 111, 6557 
(143) Allen, C. L.; Williams, J. M. J. Chem. Soc. Rev. 2011, 40, 3405 
(144) Valeur, E.; Bradley, M. Chem. Soc. Rev. 2009, 38, 606 
(145) Han, S. Y.; Kim, Y. A. Tetrahedron 2004, 60, 2447 
(146) Chen, H. L.; Feng, Y. Q.; Xu, Z. S.; Xu, Z. S.; Ye, T. Tetrahedron 2005, 61, 11132 
(147) Sauve, G.; Rao, V. S.; Lajoie, G.; Belleau, B. Can. J. Chem. 1985, 63, 3089 
(148) Siebum, A. H. G.; Woo, W. S.; Lugtenburg, J. Eur. J. Org. Chem. 2003, 4664 
(149) Sorg, A.; Siegel, K.; Bruckner, R. Chem. Eur. J. 2005, 11, 1610 
(150) Jeong, N.; Kim, D. H.; Choi, J. H. Chem. Commun. 2004, 1134 
(151) Patel, M. C. L., T.; Pagenkopf, B. L. Org. Synth. 2003, 80, 93 
(152) Buchwald, S. L.; Bolm, C. Angew. Chem. Int. Ed. 2009, 48, 5586 
(153) Dunetz, J. R.; Danheiser, R. L. Org. Lett. 2003, 5, 4011 
(154) Kohnen, A. L. D., J. R.; Danheiser, R. L. Org. Synth. 2007, 84, 88 
(155) Coste, A.; Karthikeyan, G.; Couty, F.; Evano, G. Angew. Chem. Int. Ed. 2009, 48, 
4381 
(156) Gibtner, T.; Hampel, F.; Gisselbrecht, J. P.; Hirsch, A. Chem. Eur. J. 2002, 8, 408 
(157) Corey, E. J.; Fuchs, P. L. Tetrahedron Lett. 1972, 3769 
(158) Istrate, F. M.; Buzas, A. K.; Jurberg, I. D.; Odabachian, Y.; Gagosz, F. Org. Lett. 2008, 
10, 925 
(159) Simpson, G. L.; Gordon, A. H.; Lindsay, D. M.; Promsawan, N.; Crump, M. P.; 
Mulholland, K.; Hayter, B. R.; Gallagher, T. J. Am. Chem. Soc. 2006, 128, 10638 
(160) Chakraborti, A. K.; Basak, A.; Grover, V. J. Org. Chem. 1999, 64, 8014 
(161) Dooleweerdt, K.; Birkedal, H.; Ruhland, T.; Skrydstrup, T. J. Org. Chem. 2008, 73, 
9447 
List of References 
 201 
(162) Sasaki, T.; Minamoto, K.; Itoh, H. J. Org. Chem. 1978, 43, 2320 
(163) Trost, B. M.; Stiles, D. T. Org. Lett. 2005, 7, 2117 
(164) Bennani, Y. L.; Hanessian, S. Tetrahedron 1996, 52, 13837 
(165) Allred, G. D.; Liebeskind, L. S. J. Am. Chem. Soc. 1996, 118, 2748 
(166) Fatas, P.; Jimenez, A. I.; Calaza, M. I.; Cativiela, C. Org. Biomol. Chem. 2012, 10, 640 
(167) Guruprasad, K.; Rajkumar, S. J. Bioscience. 2000, 25, 143 
(168) IJsselstijn, M.; Aguilera, B.; van der Marel, G. A.; van Boom, J. H.; van Delft, F. L.; 
Schoemaker, H. E.; Overkleeft, H. S.; Rutjes, F. P. J. T.; Overhand, M. Tetrahedron Lett. 
2004, 45, 4379 
(169) Ghalit, N.; Poot, A. J.; Furstner, A.; Rijkers, D. T. S.; Liskamp, R. M. J. Org. Lett. 
2005, 7, 2961 
(170) Huang, W.; Shen, Q. S.; Wang, J. L.; Zhou, X. G. J. Org. Chem. 2008, 73, 1586 
(171) Khan, M. N. J. Org. Chem. 1995, 60, 4536 
(172) Macor, J. E.; Chenard, B. L.; Post, R. J. J. Org. Chem. 1994, 59, 7496 
(173) Bruekelman, S. P.; Leach, S. E.; Meakins, G. D.; Tirel, M. D. J. Chem. Soc. Perkin 
Trans. 1 1984, 2801 
(174) Yamada, W.; Kitaichi, Y.; Tanaka, H.; Kojima, T.; Sato, M.; Ikeno, T.; Yamada, T. 
Bull. Chem. Soc. Jpn. 2007, 80, 1391 
(175) Evans, A. B.; Knight, D. W. Tetrahedron Lett. 2001, 42, 6947 
(176) Hoarau, C.; Couture, A.; Deniau, E.; Grandclaudon, P. Eur. J. Org. Chem. 2001, 2559 
(177) Yang, B. V.; Orourke, D.; Li, J. C. Synlett 1993, 195 
(178) Kashima, C.; Maruyama, T.; Fujioka, Y.; Harada, K. J. Chem. Soc. Perkin Trans. 1 
1989, 1041 
(179) Butler, S. J.; Jolliffe, K. A. Org. Biomol. Chem. 2011, 9, 3471 
(180) Ajamian, A.; Gleason, J. L. Org. Lett. 2001, 3, 4161 
(181) David, O.; Meester, W. J. N.; Bieraugel, H.; Schoemaker, H. E.; Hiemstra, H.; van 
Maarseveen, J. H. Angew. Chem. Int. Ed. 2003, 42, 4373 
(182) Soellner, M. B.; Nilsson, B. L.; Raines, R. T. J. Org. Chem. 2002, 67, 4993 
(183) He, Y.; Hinklin, R. J.; Chang, J. Y.; Kiessling, L. L. Org. Lett. 2004, 6, 4479 
(184) Avogadro: an open-source molecular builder and visualization tool. Version 1.1.0. 
http://avogadro.openmolecules.net/ 
(185) Hanwell, M. D.; Curtis, D. E.; Lonie, D. C.; Vandermeersch, T.; Zurek, E.; Hutchison, 
G. R. J. Cheminf. 2012, 4, 17 
List of References 
 202 
(186)  D'Arrigo, P.; Saraceno, C.; Servi, S.; Tessaro, D.; Kanerva, L. T.; Li, X-G. 
Tetrahedron-Asymmetr. 2009, 20, 1641 
(187)  Perez-Picaso, L.; Escalante, J.; Rios, M. Y.; Horacio, F. Molecules 2009, 14, 2836 
(188) Masquelin, T.; Obrecht, D. Synthesis 1995, 276 
(189) Janey, J. M.; Iwama, T.; Kozmin, S. A.; Rawal, V. H. J. Org. Chem. 2000, 65, 9059 
(190) Shaye, N. A.; Chavda, S.; Coulbeck, E.; Eames, J.; Yohannes, Y. Tetrahedron-
Asymmetr. 2011, 22, 439 
(191) Pannemanm H, J.; Marx, A. F.; Arens, J. F. Recl. Trav. Chim. Pay-B. 1959, 78, 487 
(192) Huy, P.; Neudoerfl, J-M.; Schmalz, H-G. Org. Lett. 2011, 13, 216 
(193) Wozniak, D.; Szymanska, A.; Oldziej, S.; Lankiewicz, L.; Grzonka, Z. Pol. J. Chem. 
2006, 80, 265 
(194) Hartrodt, B.; Neubert, K.; Matthies, H.; Rekowski, P.; Kupryszewski, G.; Barth, A. 
Pharmazie 1985, 40, 201 
(195) Tantry, S. J.; Ananda, K.; Suresh, B.; Indian J. Chem. B. 2002, 41, 1028 
(196) Pace, V.; Holzer, W; Hoyos, P.; Sinisterra, J. V.; Alcantara, A. R. Synlett 2011, 13, 
1831 
 
Appendices 
 203 
Appendices 
 
 
 
 
 
 
 
8
.
0
7
.
5
7
.
0
6
.
5
6
.
0
5
.
5
5
.
0
4
.
5
4
.
0
3
.
5
3
.
0
2
.
5
2
.
0
1
.
5
1
.
0
0
.
5
p
p
m
3.000
2.145
2.948
1.859
2.271
2.109
1.012
0.954
1.141
2.038
5.036
2.101
2.064
O
MeO
H
N
Ph
O
N
H
O
N
Ts
Br
Appendices 
 204 
2
0
0
1
8
0
1
6
0
1
4
0
1
2
0
1
0
0
8
0
6
0
4
0
2
0
0
p
p
m
21.643
37.743
40.190
42.774
50.440
52.426
53.322
72.028
77.586
127.167
128.070
128.626
129.279
129.879
133.704
135.715
144.848
167.931
168.040
171.586
O
MeO
H
N
Ph
O
N
H
O
N
Ts
Br
Appendices 
 205 
 
8
.
0
7
.
5
7
.
0
6
.
5
6
.
0
5
.
5
5
.
0
4
.
5
4
.
0
3
.
5
3
.
0
2
.
5
2
.
0
1
.
5
1
.
0
0
.
5
p
p
m
1.082
1.003
1.046
0.943
2.921
1.072
4.024
3.957
2.041
1.006
1.134
1.987
2.000
O
MeO
H
N
O
N
O
N
Ts
Br
Appendices 
 206 
 
 
1
8
0
1
7
0
1
6
0
1
5
0
1
4
0
1
3
0
1
2
0
1
1
0
1
0
0
9
0
8
0
7
0
6
0
5
0
4
0
3
0
2
0
1
0
p
p
m
21.615
25.069
27.455
38.863
41.197
45.592
47.160
48.610
52.285
60.187
72.887
127.811
129.699
135.137
144.141
167.222
170.080
171.085
O
MeO
H
N
O
N
O
N
Ts
Br
Appendices 
 207 
 
8
.
0
7
.
5
7
.
0
6
.
5
6
.
0
5
.
5
5
.
0
4
.
5
4
.
0
3
.
5
3
.
0
2
.
5
2
.
0
1
.
5
1
.
0
0
.
5
p
p
m
8.940
3.158
2.049
3.058
1.033
0.981
1.020
2.032
1.955
1.990
2.000
O
t-BuO
N
Ts
OH
NH2
Appendices 
 208 
 
1
7
0
1
6
0
1
5
0
1
4
0
1
3
0
1
2
0
1
1
0
1
0
0
9
0
8
0
7
0
6
0
5
0
4
0
3
0
2
0
1
0
p
p
m
21.547
24.815
27.982
37.865
46.056
47.712
69.889
75.165
82.358
82.474
127.599
129.548
136.324
143.651
167.609
O
t-BuO
N
Ts
OH
NH2
